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Abstract 
Brown adipose tissue (BAT) dissipates energy, whereas white adipose tissue (WAT) is an 
energy storage site. The worldwide increase in obesity and its associated metabolic 
complications represents a growing challenge for health care systems. With the recent 
demonstration of significant deposits of adult human BAT, and that WAT is dynamic and can 
gain BAT characteristics, there is therefore a possibility for manipulative control of energy 
homeostasis via the induction of specific genes to enhance BAT levels. Nrg4 and Gpr120 are 
two genes we identified to be highly expressed in BAT and regulated in a temperature-
dependent manner. Nrg4 is a member of the Neuregulin family that activates the ErbB-4 
(HER4) tyrosine kinase receptor. Nrg4 was secreted from brown adipocytes and promoted 
neurite outgrowth, a function that may improve BAT thermogenesis by enhancing 
sympathetic innervation.  
Gpr120 is a member of the superfamily of G protein-coupled receptors that is activated by 
long chain fatty acids. Although Gpr120 is known to mediate anti-inflammatory and insulin-
sensitizing effects in humans and mice, its role in BAT is unknown. In order to identify the 
signalling pathways and downstream functions activated by this receptor in brown 
adipocytes, distinct known and novel Gpr120 ligands, GW9508, TUG891 and TUG1096, 
were employed. These ligands increased expression of genes associated with glucose and 
fatty acid metabolism and reduced inflammatory gene markers. All of these effects were 
reversed in Gpr120 knockout cells. However, the levels of gene expression varied 
considerably with each ligand.  
Although Gpr120 is a known Gαq/11-coupled receptor in other cell systems, these distinct 
ligands exhibited various degrees of bias towards Gαq/11 and distinct signalling pathways. 
These findings could provide insight into the requirements for Gpr120 function in BAT, the 
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exploitation of which could generate ligands for therapeutic benefit and represents a 
promising opportunity to develop safer and more efficacious drugs. 
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Introduction 
1.1 Adipose tissue and adipocytes 
Adipose tissue or fatty tissue is the major site of energy storage in the form of 
triacylglycerols. In adult mammals, the major bulk of adipose tissue is a loose connective 
tissue of lipid-filled cells called adipocytes, which are held in a framework of collagen fibres. 
It is the biggest endocrine organ in humans, comprising up to 20% of body weight in healthy 
individuals (Cinti, 2005). It exerts a profound influence on whole body homeostasis, and 
plays a vital role in the regulation of energy balance. Energy homeostasis is crucial since 
excess fat storage leads to obesity, obesity-associated vasculopathy and cardiovascular risks 
(Berg and Scherer, 2005). Adipose tissue is found in two forms: white adipose tissue (WAT) 
and brown adipose tissue (BAT) (Cannon and Nedergaard, 2004), both of which are 
innervated by the sympathetic nervous system (Collins et al., 2010; Germack et al., 2000).  
 
1.1.2 White adipose tissue (WAT) 
Histologically, white adipocytes are spherical with a single large lipid droplet surrounded by 
a thin layer of cytoplasm containing the nucleus, and few mitochondria. The WAT depots can 
be classified into three main groups: subcutaneous, visceral and intramuscular (Gesta et al., 
2007). Adipocyte size varies in relation to the cell lipid content, ranging from about 30–
130 μm in diameter. The volume of an adipocyte is a determinant of the cell's functionality, 
with larger adipocytes generally exhibiting higher metabolic activity and secreting more 
chemoattractants for immune cells (Skurk et al., 2007). White adipose tissue is a major 
secretory and endocrine organ involved in a range of functions beyond simple fat storage. 
These functions include secretion of cell-signalling molecules (adipokines), cytokines such as 
TNFα, Plasminogen activator inhibitor 1 (PAI-1), IL-6, (Pond, 2005), and hormones such as 
leptin, adiponectin, oestradiol, and resistin (Trayhurn, 2007). It is innervated mainly by the 
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sympathetic nervous system (SNS) with nerve fibres accompanying arteries and arterioles 
(Bartness and Song, 2007). However, the use of anterograde tracing technique in Siberian 
hamster revealed the existence of sensory nerve fibres originating in inguinal WAT (Song et 
al., 2009), which provide the brain information on the lipolytic activity of the adipose tissue 
depots, and by affecting SNS output may provide negative feedback control of lipid 
mobilization (Bartness et al., 2010a).  
               
1.1.3 Brown adipose tissue (BAT) 
BAT differs considerably from WAT in morphology and function (Table 1.1). Histologically, 
brown adipocytes are much smaller than the white adipocytes. They contain multiple small 
lipid droplets dispersed throughout the cytosol, with the nuclei being centrally located. They 
are equipped with numerous mitochondria. The major function of BAT is to transfer energy 
from food into heat. This heat production and the recruitment process in the tissue are under 
sympathetic control (Cannon and Nedergaard, 2004). BAT is characterized by the expression 
of a discrete set of genes which include Cell death-inducing DFFA (DNA fragmentation 
factor-alpha)-like effector A (CIDEA) (Hallberg et al., 2008; Zhou et al., 2003) and 
peroxisome proliferator-activated receptor co activator 1α (PGC-1α) (Finck and Kelly, 2007). 
The major BAT depots in rodents are in the interscapular region (interscapular, axillary and 
cervical pads) embedded in and around deep back muscles. Following cold exposure, the 
induction of Uncoupling Protein 1 (UCP1) in BAT mediates a ‘proton’ leak thereby 
uncoupling oxidative phosphorylation from ATP generation to produce heat (Cannon and 
Nedergaard, 2004). Expression of Ucp1 is highly regulated by the SNS, through the 
activation of β3-adrenergicrReceptor (β3-AR) (Klaus et al., 1994). All adipocytes express β3-
AR (Robidoux et al., 2004), and are involved in the epinephrine and the norepinephrine-
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induced activation of adenylyl cyclase via receptor coupling to Gαs protein, which acutely 
regulates adipose triglyceride lipase in BAT (Deiuliis et al., 2010).   
 
Table1.1: Differences between brown and white adipose tissues 
 BAT WAT 
Cellular Morphology   
 Size 15-60µm 25-200µm 
 Shape Polygonal or ellipsoid Spherical 
 Cytoplasm Large volume Small amount in the periphery 
of the cell 
 Mitochondria Numerous, large Few, elongated 
 Lipid droplets Multiple small droplets Large single 
Tissue organization and 
function 
  
 Vascularity Highly vascularized Less dense 
 Innervation Dense sympathetic 
innervation 
Less dense innervation 
 General function Thermogenesis, storage of 
triglycerides for use in BAT 
Storage of triglycerides, 
secretion of hormones and 
adipokines 
 
Table  Adapted from (Fenzl and Kiefer, 2014). 
BAT: Brown adipose tissue 
WAT: White adipose tissue 
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1.2 Development of adipose tissues 
Adipogenesis is the process of cell differentiation by which pre-adipocytes become 
adipocytes. It is characterized by sequential changes in the expression of specific genes that 
determine the specific adipocyte phenotype of the cells reflected by the appearance of various 
early, intermediate and late mRNA and protein markers, and triglyceride accumulation 
(Niemela et al., 2007). Although both white and brown adipocytes are derived from 
mesenchymal stem cells originating in the mesoderm (Billon et al., 2008), they are generated 
through different developmental pathways (Seale et al., 2008). The brown adipocytes in BAT 
develop from myogenic factor 5 (Myf5)-expressing precursor cells (Seale et al., 2008), which 
are also muscle precursors. However, PRDM16, together with C/EBPβ form a lineage-
switching transcriptional complex that promotes brown fat differentiation and suppresses 
muscle cell differentiation (Kajimura et al., 2009; Seale et al., 2009). 
The differentiation of pre-adipocytes into adipocytes is a complex process characterized by 
changes in cell morphology, gene expression, hormone sensitivity, and secretory capacity 
(Perera et al., 2006), and is regulated by an elaborate network of transcription factors. At the 
centre of this network of changes in gene expression are two principal adipogenic factors, 
PPARγ and C/EBPα (Farmer, 2006), interacting with different corepressors and coactivators 
to determine adipocyte function (Leonardsson et al., 2004). Alongside the identification of an 
increasing number of transcription factors controlling adipogenesis, several new mechanisms 
regulating their function have also been described recently including histone modification, 
microRNAs, and ubiquitin modification (Lowe et al., 2011). However, there seems to be a 
unified pathway by which PPARγ and CEBPs control adipogenesis (Rosen et al., 2002). 
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1.3 Beige/brite 
It has been known for many years that some white adipose tissues contain cells that can 
express high levels of UCP1 and take on a multilocular appearance upon prolonged 
stimulation by cold or pathways that elevate intracellular cyclic AMP (cAMP) (Cousin et al., 
1992).  These adipocytes have been named beige, 'brite' (brown in white), iBAT (inducible), 
recruitable BAT and wBAT (Harms and Seale, 2013). The bona fide white and brown 
adipose depots are located in anatomically different regions in both rodents and humans. 
Development from Myf5-positive muscle precursors is not the only way to generate brown 
adipocytes. Interspersed within white adipose tissue are brown adipocytes that appear 
following cold exposure.  
Cinti et al., 2010 demonstrated that several UCP1-immunoreactive brown adipocytes 
occurring in WAT after cold acclimatization had a mixed morphology (paucilocular 
adipocytes). Recently, an inter-organ crosstalk between skeletal muscle and WAT was shown 
to promote browning by a factor called irisin, which is regulated by PGC1-α, secreted from 
muscle into blood and activates thermogenic function in adipose tissues (Bostrom et al., 
2012). Beige cells morphologically appear to be an intermediate between BAT and WAT 
(Figure 1.1). 
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Figure 1.1: White beige and brown adipocytes are derived from distinct precursor cells and 
have distinct morphological characteristics. Adapted from Kelesha Sarjeant, and Jacqueline M. 
Stephens Cold Spring Harb Perspect Biol 2012;4:a008417 (Sarjeant and Stephens, 2012). 
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1.4 Dynamic nature of adipose tissue 
The developmental relationship between brown and white adipocytes is not clear; the 
anatomical location of BAT and WAT depots is distinct (Hansen and Kristiansen, 2006). In 
rodents, BAT depots persist into adulthood whereas in larger mammals, BAT depots are 
replaced partially or completely shortly after birth. In order to explain their coexistence the 
hypothesis of reversible physiological transdifferentiation was developed, i.e. they are able to 
convert, one into the other. In effect, if needed the brown component of the organ could 
increase at the expense of the white component and vice versa (Cinti et al., 2010). As noted 
by Cinti et al., 2010, this plasticity is important because the brown phenotype of the organ is 
associated with resistance to obesity and its related disorders.  
Humans are also susceptible to browning of their WAT as shown by the anecdotal evidence 
that omental WAT biopsies obtained from patients affected by pheochromocytoma, a 
cathecholamine secreting tumour, are enriched in brite cells (Frontini et al., 2013), but 
browning capacity can vary in different WAT depots (Wu et al., 2012). This discrepancy may 
simply reflect that when the first BAT lineage-tracing with Myf5-cre was performed, only a 
few of the adipose tissue depots were analysed, resulting in an underestimation of Myf5 
lineage contribution to the whole fat organ development (Shan et al., 2013). But whether the 
Myf5-positive cells found in the WAT depot gave rise to bona fide BAT remains to be 
proven. Conditional genetic knockout of phosphatase and tensin homolog (PTEN) in Myf5-
expressing cells caused a partial lipodystrophic phenotype, suggesting that Myf5+ 
progenitors contribute in a region-specific manner to WAT depots, which may explain the 
heterogeneity in the metabolic phenotypes of distinct adipose tissue depots (Lee et al., 
2014b). 
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1.5 Human BAT 
Until recently, human brown fat deposits were considered to be present only in newborns, 
where it serves as a protective measure during the initial hours following birth into a cold 
environment (Farmer, 2008). However, PET scans, coupled with tissue sampling, have 
conclusively identified brown adipose depots, notably between the shoulder blades and 
around kidneys, in adult humans (Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; 
Virtanen et al., 2009). The activities of these depots are increased in cold exposure and 
blunted in obesity (van Marken Lichtenbelt et al., 2009). Chronic cold exposure in outdoor 
workers or the presence of pheochromocytoma was associated with a prolonged BAT 
presence in humans (Kuji et al., 2008; Medeiros et al., 1985; Ricquier et al., 1983). 
Moreover, histological analysis demonstrated UCP1 immunostaining in the perithyroid fat of 
30% of patients undergoing thyroidectomy (van Marken Lichtenbelt et al., 2009), suggesting 
the presence of BAT around the thyroid. 
According to a recent report by (Sacks and Symonds, 2013), human BAT is distributed in the 
following regions: Visceral BAT, including perivascular BAT around the aorta, common 
carotid artery, and brachiocephalic artery; in anterior mediastinum (paracardial) fat, and 
around epicardial coronary artery and cardiac veins as well as medium-sized muscular 
arteries and veins including the internal mammary and the intercostal artery branches from 
the subclavian and aorta. Viscus BAT, defined as BAT surrounding a hollow muscular organ 
other than blood vessels, situated in variable amounts in the epicardium around the heart and 
in the eosophago-tracheal groove, as well as greater omentum and transverse mesocolon in 
the peritoneal cavity. BAT is also found around solid organs, namely, kidney, adrenal, 
pancreas, liver, and splenic hilum including paravertebral fat. Subcutaneous BAT includes 
depots lying between the anterior neck muscles and in the supraclavicular fossa posterior to 
the brachial plexus, under the clavicles, in the axilla, in the anterior abdominal wall, and in 
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the inguinal area. Importantly, BAT is present in all the aforementioned sites in infants and 
children under 10 years old and its distribution decreases in variable amounts with increasing 
age so that by 80 years old, few individuals have BAT at any site. The most metabolically 
active BAT region is the supraclavicular fossa and axilla followed by the mediastinal, 
thoracic paravertebral, perinephric, and adrenal loci (Sacks and Symonds, 2013). 
 
 
 
 
 
 
  
 
Figure 1.2:  Schematic representation of the anatomical distribution of BAT and WAT in an 
adult human (Nedergaard et al., 2007).  
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1.6 Measurement of BAT 
The most popular method of mapping brown fat located under the skin has been to scan the 
body using combined positron-emission tomography and computed tomography (PET-CT). 
Detecting BAT is typically confirmed by the uptake of the injected radioactive tracer (18) F-
Fluorodeoxyglucose ((18)F-FDG) into adipose tissue depots, as measured by PET-CT scans 
after exposing the subject to cold stimulus. This technique produces highly detailed images of 
the body's interior but requires a costly and invasive procedure. The use of magnetic 
resonance imaging (MRI) to detect brown fat does not require the use of radioisotopes 
(Holstila et al., 2013). Another relatively inexpensive and noninvasive option is thermal 
imaging, which identifies hotspots of brown fat under the skin by monitoring the temperature 
of the overlying skin. Reliably differentiating BAT from other tissues using a non-invasive 
imaging method is an important step toward studying BAT in humans. To date, the only non-
invasive way to examine the presence of brown adipose tissue has been 
18
F-fluoro-deoxy-
glucose PET scans performed in the cold. FDG-PET/CT is currently considered the gold 
standard for measuring BAT activity in humans, which correlates positively with intracellular 
glucose uptake (Fenzl and Kiefer, 2014; Lee et al., 2010). 
 
1.7 BAT Thermogenesis 
Thermogenesis refers to heat generation through metabolic processes. This can be obligatory 
or adaptive (facultative) thermogenesis. The heat normally resulting from sustaining vital 
functions is called obligatory thermogenesis (Silva, 2006). Adaptive thermogenesis can be 
shivering or non-shivering, and is recruited when heat generation is needed for survival 
(Himms-Hagen, 2001). BAT thermogenesis is facilitated by multilocular lipid stores, the 
extremely high mitochondrial content of brown adipocytes and the extensive vascular and 
nerve supply to this tissue. 
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Adaptive non-shivering thermogenesis can be cold-induced or diet-induced and requires the 
presence of BAT to be activated (Feldmann et al., 2009). Thermogenesis is controlled by 
futile cycles, such as the simultaneous occurrence of lipogenesis and lipolysis or glycolysis 
and gluconeogenesis. The high energy demands of thermogenesis mean that free fatty acids 
draw, for the most part, on lipolysis as the method of substrate production. Non-shivering 
thermogenesis is regulated mainly by thyroid hormone and the SNS. Rising insulin levels 
after eating may be responsible for diet-induced thermogenesis. 
Brown fat thermogenesis is a target of continued interest for attenuating nutrient efficiency 
and counteracting obesity and insulin resistance since future strategies could involve the 
conversion of white fat cells into thermogenic brown-fat-like adipocytes (Nubel and Ricquier, 
2006). Recent studies have demonstrated the potential for transplanted BAT to reverse 
obesity by improving thermogenesis (Liu et al., 2015). Thermogenesis in BAT is due to 
UCP1, also called thermogenin or SLC25A7. The uncoupling activity of UCP1 is explained 
by its ability to transport protons across the inner mitochondrial membrane, in particular 
when FFAs bind to the protein (Brondani et al., 2012). 
 
1.7.1 Role of UCP1 in BAT thermogenesis 
UCPs 1, 2, 3, 4, and 5 are members of an anion-carrier protein family, and are located in the 
inner mitochondrial membrane. These proteins have similarities in their structures, but 
different tissue expression in mammals. The original UCP, UCP1, is mainly expressed in 
BAT (Dalgaard and Pedersen, 2001). UCP2 is widely distributed, whereas UCP3 is mainly 
restricted to the skeletal muscle, while UCP4 and UCP5 are mainly expressed in the brain. 
The coupling of respiration to ATP synthesis is not 100% efficient, and some of the energy is 
dissipated as heat. Partial uncoupling of respiration from ATP synthesis, also known as 
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proton leak, can be mediated by UCP1 and by other mitochondrial inner membrane proteins, 
such as adenine nucleotide translocase (ANT) (Dalgaard and Pedersen, 2001).  
UCP1 is a transmembrane protein that decreases the proton gradient generated in oxidative 
phosphorylation by increasing the permeability of the inner mitochondrial membrane, 
allowing protons that have been pumped into the intermembrane space to return to the 
mitochondrial matrix. UCP1-mediated heat production causes a decrease in efficiency of 
oxidative phosphorylation leading to increased fat oxidation and to diminution in feed 
efficiency (ratio of weight gain to food intake) (Klingenspor, 2003). UCP1 ablated mice 
gained weight at a higher rate than the control (Feldmann et al., 2009). The “short circuit” in 
the proton gradient caused by UCP1 means that fuel oxidation can be accelerated and is not 
limited by saturating concentrations of ATP. Hence, all of the biochemical steps of 
mitochondrial fuel oxidation (Krebs cycle and ETC) are accelerated, and the inherent 
inefficiencies in their reactions result in heat production (Wu et al., 2013) 
 
1.7.2 Role of adrenergic signalling in thermogenesis 
β-adrenergic receptors (β-AR) belong to the superfamily of G-protein-coupled receptors 
(GPCRs). β3-AR is the adipocyte specific adrenergic receptor and is expressed in both brown 
and white in rodents and mainly BAT in humans (Zhao et al., 1994). Treatment of human 
white adipocytes cells with a specific β3-AR agonist CL-316,243 leads to the appearance of 
brite characteristics, similar to the phenotype following cold exposure (Barbatelli et al., 2010; 
Himms-Hagen et al., 2000). β3-AR activates a thermogenic pathway through lipolysis. 
Moreover, in the absence of β-adrenergic signalling, mice are unable to maintain their core 
temperature (Bachman et al., 2002). 
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β2-adrenergic receptors are not expressed in the brown adipocytes but are expressed in the 
tissue (Bengtsson et al., 2000), as binding sites can be measured in membrane preparations 
from BAT. These β2-adrenergic receptors are probably predominantly localized to the 
vascular system (Cannon and Nedergaard, 2004). Thermogenesis is β3-AR but not β1-AR 
mediated in rat brown fat cells, even after cold acclimation (Zhao et al., 1998). β-Adrenergic 
receptors normally couple to the Gαs subfamily of heterotrimeric G proteins leading to 
activation of adenylyl cyclase, increasing the levels of cAMP, and protein kinase A (PKA) 
activation, a pathway that mediates the thermogenic signal. The fatty acids are directed to the 
mitochondria for combustion. The adrenergic stimulation also leads to synthesis and release 
of lipoprotein lipase (LPL), which breaks down the triglycerides in the 
lipoproteins/chylomicrons in the circulation to supply further fatty acids for combustion in 
the mitochondria. Additionally, glucose uptake is stimulated. After cytosolic conversion to 
pyruvate, the glucose is also combusted in the mitochondria. The heat produced is rapidly 
transported out to the body by the blood. The mechanism of thermogenesis is summarized in 
figure 1.2. 
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Figure 1.3: Mechanism of UCP1 (thermogenin) activation: Sympathetic nervous system 
terminals release norepinephrine onto a β3 adrenergic receptor on the plasma membrane. This 
activates adenylyl cyclase, which catalyses the conversion of ATP to cAMP. cAMP activates 
protein kinase A which in turn, phosphorylates a triacylglycerol lipase (HSL), thereby 
activating it. The lipase converts triacylglycerols into free fatty acids, which activate UCP1, 
overriding the inhibition caused by purine nucleotides GDP and ADP. At the termination of 
thermogenesis, the mitochondria oxidize away the residual fatty acids, UCP1 inactivates and the 
cell resumes its normal energy-conserving mode (Adapted from Fedorenko et al., 2012). 
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1.8 Transcriptional control of brown fat development and function 
Multiple transcriptional regulatory cascades have been reported to control BAT development 
and thermogenic function. Peroxisome proliferator activated receptor gamma (PPARγ) is the 
master transcription factor that is unconditionally required for white and brown adipogenesis. 
However, the transcriptional activity of PPARγ can be regulated at multiple levels, enabling 
brown adipocyte-specific target gene expression (Floyd and Stephens, 2012).  
Although WAT and BAT have different developmental origins and functions, they both 
require the transcription factors PPARγ and members of the C/EBP transcription factor 
family (C/EBPα, C/EBPβ, and C/EBPδ) for their development and function (Wu et al., 2013). 
It was earlier observed that mice with a dominant-negative mutation of PPARγ (P465L) have 
defects in BAT but not white adipose tissue (WAT) function (Gray et al., 2006). PGC-1α 
expression is activated by the PKA–CREB pathway, which is downstream from the β-
adrenergic receptor signalling pathway (Herzig et al., 2001). PGC-1α is a dominant regulator 
of mitochondrial biogenesis and oxidative metabolism (Lin et al., 2005) by inducing Ucp1 
expression leading to thermogenesis. 
PRDM16 is key factors enriched in classical brown fat relative to WAT (Seale et al., 2007). 
PRDM16 was shown to be sufficient and necessary for the brown fat phenotype in cell 
culture models and sufficient to promote browning in visceral fat under β-adrenergic 
stimulation. Further studies showed that PRDM16 binds and coactivates PGC-1α, PGC-1β, 
and PPARγ (Seale et al., 2008) and together with C/EBPβ, form a lineage-switching 
transcriptional complex that promotes brown fat differentiation and suppresses muscle cell 
differentiation (Kajimura et al., 2009; Seale et al., 2009). Recently, PRDM16 was identified 
as a molecular switch between myocytes and brown adipocytes and it is considered as a 
classical brown adipocyte lineage marker (Lee et al., 2014b).  
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There are other factors which have been reported to regulate BAT activity. Some of them 
have been identified to regulate both classical and beige cells in a similar way. These include 
brown- and beige-fat recruiters and activators Irisin (Bostrom et al., 2012),  Fibroblast growth 
factor 21 (FGF21) (Chartoumpekis et al., 2011), Atrial natriuretic peptide and brain-type 
natriuretic peptide (Chainani-Wu et al., 2010), Bmp8b, produced by mature brown fat cells 
and functions to amplify the thermogenic response of brown adipocytes to adrenergic 
activators (Whittle et al., 2012), Interleukin 6 (IL-6) (Cannon et al., 1998), and thyroid 
hormone, which directly induces the expression of thermogenic genes in brown adipocytes 
through the actions of thyroid receptors and also functions centrally to activate BAT. 
 
1.9 BAT and obesity 
The capacity to accumulate fat has been a major adaptive feature of our species, but is now 
increasingly maladaptive in the modern environment where fluctuations in energy supply 
have been minimised, and productivity is dependent on mechanisation rather than physical 
effort (Wells, 2006). Since 1980, the global prevalence of obesity has doubled and billions of 
people are overweight and obese. Obesity is a risk factor for a variety of chronic conditions 
including diabetes, hypertension, high cholesterol, stroke, heart disease, certain cancers, and 
arthritis (Malnick and Knobler, 2006). Of these obesity-related conditions, diabetes may be 
the most closely linked to obesity, and the increasing incidence of diabetes worldwide is of 
considerable concern (McKinlay and Marceau, 2000). WHO reports that >65% of the world's 
population die of diseases related to being overweight rather than underweight (Johnson and 
Makowski, 2015). 
The most common method of measuring obesity is the Body Mass Index (BMI) which is 
calculated by dividing body weight (kilograms) by height (metres) squared, with a healthy 
man being 18.59kg/m
2
 to 24.9kg/m
2
. An adult BMI below 18.59kg/m
2
 is classified as 
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underweight, between 25.9kg/m
2
 and 29.99kg/m
2
 is classified as overweight and a BMI of 
30kg/m
2
 or over is classified as obese. Although BMI is the most widely used approach it is 
not a direct measure of body fat mass or distribution, and BMI measures may be skewed by 
very high muscle mass. The relationship between BMI and health also varies with ethnicity. 
Worldwide, the proportion of adults with a body-mass index (BMI) of 25 kg/m²or greater 
increased between 1980 and 2013 from 28·8% to 36·9% in men, and from 29·8% to 38·0% 
in women. Prevalence has increased substantially in children and adolescents in developed 
countries; 23·8% of boys and 22·6% of girls were overweight or obese in 2013. The 
prevalence of overweight and obesity has also increased in children and adolescents in 
developing countries, from 8·1%  to 12·9% in 2013 for boys and from 8·4%  to 13·4% in 
girls (Ng et al., 2014). 
The obesity epidemic is attributable to high calorie diets, unhealthy lifestyles and behavioural 
trends acting on a person's genetic makeup to determine body mass and susceptibility to 
obesity-related disease (Lyon and Hirschhorn, 2005; Wells, 2006). The increasing prevalence 
of obesity in our society has focused attention on many aspects of adipose tissue biology. 
Despite intensive research, current efforts to reduce obesity by diet, exercise, education, 
surgery and drug therapies are failing to provide effective long-term solutions to this 
epidemic (Herrera et al., 2011). The use of anti-obese drugs that reduce food intake and 
improve hypercholesterolemia and cardiovascular disease has been assessed in obesity, with 
drug therapy closely involved either in the prevention or induction of obesity, and non-
alcoholic fatty liver disease in man. Fundamentally, the obesity epidemic is explained by a 
dysregulation of energy balance in our ‘obesogenic’ environment. 
Drugs that inhibit fat absorption or digestion (pancreatic lipase inhibitors) such as gut based 
hormone treatments which target many pathways involved in the regulation of energy balance 
(Derosa and Maffioli, 2012), sympathomimetic drugs which act as an appetite suppressant by 
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increasing fullness and delaying food intake (Li and Cheung, 2011) have all been tested.  
Unfortunately, attempts to prevent obesity have had limited success thus far. The 
individualistic lifestyle approach of advising people to eat less and exercise more has been 
ineffective as a preventive measure for obesity (Kirk et al., 2012). Effective management of 
obesity therefore goes beyond obesity being thought of as mere food related disorder but may 
be influenced by genetics, psychology, society and public policy (Kirk et al., 2010), and 
‘obesogenic’ environment. The ‘obesogenic’ environment is characterised by decreased 
physical activity and increased intake of high caloric food and drink , and also other factors 
such as the ingestion of novel medications, the presence of pollutants, the reduction of the 
variability in seasonal temperature due to the presence of almost ubiquitous air conditioning 
(Tam and Ravussin, 2012). 
Different genes have been associated with obesity and the regulation of body weight. The 
heritability of obesity has been associated with more than 40 genetic variants (Herrera et al., 
2011). Genome-wide association studies (GWAS), have confirmed that monogenic mutations 
affecting the hypothalamic leptin–melanocortin system is critical for energy balance in 
humans, because disruption of these pathways causes the most severe obesity phenotypes and 
fat mass, and obesity associated gene polymorphisms appears to have the most important 
effects on obesity susceptibility (Xia and Grant, 2013). 
In finding new therapies to combat the present obesity pandemic, it is essential to elucidate 
the cellular and molecular mechanisms regulating energy balance, by characterizing the 
signalling pathways involved in brown fat induction and metabolism, which plays a central 
role in this energy metabolism and homeostasis. This will help to identify novel drug targets 
and design more effective management programs. 
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1.10 Free fatty acids (FFAs) 
Lipid homeostasis reflects a balance of processes, designed to generate fatty acids (FAs) and 
lipids, deliver them from their site of origin to target tissues, and catabolize them for 
metabolic purposes (Zechner et al., 2009). Fatty acids are carboxylic acids with long aliphatic 
tail, which is either saturated or unsaturated. Fatty acids are usually derived from either 
triglycerides or phospholipid. They are known as free fatty acids (FFA) when they are not 
bound to other molecules. They are important sources of fuel, and when metabolized they 
yield high amount of ATP. Unsaturated and saturated fatty acids differ in length, categorized 
as short chain fatty acids (SCFAs), medium chain fatty acids (MCFAs), long chain fatty acids 
(LCFAs), and very long chain fatty acids (VLCFAs). Unsaturated fatty acids have one or 
more double bonds between carbon atoms. Saturated fatty acids are long chain of between 12 
and 24 carbon atom and without double bonds between them. Free fatty acids act on 4 
different GPCRs (FFARs). 
 
1.11 Fatty acid metabolism 
1.11.1 Lipogenesis 
This is the creation of fatty acids from acetly-CoA and malonyl-Coa precursors through 
action of enzymes called fatty acid synthase. Lipogenesis occurs in the cytoplasm of adipose 
tissue. It is the process by which acety-CoA is converted to fatty acids. Excess energy 
ingested as fat is stored in adipose tissue. In addition, dietary carbohydrates and proteins can 
be converted and stored as fat in adipose tissue. Triaclyglycerides are the most significant 
source of fatty acids. Through lipogenesis and subsequent triglyceride synthesis, the energy 
can be efficiently stored in the form of fats. 
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1.11.2 Lipolysis 
Lipolysis is defined as a process in which triacylglycerols (TAGs) a major source of energy 
reserve in adipocytes are hydrolyzed to generate fatty acids and glycerol. The hydrolytic 
cleavage of TAG generates non-esterified fatty acids, which are subsequently used as energy 
substrates, essential precursors for lipid and membrane synthesis, or mediators in cell 
signalling processes (Lass et al., 2011). Mature adipocytes undergo lipolysis in an orderly 
manner with lipolytic enzymes acting sequentially at each step. The complete hydrolysis of 
TAG depends on the activity of three enzymes, adipose triglyceride lipase (ATGL), hormone-
sensitive lipase (HSL) and monoacylglycerol lipase, each of which possesses a distinct 
regulatory mechanism. 
β-adrenergic receptor stimulation causes the phosphorylation of perillipin-1 by PKA. 
Perillipin-1 interacts with a coactivator, called comparative gene identification-58 (CGI-58). 
CGI-58 then dissociates from perillipin-1 and interacts with adipose triglyceride lipase 
(ATGL) which is the main TAG hydrolase. Expression of ATGL is induced by PPAR 
agonists, glucocorticoids, and fasting. CGI-58 acts as a coactivator for ATGL which gains 
full activity and cleaves the first ester bond in a TAG to yield a DAG and a non-esterified 
FA. HSL is also phosphorylated by PKA and interacts with perillipin-1 to gain access into the 
lipid droplet. Then, HSL hydrolyses DAGs into monoacylglycerols (MGs). It has recently 
been shown that HSL and ATGL can be activated simultaneously, such that the mechanism 
that enables HSL to access the surface of lipid droplets also permits the stimulation of ATGL. 
HSL phosphorylation and translocation coupled with ATGL activation by CGI-58 increases 
the TAG hydrolysis more than 100-fold. 
The last step of lipolysis is the hydrolysis of MGs by MG lipase leading to the liberation of 
FFAs (Zechner et al., 2012). The FFAs liberated by lipolysis are either channelled further 
within the cell or exit the adipocyte to be oxidised in other tissues such as liver and muscle. 
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In the cytosol, TAGs are probably bound to fatty acid-binding proteins. Similar to other 
adipocytes, brown adipocytes possess the adipocyte form of the fatty acid binding protein, 
FABP4 (aP2). The intracellular pathways regulating lipogenesis and lipolysis are summarized 
in Figure1.4. 
 
 
 
 
 
 
 
 
 
Figure 1.4: Intracellular pathways of factors regulating adipogenesis, lipogenesis, and lipolysis 
in the adipocyte. Triglycerides (TG) circulate in blood in the form of lipoproteins. Free fatty 
acids (FFA) that are released from lipoproteins, catalyzed by lipoprotein lipase (LPL), diffuse 
into the adipocyte. Lipolysis occurs via a cAMP-mediated cascade, which results in the 
phosphorylation of hormone-sensitive lipase (HSL), an enzyme that hydrolyzes TG into FFA 
and glycerol. These FFA are then free to diffuse into the blood. Insulin enhances the storage of 
fat as TG by increasing LPL and lipogenic enzyme activities. It also facilitates the transport of 
glucose by stimulating GLUT4 glucose transporter. Insulin binding to its receptor (InsR) 
induces receptor tyrosine autophosphorylation and activation of insulin receptor substrate 
(IRS)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt/PKB) signalling pathways 
(Adapted from Lukaszewski et al., 2013). 
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1.11.3 Regulation of fatty acid metabolism 
Lipolysis and lipogenesis are highly regulated processes releasing or re-esterify FAs in a 
futile cycle in order to avoid detrimental effects associated with non-physiological increases 
in FA concentrations (Duncan et al., 2007). In brown adipose tissue, lipolysis is induced by 
norepinephrine, and stimulated via β3-ARs (Chaudhry and Granneman, 1999). Alterations in 
lipolysis are frequently associated with obesity, including an increase in basal rates of 
lipolysis that may contribute to the development of insulin resistance, as well as an impaired 
responsiveness to stimulated lipolysis (Large et al. 1999). Several agents contribute to the 
control of lipolysis in adipocytes by modulating the activity of HSL and ATGL (Chaves et 
al., 2011). 
Both lipolysis and thermogenesis occur downstream of cAMP formation as they can be 
induced by cAMP agonists (Cannon and Nedergaard, 2004). The classical pathway of 
lipolysis activation in adipocytes is cAMP-dependent. The production of cAMP is modulated 
by G-protein-coupled receptors of the Gαs and Gαi/o family and cAMP degradation is 
regulated by phosphodiesterases. There is also evidence that increased lipolytic activity in 
adipocytes occurs after stimulation of the mitogen activated protein kinase (MAP) pathway or 
after cGMP accumulation and activation of protein kinase G. Hormonal control of lipolysis 
can also be achieved by the Gαq/11 family of G-proteins.  
Adipose HSL activity is controlled in response to β-adrenergic stimulation. First, HSL is 
phosphorylated by cAMP-dependent PKA. This leads to an increase of the intrinsic enzyme 
activity. Besides PKA, other protein kinases, such as ERK and glycogen synthase kinase have 
also been shown to phosphorylate HSL and regulate enzyme activity. Phosphorylated HSL 
interacts with perilipin-1 which itself is a target of PKA phosphorylation (Lass et al., 2011). 
The activation of HSL by PKA-dependent phosphorylation increases the release of fatty acids 
into the blood. The activity of HSL is also affected via phosphorylation by AMPK (Zechner 
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et al., 2009). Remarkably, mice lacking HSL exhibited normal thermogenesis (Osuga et al., 
2000) and were not cold sensitive despite a lipolytic defect that resulted in brown adipocyte 
hypertrophy due to TAG and DAG accumulation. Apparently, in the absence of HSL, 
sufficient amounts of FAs are mobilized for mitochondrial heat production. In contrast, 
ATGL-knockout mice are extremely cold sensitive and die after cold exposure of more than 6 
hours, indicating that the enzyme is essential for the provision of FA as substrate for 
thermogenesis (Haemmerle et al., 2006). 
Insulin and insulin-like growth factor represent the most potent inhibitory hormones in 
lipolysis (Degerman et al., 2001). Other factors involved in the regulation of fatty acid 
metabolism include tumour necrosis factor-α (TNFα), growth hormone and the CIDE 
domain-containing proteins family of proteins (CIDE-A, -B, and –C).  
 
1.12 Free fatty acid receptors 
The free fatty acid receptors (FFARs) area a family of G protein-coupled receptors (GPCRs) 
activated by free fatty acids (FFAs). They play vital roles as essential nutritional components 
and as signalling molecules in numerous physiological processes. FFARs appear to act as 
physiological sensors for food-derived FFAs and digestion products in the gastrointestinal 
tract. They are also considered to be involved in the regulation of energy metabolism 
mediated by the secretion of insulin and incretin hormones and by the regulation of the SNS, 
taste preferences, and inflammatory responses related to insulin resistance. FFARs have been 
targeted in therapeutic strategies for the treatment of metabolic disorders including type 2 
diabetes and metabolic syndrome.  
Following a deorphanization project in the early 2000s (Wise et al., 2004), a few GPCRs 
were identified whose endogenous ligands are FFAs (Table 1.2). The first was Gpr40 (also 
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known as free fatty acid receptor 1 or FFAR1). Subsequently, Gpr41 (FFAR3), Gpr43 
(FFAR2) and Gpr120 (FFAR4) were deorphanized (Wise et al., 2004). Medium- and long-
chain FFAs activate FFA1/GPR40 and FFA4/GPR120. Short-chain FFAs activate 
FFA2/GPR43 and FFA3/GPR41. However, only medium-chain FFAs, and not long-chain 
FFAs, activate GPR84 receptor (Wang et al., 2006). 
GPCRs form the largest family of signalling receptors. They modulate diverse physiological 
and behavioural signalling pathways by virtue of changes in receptor activation and 
inactivation states. These membrane proteins are comprised of seven transmembrane regions 
(TM), an extracellular amino-terminus and an intracellular carboxyl-terminal domain. GPCRs 
were originally identified as receptors capable of coupling to specific guanine nucleotide-
binding proteins (G proteins), thereby transducing an extracellular signal to an intracellular 
effector (Drake et al., 2006). The exact size of the GPCR superfamily is unknown. However, 
comprehensive phylogenetic analysis of the GPCRs in human and mouse predicted nearly 
800 human GPCRs (Bjarnadottir et al., 2006).   
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Table 1.2: GPCRs that are activated by FFAs 
Gpr40
1,2
 Tissue Localization Pancreatic β-cells 
 Ligands Medium and long chain saturated and unsaturated fatty 
acids, PPARγ agonists 
 Functions Mediates insulin secretion by β-cells 
Gpr41
1
 Tissue Localization Adipose tissue endothelial cells 
 Ligands Short chain fatty acids (C2-C4) 
 Functions Leptin and Peptide YY secretion. 
Gpr43
1
 Tissue Localization White adipose tissue and intestine, leukocytes 
 Ligands Short chain fatty acids (C2-C4) 
 Functions Peptide YY secretion and 5-HT 
Gpr120
1
 Tissue Localization Brown adipose tissue, lung, intestine, taste buds 
 Ligands Medium and long chain saturated and unsaturated fatty 
acids. 
 Functions Taste buds: Lipid sensing 
Immune cells: anti-inflammation and anti-apoptosis 
Adipose tissue: insulin sensitivity, adipogenesis 
Intestine: GLP-1 and CCK secretion. 
 
1. (Miyauchi et al., 2009a);  
2. (Itoh et al., 2003) 
Gpr40: G-protein coupled receptor 40 
Gpr41: G-protein coupled receptor 41 
Gpr43: G-protein coupled receptor 43 
Gpr120: G-protein coupled receptor 120 
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1.13 G-proteins 
G proteins are also known as guanine nucleotide-binding proteins. There are two classes of 
G-proteins: Heterotrimeric G-proteins and monomeric small GTPases. The Heterotrimeric G-
proteins are made up of α, β and γ subunits. These heterotrimeric G-proteins are classified 
into four families based on the signalling pathway of their Gα subunits. These are Gαs 
(stimulatory), Gαi/o (inhibitory), Gαq/11 and Gα12/13. Although G-proteins respond 
differently in recognition of effector molecule, they share similar mechanism of activation 
(Kobilka, 2007).  
Classically, the binding of specific ligands to a GPCR causes activation of the receptor, 
which leads to signal transmission into the cell via a conformational change in the receptor. 
This conformational change results in the activation of the bound G protein by promoting the 
exchange of bound GDP for GTP on the α -subunit. This is the rate-limiting step in G protein 
activation. The binding of GTP changes the conformation of ‘switch’ regions within the α-
subunit, which allows the bound trimeric G protein (inactive) to be released from the receptor 
and the α-subunit (GTP-bound) dissociates from the βγ dimer. The α subunit and 
the βγ dimer go on to activate distinct downstream effectors, such as adenylyl cyclase, 
phosphodiesterases, phospholipase C, and ion channels. These effectors in turn regulate the 
intracellular concentrations of secondary messengers, such as cAMP, cGMP, diacylglycerol, 
IP3, DAG, arachidonic acid, sodium, potassium or calcium cations, ultimately leading to a 
physiological response, usually via the downstream regulation of gene transcription. The 
cycle is completed by the hydrolysis of a subunit-bound GTP to GDP, due to the intrinsic 
GTPase activity of the Gα subunit, resulting in the re-association of the α- and βγ- subunits 
and their binding to the receptor, which terminates the signal (Figure 1.4). 
Specifically, Gαs activates cAMP-dependent pathway by stimulating the production of cAMP 
from ATP, catalysed by adenylyl cyclase. Gαi subunit inhibits adenylyl cyclase activity thus 
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the production of cAMP from ATP is reduced. The Gαq/11 pathway is the pathway that 
stimulates PLC-β to hydrolyse phosphatidylinositol 4,5-bisphosphate (PIP2) in to the 
intracellular messengers, inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers 
the release of calcium from intracellular stores, and DAG recruits protein kinase C (PKC) to 
the membrane and with calcium, activates it. Gα12/13 is involved in the Rho family GTPase 
signalling. Figure 1.4 summarizes G-protein mediated signalling events. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Receptor activation of GPCR. Agonist binding triggers a conformational change in 
the receptor, which catalyses the dissociation of GDP from the α-subunit followed by GTP-
binding to Gα and the dissociation of Gα from Gβγ subunits. Typically Gαs stimulates adenylyl 
cyclase and increases levels of cyclic AMP (cAMP), whereas Gαi inhibits adenyly cyclase and 
lowers cAMP levels, and members of the Gαq family bind to and activate phospholipase C 
(PLC), which cleaves phosphatidylinositol bisphosphate (PIP2) into diacylglycerol and inositol 
triphosphate (IP3). The Gβγ subunits function as a dimer to activate many signalling molecules, 
including phospholipases, ion channels and lipid kinases (Dorsam and Gutkind, 2007; Leurs et 
al., 2005). 
 
 
51 
 
1.14 Diversification and specification/regulation of GPCR signalling 
The GPCR-G-protein linear pathway is a model that does not explain all the jobs GPCRs 
have to do in vivo. GPCRs can activate signalling pathways independent of heterotrimeric G-
proteins to diversify signalling, such as homo and heterodimerization. In some cases 
dimerization has been shown to have a primary role in correct transport of GPCRs from the 
endoplasmic reticulum to cell surface. They simultaneously activate multiple proteins, and a 
single agonist can activate multiple receptor subtypes, with different G-protein coupling 
specificities. Some receptor genes also have multiple exons resulting in alternative splicing of 
the receptor genes. Once at the plasma membrane, dimers can be regulated by ligand binding. 
Heterodimerization leads to positive and negative ligand binding cooperativity, as well as 
promoting co-internalization of two receptors after stimulation of only one. This has a clinical 
implication as it can result in altered pharmacology and function, requiring variable 
combinations of drugs to effect the desired response. The regulation of signalling is important 
in specific signal responses and allows cells to decode complex signals. Mechanisms that 
regulate and specify GPCR signalling include receptor desensitization, endocytosis post-
endocytic sorting and recycling balance. An important feature of agonist-stimulated GPCRs 
is their waning responsiveness to repeated stimulation with agonists, which is accomplished 
by a coordinated series of events leading to receptor desensitization, sequestration and 
downregulation (Luttrell and Lefkowitz, 2002). Desensitization/re-sensitization and 
trafficking are one way to do this. β-arrestins are part of the desensitization machinery but 
also way of diversifying signalling by being a signal scaffold.  
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1.15 Role of β-arrestins in GPCR signalling 
Three families of proteins mediate the function of the receptors: the heterotrimeric G-
proteins, the G-protein–coupled receptor kinases (GRKs), and the β-arrestins.  β-arrestins 
have emerged as remarkably versatile adaptor molecules that regulate receptor endocytosis 
and also serve as signal transducers in their own right. β-arrestins shuttle between nucleus 
and cytoplasm. Desensitization is initiated by phosphorylation of the receptor. Second-
messenger-dependent protein kinases, including cyclic-AMP-dependent protein kinase (PKA) 
and protein kinase C (PKC), phosphorylate serine and threonine residues within the 
cytoplasmic loops and C-terminal tail domains of many GPCRs. Phosphorylation of these 
sites is sufficient to impair receptor G-protein coupling efficiency in the absence of β-
arrestins.  Apart from function interactions with GPCRs, β-arrestins also act as scaffold 
proteins that interact with several cytoplasmic proteins and link GPCRs to intracellular 
signalling pathways such as MAPK cascades. 
Agonist-induced internalization of GPCRs is a well-characterized phenomenon that is 
believed to contribute to receptor desensitization. Upon agonist activation there is 
redistribution of the receptor-protein away from the cell surface into internal cellular 
compartments through a process of endocytosis known as internalization (Fukunaga et al., 
2006). The propensity for a receptor to respond to an agonist can be a function of not only the 
agonist-receptor interaction but also the context of the system β-arrestins. Different ligands 
have distinct activation property. Individual ligands can differ remarkably in their effects on 
the regulated endocytic sorting trafficking of the same GPCR, suggesting the existence of 
unanticipated diversity among ligands (Hanyaloglu and von Zastrow, 2008). Both GRK-
mediated GPCR phosphorylation and binding of β-arrestin to the receptor facilitate the 
agonist-promoted endocytosis of many GPCRs (Luttrell and Lefkowitz, 2002). 
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Figure 1.6:  GPCRs can signal through both G-protein and arrestin pathways. Upon agonist 
binding to receptor, GPCR is activated leading to the dissociation of G-proteins into activated α 
subunit and βγ dimer. This triggers the activation of various effectors such as adenyly cyclase 
and PLC. The agonist-occupied GPCR is phosphorylated by GRKs, leading to signal 
desensitization, binding of β-arrestin to the activated phosphorylated GPCR and subsequent 
endocytosis of the receptor (Adapted from Ma and Pei, 2007; Ritter and Hall, 2009). 
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1.16 G-protein-coupled receptor 120 (Gpr120)  
Gpr120 is a membrane bound receptor. member of the family of GPCRs and binds both 
saturated and unsaturated fatty acids (Hirasawa et al., 2005), where it has a critical role in 
various physiological homeostatic mechanisms such as adipogenesis, regulation of appetite 
and food preference (Gotoh et al., 2007a). Gpr120 was originally described as an orphan 
receptor until a recent GPCR deorphanising process identified its endogenous ligands, poly-
unsaturated long-chain free fatty acids (FFAs) (Chung et al., 2008). In humans, the gene is 
encoded on chromosome 10, and in mouse on chromosome 19. Human Gpr120 has two 
splice variants. Gpr120 belongs to the class A (Rhodopsin-like) family, that has only limited 
homology to other family members, but has been highly conserved among species and 
represents the most studied subfamily of GPCRs (Fredriksson et al., 2003). 
There is a wide variation in the tissue expression of Gpr120. Gpr120 protein was found to be 
highly and widely expressed on the plasma membrane of adipocytes which increased during 
adipogenesis (Miyauchi et al., 2009b). In terms of gene expression, Gpr120 is the only lipid 
sensing GPCR which is highly expressed in adipose tissue, proinflammatory CD11c
+
 
macrophages (BMDCs), mature adipocytes, and monocytic RAW 264.7 cells (Oh et al., 
2010). Its mRNA has been found at high levels in taste buds (Galindo et al., 2012), where it 
may be functioning as a dietary sensor. Gpr120 expression has been reported to increase in 
WAT of mice on high fat diet and high levels also detected in human differentiated 
adipocytes (Gotoh et al., 2007b). Although Gpr120 expression was found to be higher in 
obese individuals than in lean controls, Gpr120 knockout mice fed a high fat diet gained more 
weight, had decreased energy expenditure, but with decreased insulin sensitivity (Ichimura et 
al., 2012b). A preliminary micro array data showed that Gpr120 is expressed in brown 
adipose tissue and induced upon cold exposure giving a potential role of this receptor by 
linking dietary fat sensing to energy homeostasis and metabolic control. 
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The function of Gpr120 in adipose tissue is not entirely understood. It is known to be a 
nutrient-sensing receptor, which may have an important role in the activation of metabolic 
pathways that control energy utilisation of adipocytes, including β-oxidation and glucose 
uptake (Gotoh et al., 2007). It has been found to promote secretion of cholecytokinin and 
glucagon-like peptide from intestinal luminal cells in response to stimulation by unsaturated 
long chain fatty acids (Tananka et al 2008a/b). Gpr120 activation in primary adipose tissue 
and 3T3-L1 adipocytes led to an increase in glucose transport and translocation of GLUT4 to 
the plasma membrane, and this effect was abolished upon Gpr120- and Gαq/11 knockdown 
(Talukdar et al., 2011). Stimulation of Gpr120 with ω-3 fatty acid also causes broad anti-
inflammatory effects in monocyte 264.7 cells and in primary intraperitoneal macrophages 
(Olefsky et al., 2010). Gpr120 dysfunction has been reported to be involved in the 
development of obesity in mice and humans (Ichimura et al., 2012a; Waguri et al., 2013). By 
sequencing Gpr120 exons in obese individuals Ichimura et al reported a deleterious non-
synonymous mutation (p.R270H) that inhibits Gpr120 signalling activity. They reported that 
agonist-induced calcium response was reduced in cells expressing the p.R270H mutation 
compared to cells expressing wild type. Furthermore, the p.R270H variant was reported to 
increase the risk of obesity in European populations (Ichimura et al., 2012b). 
The important role Gpr120 plays in the control of inflammation raises the possibility that 
targeting this receptor could have therapeutic potential in many inflammatory diseases 
including obesity and type 2 diabetes (Talukdar et al., 2011). Targeting Gpr120 may therefore 
be useful in addressing obesity and its associated complications. 
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1.17 Signalling pathways activated by Gpr120 
In many in vitro models, Gpr120 couples to Gαq/11 and activates PKC and MAP kinase 
pathways. In 3T3-L1 adipocytes ligand activation of Gpr120 caused an increase in glucose 
uptake through coupling to Gαq/11 pathway (Oh et al., 2010). However, recent studies have 
reported Gpr120 can also signal through a G-protein-independent pathway, notably a β-
arrestin-dependent pathway in macrophages (Oh et al., 2010), suggesting that Gpr120 
signalling may be different in distinct cell types. In 3T3-L1 adipocytes, β-arrestin-1 was 
implicated in the stimulation of glucose transport (Imamura et al., 2001). In macrophages, the 
activated Gpr120-β-arrestin2 complex mediated downstream signalling events, such as ERK 
phosphorylation, independent of Gαq/11, indicating that Gpr120 mechanism of activation 
differs with cell type (Talukdar et al., 2011).  
 
1.18 Development of selective ligands for Gpr120  
GPCRs represent the most successful drug target with 30-50 % of pharmacological agents 
targeting these receptors (Salon et al., 2011). Use of agonists and antagonists to modulate 
GPCRs action is not without it demerits. While some antagonists can still activate GPCRs, 
some of the agonists engage regulatory mechanisms leading to off target effects. This 
underscores the need to develop pathway selective (bias) ligands that will specifically target 
the signalling pathway.  
Medium to long chain fatty acids were identified as endogenous ligands for Gpr120 
(Fukunaga et al., 2006). Gpr120 was activated by both saturated and unsaturated fatty acids. 
Since fatty acids can bind to other receptors, development of specific ligands is of importance 
in achieving a targeted effect of receptor activation. Several compounds have been, and are 
still being developed as Gpr120 agonists. The first was GW9508, which was originally 
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developed as agonist for Gpr40 but also binds Gpr120 (Briscoe et al., 2006a). Other agonist, 
NCG21, which is also non-selective, was developed but not yet readily available (Sun et al., 
2010).  However, the drive to develop specific ligands for human Gpr120 led to the discovery 
of TUG891 (Hudson et al., 2013). Another small-molecule Gpr120 agonist (cpdA) was used 
to improve glucose tolerance, decrease hyperinsulinaemia, increase insulin sensitivity and 
decrease hepatic steatosis, and exert anti-inflammatory effect on macrophages in vitro and in 
obese mice in vivo, suggesting that Gpr120 agonists could become new insulin-sensitizing 
drugs for the treatment of type 2 diabetes and other human insulin-resistant states in the 
future (Oh da et al., 2014). Another agonist, TUG1096, thought to be highly selective for 
mouse Gpr120 was developed by our collaborator (Trond Ulven-University of Southern 
Denmark) but there is yet no published data. The pharmacological properties are therefore not 
immediately available. However, preliminary data (personal communication) has shown that 
at low concentration this agonist was able to activate the functions of Gpr120. 
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GW9508 
 
 
 
 
 
 
Molecular formula: C22H21NO3 
GW9508, also known as 4-[[(3-phenoxyphenyl) methyl] amino]-benzenepropanoic acid,  is a 
small-molecule agonist of Gpr40 and Gpr120 with a molecular weight of 347.41. It was 
originally identified from a high-throughput screen of the GlaxoSmithKline chemical 
collection (Briscoe et al., 2006a). Stimulation of intracellular Ca
2+ mobilization by GW9508 
in human embryonic kidney (HEK) 293 cells expressing Gpr40 and Gpr120 was observed 
with EC50values of 47 nM and 2.2 µM, respectively (Briscoe et al., 2006a). However, it was 
found to have distinct pEC50 potency values at human Gpr120 in various functional assays, 
with values of 6.07 ± 0.08 for intracellular Ca
2+ 
release, 6.04 ± 0.04 in β-arrestin-2 and 5.64 ± 
0.04 β-arrestin-1 recruitment assays (Hudson et al., 2013). 
The pharmacological mechanism of this agonist in the improvement of glycemic control 
remains unclear. Nevertheless it was found to dose-dependently potentiate glucose-dependent 
insulin secretion and the KCL-mediated increase in insulin secretion in MIN6 cells (Briscoe 
et al., 2006a), and to activate the Akt/GSK-3β pathway to increase glycogen levels in HepG2 
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cells (Ou et al., 2013), defining a function for this ligand in the regulation of glucose 
homeostasis. 
 
 
TUG891 
 
 
 
 
 
 
 
Molecular formula: C23H21FO3 
TUG891, also known as 4-[(4-Fluoro-4'-methyl [1, 1’-biphenyl]-2-yl) methoxy]-
benzenepropanoic acid is a recently developed compound (Hudson et al., 2013). It has a 
molecular weight of 364.41. At human Gpr120, its pEC50 values were found to be 6.93 ± 
0.07 for intracellular Ca
2+ 
release, 7.19 ± 0.07 in β-arrestin-2 and 6.83 ± 0.06 β-arrestin-1 
recruitment assays (Hudson et al., 2013). This ligand has been found to be more selective for 
human Gpr120 than mouse, where it also binds Gpr40. However, higher doses of  TUG891 
induced anti-inflammatory and anti- metabolic effects in 3T3-L1 cells (Hudson et al., 2013). 
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1.19 Hypothesis and Aims of the study 
The worldwide increase in obesity and its associated metabolic disorders represents a 
growing challenge for health care systems. The activation of human BAT is an opportunity to 
increase energy expenditure and weight loss, alongside improved lipid and glucose 
homeostasis. With the recent demonstration of significant deposits of adult BAT and the 
potential of tissue remodelling in response to temperature changes, new approaches targeting 
this tissue could provide effective treatments for obesity and its associated diseases, including 
insulin resistance, and diabetes. There is therefore a potential for a manipulative control of 
energy homeostasis via the induction of specific genes to enhance BAT levels.  
A preliminary microarray-based gene expression analysis of mice maintained for 10 days in 
either 6
0
C or 28
0
C, identified a number of genes whose expression changed with temperature 
changes. Two of the genes, Nrg4 and Gpr120, apart from being regulated in a temperature-
dependent manner, were highly expressed in BAT. Their expressions were significantly 
upregulated by cold acclimation. Based on these effects demonstrated and the high 
thermogenic capacity of BAT, Nrg4 and Gpr120 were chosen for further studies. 
The broad aim of the study is to determine the cellular processes and signalling factors and 
pathways of Nrg4 and Gpr120 in brown adipocytes. To address this hypothesis, the specific 
aims are: 
1. To investigate the expression of Nrg4 in adipocytes and its role in the activation of 
BAT function  
2. To investigate the expression of Gpr120 and determine factors that regulate the 
expression of Gpr120 in BAT 
3. To assess the role of Gpr120 via Gpr120 knockout models 
4. To investigate impact of novel and specific  Gpr120 ligands  
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5. To investigate the Gpr120 signalling pathways and determine their downstream role 
in brown adipocytes 
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Chapter 2 
 
Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63 
 
2.1 Materials 
 
2.1.1 Antibodies 
Primary antibodies 
ERK (Cell signalling 9102) 
Beta actin (Santa cruz 47778) 
GAPDH (Millipore MAB374) 
Tuj 1 (abcam14545) 
ERK1/2 (Cell Signalling D11A8) 
phospho-ERK1/2 (Cell Signalling 9101) 
phospho-p38 (Cell Signalling 9215) 
p38 (Cell Signalling 9212) 
phospho-AMPKα (Cell Signalling 2531) 
AMPKα (Cell Signalling 2532) 
Anti NRG4 (ab60090) 
 
Secondary antibodies 
HRP conjugated Goat Anti-rabbit IgG (Invitrogen 656120) 
HRP conjugated Rabbit Anti-goat IgG (Dako P0449) 
HRP conjugated Rabbit Anti-mouse IgG (Invitrogen 626520) 
 
2.1.2 Plasmids 
pcDNA3.1 (+) (Invitrogen) 
pGL3 basic (Promega) 
pGL3 basic- Nrg4 promoter and enhancer (generated during PhD) 
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pGL4 basic- Nrg4 promoter and enhancer (generated during PhD) 
pSuperior shNrg4 (generated during PhD) 
β-arrestin1-YFP 
β-arrestin2-YFP 
 
2.1.3 Chemicals and Reagents 
10mM dNTPs (Invitrogen) 
3-Methyadenine (3-MA) (Sigma) 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Sigma) 
10x MMLV buffer (Sigma) 
100x ROX reference dye (Sigma) 
5X Reporter lysis buffer (Promega) 
Agarose, molecular biology grade (Sigma) 
Ammonium persulphate (APS) (Sigma) 
Ampicillin (Sigma) 
Beta-mercaptoethanol (Sigma) 
Bovine serum albumin (BSA (Sigma) 
Bromophenol blue (Sigma) 
Chloramphenicol (Sigma) 
Chloroform (Sigma) 
Complete EDTA-free protease inhibitors tablets (Roche) 
Dexamethasone (Sigma) 
Dharmafect 3 (Dharmacon) 
Diethylpyrocarbonate (DEPC) - treated water (Sigma) 
Dimethyl sulfoxide (DMSO) (Sigma) 
 
 
65 
 
Dithiothreitol (DTT) (Sigma) 
DNase I, amplification grade (Invitrogen) 
Ethanol (BDH) 
Ethylenediaminetetraacetic acid (EDTA) 
Formaldehyde 16% (w/v) (Thermo Scientific) 
Forskolin (Enzo Life Sciences) 
Glycine (Sigma) 
IBMX (Sigma) 
Imidazole (Sigma) 
Indomethacin (Sigma) 
Insulin (Sigma) 
Jumpstart SYBR Green I Mix (Sigma) 
Lipofectamine 2000 (Invitrogen) 
Kanamycin (Sigma) 
Luciferase Assay Reagent (Promega) 
Methanol (Sigma) 
MMLV Reverse Transcriptase (Sigma) 
Non-fat milk powder (Sigma) 
Nonidet P-40 (NP-40) (BDH) 
Paraformaldehyde (PFA) (Sigma) 
PBS  
Phenylmethylsulfonyl fluoride (PMSF) (Sigma) 
Phosphatase inhibitors cocktail 2 and 3 (Sigma) 
Potassium Chloride (Sigma) 
PPARα agonist (GW-7647) (Sigma) 
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PPARα antagonist (GW-6471) (Sigma) 
PPARγ antagonist (GW-9662) (Sigma) 
PPARδ agonist (GW-501516) (Sigma) 
Propan-2-ol (BDH) 
Protogel 30% acrylamide (37.5:1 acrylamide to bisacrylamide) (National Diagnostics) 
Puromycin (Sigma) 
Random hexamers (Invitrogen) 
Restriction endnucleases and buffers (New England Biolabs) 
RNAse A (Sigma) 
RNAse OUT Ribonuclease inhibitor (Invitrogen) 
Rosiglitazone (Enzo Life Sciences) 
Sodium azide (Sigma) 
Sodium chloride (Sigma) 
Sodium dodecyl sulphate (SDS) (BDH) 
SYBR safe DNA gel stain (Invitrogen) 
Tetramethylethylenediamine (TEMED) (Sigma) 
TRIzol reagent (Sigma) 
tris(hydroxymethyl)aminomethane (Tris) (Sigma) 
Triton X-100 (Sigma) 
Tween-20 (Sigma) 
WY-14643 (Sigma) 
 
2.1.4 Kits 
Amplification grade DNase I kit (Sigma) 
BCA kit (Thermo Scientific) 
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cAMP EIA kit (Enzo Life Sciences) 
Fluo-4 Direct™ Calcium Assay Kit (Invitrogen) 
GenElute DNA Gel extraction kit (Sigma) 
HiSpeed Maxiprep kit (Qiagen) 
KOD DNA polymerase (Novagen) 
PCR array (SaBiosciences) 
Profection Mammalian cell Transfection kit (Promega) 
QIAprep Spin Miniprep kit (Qiagen) 
QIAquick PCR Purification Kit. (Qiagen) 
T4 DNA ligase (Invitrogen) 
 
2.1.5 Cell culture Materials 
Dulbeco‘s Modified Eagle Medium containing L-glutamine (DMEM) (Invitrogen) 
Dulbeco‘s Modified Eagle Medium containing L-glutamine (DMEM-F12) (Invitrogen) 
Heat Inactivated Fetal Bovine Serum (FBS) (Invitrogen) 
Heat Inactivated Newborn Calf Serum (NCS) (Invitrogen) 
100x Penicillin (100 U/mL)/ Streptomycin (50 μg/ml) (Invitrogen) 
RPMI (Invitrogen) 
Tissue Culture Plasticware and cell culture plates/dishes (Corning) 
0.05% Trypsin-EDTA (Invitrogen) 
Optimem reduced serum medium (Invitrogen) 
 
2.1.6 Cell lines 
Immortalized brown adipose tissue cell line (Wild type IMBAT cells, generated in the lab) 
Immortalized-Gpr120 Knockout (KO) and Gpr120 Heterozygous (Het) (from Karsen 
Kristiansen’ lab, University of Copenhagen). 
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PC12/HER4 cells (provided by Prof William Gullick, University of Kent) 
HEK293 human embryonic kidney cells 
 
2.1.7 Mouse tissues 
FVBN female 
CB53-Gpr120 WT and KO BAT 
 
2.1.8 Buffers and solutions 
High Salt Buffer 
20 mM Tris-HCl pH 8.1 
500 mM NaCl 
2 mM EDTA 
0.1% SDS 
1% Triton-X100 
 
Lithium Chloride Buffer 
10 mM Tris-HCl pH 8.1 
250mM LiCl 
1 mM EDTA 
1% Nonidet p40 
1% Deoxycholate 
 
Low Salt Buffer 
20 mM Tris-HCl pH 8.1 
150 mM NaCl 
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2 mM EDTA 
0.1% SDS 
1% Triton-X100 
 
SDS Lysis Buffer 
0.5 M Tris-HCl pH 8.1 
10 mM EDTA 
1% SDS 
1% Triton-X100 
0.5% Deoxycholate 
 
RIPA Buffer  
20nM Tris-HCl pH 7.5  
1 mM Na2 EDTA 
1 mM EGTA 
150 mM NaCl 
1% NP-40 
1% sodium deoxycholate  
2.5 mM sodium pyrophosphate 
1 mM Na3 VO4  
 
Swelling Buffer 
25 mM HEPES pH 7.9 
1.5 mM MgCl2 
10 mM KCl 
0.1% Nonidet 
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Tris-EDTA (TE) buffer 
10 mM Tris, pH 8.0 
1 mM EDTA, pH 8.0 
 
New England Biolabs Restriction Endonuclease Buffers (10x) 
NEBuffer 1 
10mM Tris Propane-HCl pH 7.0, 10mM MgCl2, 1mM DTT 
NEBuffer 2 
10mM Tris-HCl pH 7.9, 10mM MgCl2, 50mM NaCl, 1mM DTT 
NEBuffer 3 
50mM Tris-HCl pH 7.9, 10mM MgCl2, 100mM NaCl, 1mM DTT 
NEBuffer 4 
 
20mM Tris-Acetate pH 7.9, 10mM MgCl2, 50mM potassium acetate, 1mM 
DTT 
Qiagen Buffers 
 
Plasmid prep suspension buffer P1 
50 mM Tris-HCl, pH 8.0 
10 mM EDTA 
100 mg/ml RNase A 
 
Plasmid prep lysis buffer P2 
200 mM NaOH 
1 % w/v SDS 
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Plasmid prep neutralization buffer P3 
3 M KAc pH 5.5 
Plasmid prep equilibration buffer QBT 
750 mM NaCl 
50 mM MOPS, pH 7.0 
15 % v/v isopropanol 
 
Plasmid prep wash buffer QC 
1 M NaCl 
50 mM MOPS, pH 7.0 
15 % v/v isopropanol 
 
Plasmid prep elution buffer QF 
1.25 M NaCl 
50 mM Tris-HCl, pH 8.5 
15 % v/v isopropanol 
 
Plasmid prep elution buffer EB 
10 mM Tris-HCl, pH 8.5 
Tris-EDTA (TE) buffer 
10 mM Tris, pH 8.0 
1 mM EDTA, pH 8.0 
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Western Blotting Buffers 
Blocking Solution 
5% (w/v) non-fat milk powder in TBS-T or 5% (w/v) BSA in TBS-T 
NuPAGE® Tris-Acetate SDS Running Buffer 
Tris base 50 mM pH 8.24 
Tricine 50 mM 
SDS 0.1% 
 
SDS Running buffer 
25mM Tris pH 8.3 
190mM glycine 
0.1% (w/v) SDS 
 
Transfer Buffer 
48 mM Tris-base pH 8.0 
39 mM Glycine 
0.037% (w/v) SDS 
20 % (v/v) methanol 
 
Tris Buffered Saline-Tween (TBS-T) 
130mM NaCl, 
20mM Tris, pH 7.6 
Tris Buffered Saline- Tween 20 (TBS-T) 
130mM NaCl, 
20mM Tris, pH 7.6, 
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0.1% Tween 
 
Miscellaneous Buffers 
10x DNA loading buffer: 
0.2% (w/v) Bromophenol blue 
40% (v/v) Glycerol 
100mM EDTA pH 8.0 
10x DNAase I Reaction Buffer (Sigma) 
200 mM Tris-HCl, pH 8.3 
20 mM MgCl2 
 
10x M-MLV Reverse Transcriptase Buffer (Sigma) 
500 mM Tris-HCl, pH 8.3 
500 mM KCl, 
30 mM MgCl2 
50 mM DTT 
 
2x Laemmli loading buffer: 
50 mM Tris-HCl, pH 6.8 
50 mM Imidazole, pH 6.8 
1% (w/v) SDS 
10% (v/v) Glycerol 
2% (v/v) 2-Mercaptoethanol 
0.002% (w/v) Bromophenol blue 
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5x T4 Ligase Buffer (Invitrogen) 
250mM Tris HCl pH7.6 
50mM MgCl2 
5mM ATP 
5mM DTT 
25% (w/v) polyethylene glycol-8000 
 
Antibody Dilution buffers 
5% non-fat milk in TBS-T with 0.1% (v/v) NaN3 
5% BSA in TBS-T with 0.1% (v/v) NaN3 
DNase Stop solution 
50 mM EDTA 
 
Oil Red O Stock solution 
0.7g Oil Red O 
200ml isopropanol 
Oil Red O Working solution 
6 Parts of Oil Red O Stock and 4 of dH20 
 
Phosphate Buffered Saline (PBS) 
140mM NaCl 
2.5mM KCl 
1.5mM KH2PO4 pH7.2 
10mM Na2HPO4 pH7.2 
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Protein lysis buffer 
1% Triton-X 
Tris pH 7.0 
150mM NaCl 
1mM PMSF 
1x protease inhibitor cocktail 
1x phosphatase inhibitor cocktail 2 and 3 
 
Renilla Buffer 
0.5M HEPES pH 7.8 
40mM EDTA 
 
Stripping Buffer (Protein) 
100mM β-Mercaptoethanol 
2% (w/v) SDS, 
62.5mM Tris-HCl pH 6.7 
Tris Borate EDTA (TBE) 
90mM Tris Borate 
2mM EDTA pH 8.0 
 
2.1.9 Bacterial strains and Media 
LB-agar 
1% (w/v) Bactotryptone, 
0.5% (w/v) Yeast Extract, 
0.5% (w/v) NaCl, 
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0.1% (w/v) Glucose, 
1.5% Bactoagar 
 
LB-broth 
1% (w/v) Bactotryptone, 
0.5% (w/v) Yeast Extract, 
0.5% (w/v) NaCl, 
0.1% (w/v) Glucose 
 
S.O.C Medium (Invitrogen) 
2% Bactotryptone 
0.5% Yeast Extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 
 
2.1.10 Competent Cells 
DH5α chemically competent cells 
DH5α electrocompetent cells 
Electrocompetent Top10 
 
2.1.11 SDS gels 
Resolving gels 
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375 mM Tris-HCl, pH 8.9 
0.1 % w/v SDS 
10 %, 12% or 14% v/v acrylamide/bis-acrylamide (37.5:1) 
0.03 % w/v APS 
0.06% v/v TEMED 
 
Stacking gels 
80 mM Tris-HCl, pH 6.8 
80 mM Imidazole pH 6.8 
0.1 % w/v SDS 
4.1 % v/v acrylamide/bis-acrylamide (37.5:1) 
0.09 % v/v APS 
0.09 % v/v TEMED 
 
Miscellaneous 
Amicon 10,000 NMWL centrifugal filter units (Millipore) 
ECL Plus Western Blotting Detection System (Thermo Scientific) 
Electroporation Cuvettes (Cell projects) 
Hyperladder I and IV DNA ladders (Bioline) 
Immobilon Polyvinylidene difluoride (PVDF) membrane (Millipore) 
Oil Red O (Sigma) 
Oligonucleotides (Invitrogen) 
Optically clear adhesive seal sheets (Appleton Woods) 
PageRuler pre-stained protein ladder (Fermentas) 
RNase ZAP (Ambion) 
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Super RX autoradiography film (Fujifilm) 
384-well plates for qRT-PCR (Applied Biosystems) 
NuPAGE® Novex 7% Tris-Acetate Gel 1.5 mm, 10 Well 
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2.2 Methods 
2.2.1 Cell culture 
PC12/HER4 cells: Cells were grown in RPMI-1640 supplemented with 10% horse serum 
and 5% FBS , 1% L-glutamine and 1%penicillin/streptomycin in 75cm
2
 tissue culture flasks, 
and incubated at 37
0
C in a humid atmosphere maintained at 5% (v/v) CO2
 
(BOC Ltd, 
Guildford, UK). The medium was replenished every 2-3 days and culture was passaged 
depending on the growth rate. When the cells were approaching confluence, the medium was 
removed and the cells washed with PBS, incubated for 1 minute at 37
0
C with 1ml of pre-
warmed trypsin-EDTA, replenished with medium and transferred to a 15ml centrifuge tube. 
The tube was centrifuged at 1,000 rpm for 10 minutes and the pellet was gently re-suspended 
in 10ml of pre-warmed fresh medium. A proportion of the cells was diluted and used to re-
seed a new flask; another proportion was used to seed in culture plates. For study of neurite 
outgrowth, cells were plated on poly-L-lysine-coated glass coverslips and exposed to 
unconditioned DMEM-F-12, 10% FBS medium, or conditioned medium from differentiated 
adipocytes. 
Cells were also prepared for storage in liquid nitrogen. Cells were trypsinized and pelleted as 
described above. The pellets were re-suspended in media containing 10%v/v DMSO. 1 ml 
aliquots of cells were placed in cryogenic vials and then placed in an isopropanol-filled 
freezing container, to ensure a constant cooling rate of 1 °C/min at -80 °C. The vials were 
then transferred into liquid nitrogen for long term storage. Cells recovered from liquid 
nitrogen were thawed in a 37 °C water bath and added to 20 ml of pre-warmed 10% (v/v) 
FBS in DMEM in a 75cm2 flask. 
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2.2.2 Generation of immortalized cell lines.  
Primary cultures of brown adipose and subcutaneous, mesenteric, and gonadal white adipose 
tissues were generated by first digesting the tissue with collagenase and pelleting the stromal 
vascular fraction. Preadipocytes were purified by collecting the cells that passed through 100 
m of mesh. Next, cells were passed through strainers of 70- or 25µm mesh size for brown and 
white preadipocytes, respectively, and were plated and cultured in DMEMF-12, 10% FBS, 
and 1% antibiotic-antimycotic. After culture for 2 days, preadipocytes were immortalized by 
retroviral-mediated expression of temperature-sensitive SV40 large T-antigen H-2kb-tsA58 
(a gift from Prof P. Jat, UCL). Cells were cultured at 33
0
C and selected with G418 (100 
mg/ml) for 2 week and then maintained in 50 mg/ml G418. Experiments were performed 
between passages 12 and 22. Cells were differentiated as described below. 
 
2.2.3 Culture and differentiation of IMBAT cells 
Immortalized brown adipocytes were cultured and maintained in 75cm
2
 flasks at 33
0
C, 10% 
CO2 with DMEM/F12, 1:1 (Life Technologies, Paisley, Scotland), supplemented with 4.5 g/l 
glucose, 10% FBS (Sigma–Aldrich Co.; St. Louis, MO, USA), 1% penicillin/streptomycin 
(BioWhittaker, Vervier, Belgium), and 1% L-glutamine . Cells were plated in 6-well plates 
and incubated at 37
0
C and 5% CO2 for treatment with ligands. Two days after attaining 
confluence, induction of differentiation was started. At the end of the differentiation, 
conditioned medium from differentiated cells was obtained and used to treat PC12/HER4 
cells. 
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IMBAT: For standard differentiation protocol: An induction medium was used for the 
first 2-3 days, and then a maintenance medium until full differentiation; the maintenance 
medium changed every 2-3 days.  
Induction medium     Maintenance medium  
Standard culture medium    Standard culture medium  
1nM Triiodothyronine (T3)    1nM Triiodothyronine (T3) 
170nM Insulin     170nM Insulin 
500µM IBMX 
250nM Dexamethasone 
125nM Indomethacin     
 
2.2.4 Oil Red O staining 
IMBAT cells were fixed with 4% parafomaldehyde in PBS for 20 minutes at room 
temperature and washed twice with PBS buffer. An ORO stock was diluted 60:40 in water 
and filtered. 200µl ORO was added to each well for 30 minutes at room temperature. This 
was washed off twice with 60% isopropanol and rinsed with PBS. ORO-stained cells in PBS 
were viewed with a light microscope. 
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2.2.5 Immunostaining of PC12/HER4 cell: 
PC12/HER4 cells were treated with conditioned medium from differentiated IMBAT cells. 
Following the development of neurite outgrowths cells were fixed in 4% paraformaldehyde 
(PFA) for 30 minutes. Fixed cells were washed three times in PBS and were replaced with a 
blocking solution comprising 0.5% BSA, 0.05% Saponin and 50mM ammonium chloride in 
PBS. This was incubated for 20 minutes at room temperature, and washed with PBS. Then 
1µl Tuj1 (primary antibody, raised in mouse) in 250µl blocking solution preserved in 2.5µl 
sodium azide, was added. After an overnight incubation in the primary antibody at 4
0
C, the 
cover slip was removed and washed 3 times in PBS, and a secondary antibody diluted in 
blocking solution was incubation at room temperature for 45 minutes. The secondary 
antibody used was conjugated to alexer 555nm wavelength, and raised in mouse. The cells 
were washed 3 times with PBS and mounted in DAPI-antifade reagent (Invitrogen). The 
immunostained cells were then visualised with the confocal microscope.  
 
2.2.6 Western Blotting:  
The Cells were lysed with RIPA buffer, mixed with EDTA, Protease Inhibitor (cocktail 
roche), 1mM PMSF, 5mM Sodium fluoride, and 500mM sodium orthovanadate. Lysates 
were transferred into 1.5ml tubes, incubated on ice for 5 minutes, and centrifuged at 12,000g 
for 5 minutes at 4
0
C. The supernatant was then transferred into pre-cooled 1.5ml tubes, and 
snap frozen. 2µl of lysates was used for the determination of protein concentration. 
 
2.2.7 Determination of protein concentration (BCA assay) 
Three replicates of each sample and standards were used in a 96- well plate. The BCA kit 
(Thermo Scientific, USA) was used for the preparation of the standard, and 50 part reagent A 
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were mixed with 1 part reagent B. 100µl BCA preparation was added to all samples and 
standards and the plate incubated for 30 minutes at 37
0
C, then allowed to cool at room 
temperature. The protein concentrations were read with a spectrophotometric plate reader at 
562nm.  
 
2.2.8 SDS-polyacrylamide gel electrophoresis: 
10-20µg of the protein was diluted to 20µl, an equal volume of laemmli 2X buffer was added 
and the sample heated for 5 minutes at 95
0
C before loaded into a 12% polyacrylamide gel. 
The gel was run for 1 hour at 150 volts, and the separated proteins transferred onto a PVDF 
membrane at 100 volts and 230mA for 2 hours. Membranes were blocked for 1 hour in 5% 
BSA in TBS-T and incubated in primary antibody overnight at 4
0
C. After washing three 
times with TBS-T, the membranes were then incubated in secondary antibody for 1 hour at 
room temperature. The membranes were then washed three times with TBS-T and ECL+ 
added to the membranes and placed on saran wrap. The proteins of interest were detected 
with a chemiluminescent imager following manufacturer’s instructions. Densitometry was 
carried out by analysing Western blot images for p-ERK and total-ERK, and for the phospho-
kinase array with ImageJ software. 
 
2.2.9 RNA preparation: 
Total RNA was isolated from cells and tissues using TRIzol Reagent. To avoid ribonuclease 
(RNAase) contamination RNAase-free tips, tubes and DEPC-treated water were used. 
Moreover, disposable gloves were worn at all times and the surfaces and pipettes were 
cleaned with RNAase Away. Each sample was homogenised in 1ml TRIzol per 50-100mg 
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tissue using a power homogenizer. 1ml TRIzol was added per well of a 6-well plate to lyse 
the cells and the lysate was transferred to a 1.5ml microcentrifuge tube. The homogenised 
samples were incubated for 5 minutes at room temperature to permit the complete 
dissociation of nucleoprotein complexes. 0.2ml of chloroform was then added per 1ml of 
TRIzol. The sample was mixed vigorously, incubated for 2-3 minutes at room temperature 
and centrifuged at 12,000g for 15 minutes at 4
0
C. Following centrifugation, the mixture 
separated into a lower organic red, phenol-chloroform phase, an interphase, and a colourless 
upper aqueous phase. RNA remained exclusively in the aqueous phase while DNA and 
proteins remained in the interphase and in the organic phase respectively. Total RNA was 
precipitated from the aqueous phase by mixing with 0.5ml isopropanol per 1ml TRIzol, 
incubated for 10 minutes at room temperature and pelleted by centrifuging at 12,000g for 15 
minutes. The pellet was then washed with 1ml of 75% ethanol and air-dried. The RNA pellet 
was dissolved in RNase-free water and the concentration determined from the absorbance at 
260 nm with a NanoDrop ND1000 spectrophotometer and samples were stored at -80ºC. 
  
2.2.10 cDNA preparation:  
One microgram of total RNA was reverse-transcribed to cDNA in a 20µl reaction volume. 
Then 1µg RNA was diluted to 4µl and DNAse treated with 0.5µl DNAse I Amplification 
grade (Sigma-Aldrich) for 15 minutes, to remove any genomic DNA which would be 
amplified along with the target cDNA, and 0.5µl Reaction Buffer (Invitrogen) for 15 minutes 
at RT. 0.5 µl EDTA (25mM, Invitrogen) pH 8.0 was added to stop the reaction, and sample 
incubated at 65
0
C for 10 minutes, then on ice. A mastermix containing 1µl Random hexamers 
(50ng/µl, Invitrogen) and 1µl dNTP (10mM, Invitrogen) and 4.5µl water was added to the 
sample, heated at 65
0
C for 5 minute and cooled on ice. Another mastermix containing 4µl 5X 
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reverse transcriptase buffer (invitrogen), 2µl 0.1M DTT (Invitrogen) and 1µl RNase OUT
TM
 
(Invitrogen) was added to each sample and incubated at 37
0
C for 2 minutes. Finally, 1µl M-
MLV (Invitrogen) was added to each sample and a cycle of incubation was done at 25
0
C for 
10 minutes, 37
0
C for 50 minutes and 70
0
C for 15 minutes, and thereafter the 20µl reaction 
volume was diluted to 200 with water. The synthesized cDNA was then used for quantitative 
real-time PCR (qRT-PCR) or stored at -20
o
C. 
 
2.2.11 Primer design 
Primers were designed to give a product of approximately 100 bp crossing intron exon 
boundaries to eliminate the amplification of genomic DNA. Sequences were obtained from 
Ensembl mouse genome database and applied to the software Primer Design or Primer 3. 
Primers were dissolved in DEPC-treated water to a final concentration of 100 pmol/μl, this 
was then diluted again to a working concentration of 20 pmol/μl. The primers used for q-RT-
PCR are listed in the Appendix.  
 
2.2.12 q-RT-PCR:   
For each gene tested, a master mix of the samples was prepared. The master mix of 16µl 
consisted of the following: 10µl SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich), 
0.15µl each of the forward and reverse primers (at 20µM), 0.2µl ROX (Sigma-Aldrich) and 
5.5µl DEPC-treated water. This was added into each well followed by 4µl cDNA, giving a 
reaction volume of 20µl. 4µl DEPC-treated water was added to the non-template control 
(NTC) in place of cDNA. Two replicates were loaded for each sample and two wells of the 
plate were used as the NTC. The plate was then sealed with optically clear adhesive seal 
(4titude), centrifuged for 2 minutes at 1,000 rpm and loaded into the PCR machine. qRT-PCR 
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was carried out using either 7900HT Fast Real-Time PCR System (Applied Biosystems) or 
StepOnePlus Real-Time PCR Systems (Applied Biosystems/(Life Technologies Corporation, 
Carlsbad, CA, USA). The samples were programmed to run at an initial denaturation 
temperature of 95
0
C for two minutes, and then melting, annealing and elongation 
temperatures of 95
0
C for 15 seconds, 60
0
C for 30 seconds and 72
0
C for 30 seconds 
respectively for a total of 40 cycles. Gene expression was normalised with the expression of 
the housekeeping gene β-actin, and the relative gene expression was calculated using the 2-
ΔΔCT
 method (Livak and Schmitgen, 2001). 
 
2.2.13 Bacterial propagation of plasmids 
2.2.13.1 Transformation of chemically competent DH5α E.coli by heat shock 
For the preparation of large plasmid DNA quantities, chemically competent DH5α cells were 
thawed on ice (typically 50μl). In a microcentrifuge tube, bacteria were mixed with the 
relevant plasmid (50 ng DNA). After 30 minutes on ice, cells were heat shocked in a 42
o
C 
water bath for 30 seconds and then placed on ice for a further two minutes. Then 200 μl of 
SOC medium was added to the reaction and the cells incubated at 37
o
C for 1 hour. The cells 
were then spread on L-agar plates containing 100μg/ml ampicillin to select for transformants. 
The plates were inverted and incubated at 37
o
C overnight and the next day colonies were 
picked. 
 
2.2.13.2 Transformation of electrocompetent Top10 or DH5α E.coli by electroporation 
Electrocompetent DH5α cells were thawed on ice. 50μl of bacteria was mixed with the 
ligation in a pre-chilled 1mm electroporation cuvette and electroporated using a Bio-Rad 
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gene pulser, at 1.65kV, giving a time constant of approximately 4 milliseconds. Following 
electroporation, 200μl SOC medium was added and the cells were incubated at 37oC for 1h, 
and then spread on L-agar plates containing 100μg/ml ampicillin, inverted and incubated at 
37
o
C overnight and the next day colonies were picked. 
 
2.2.14 Small-scale preparation of plasmid DNA (Miniprep) 
Individual bacterial colonies were used to inoculate 5 ml of LB containing 50μg/ml 
ampicillin and incubated in a shaking incubator at 37
o
C overnight. Bacteria were then 
pelleted by centrifugation for 15 min, at 3900 rpm at 4
o
C. Plasmid DNA was purified by 
using QIAprep Spin MiniPrep Kit. Cells were resuspended in 250 μl buffer P1 and lysed 
under alkaline conditions by the addition of 250μl buffer P2. The lysates were subsequently 
neutralised and adjusted to high-salt binding conditions by the addition of 350μl of buffer N3. 
Samples were centrifuged and the supernatants were passed through a silica membrane. The 
membrane allowed selective adsorption of plasmid DNA under the high-salt conditions, 
while RNA, cellular proteins, and metabolites flow through. Endonucleases were removed by 
a wash step with buffer PB to ensure plasmid DNA was not degraded. The membrane was 
then desalted by the addition of 750μl of buffer PE. Plasmid DNA was eluted with 50μl 
elution buffer. Eluted DNA was suitable for diagnostic digestion or sequencing. 
 
2.2.15 Large-scale plasmid DNA preparation (Maxiprep) 
Higher amounts of recombinant plasmids were prepared by using the Qiagen HiSpeed Maxi 
Kit and were suitable for mammalian cell transfection. As described above, a single colony 
was picked and 5 ml of LB broth containing 50μg/ml ampicillin was inoculated and grown at 
37
o
C for approximately 8 h with continuous shaking. This was then diluted into 200 ml of LB 
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broth with 50μg/ml ampicillin, which was incubated overnight at 37oC with constant shaking. 
Bacteria were recovered by centrifugation at 3900 rpm for 15 min at 4
o
C. Supernatants were 
removed and pellets were processed according to the manufacturer’s protocol. The protocol is 
based on a modified alkaline lysis procedure in which bacterial cells (suspended in buffer P1) 
were lysed in sodium hydroxide/SDS in the presence of RNase A (buffer P2). SDS 
solubilised the phospholipid and protein components of the cell membrane, leading to cell 
lysis. Sodium hydroxide denatured chromosomal DNA, plasmid DNA and proteins, while 
RNase A digested the liberated RNA. The lysate was neutralized by the addition of acidic 
potassium acetate (buffer P3). The high salt condition caused SDS to precipitate with the 
denatured proteins, chromosomal DNA and cellular debris, trapped in salt-detergent 
complexes. The smaller, covalently closed plasmid DNA re-natured and remained in solution. 
The lysates were passed through a pre-equilibrated (buffer QBT) anion-exchange resin 
operating by gravity flow under low salt and low pH conditions to trap the plasmid DNA, 
RNA, protein, dyes and low-molecular weight impurities were removed by a medium salt 
wash (buffer QC). Plasmid DNA was eluted in a high salt buffer (buffer QF) and then 
concentrated and desalted by isopropanol precipitation. The purified DNA was washed with 
70 % v/v ethanol, air-dried and redissolved in TE buffer. DNA concentration was measured 
with a Nanodrop ND1000 spectrophotometer. 
 
2.2.16 Cloning 
2.2.16.1 ShNrg4 constructs:  
The primers were designed using the Oligoengine software. The pSUPERIOR vector was 
used in concert with the custom oligonucleotides that were designed to target the Nrg4 
mRNA. The pSUPERIOR vector was cut with BglII and NotI enzymes and 
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dephosphorylated. The sense and antisense oligos were annealed, phosphorylated and ligated 
into the vector between the BglII and HindIII enzyme sites and the product transformed into 
electro competent E.coli for miniprep and sequencing. The plasmid DNA was then used to 
transfect IMBAT cells. IMBAT cells were plated on a 6-well plate and, at 80% confluence, 
transfected with shNrg4 plasmid according to standard protocol with lipofectamin2000 
(invitrogen, USA). A Puromycin kill-curve was used to arrive at the dose that effectively 
selected the stable cell line expressing the antibiotic resistant gene. Transfected cells were 
selected with 5μg/ml puromycin and knockdown of Nrg4 assessed. 
 
2.2.16.2 5’RACE:   
The transcription start site was determined using FirstChoice® RLM-RACE Kit (Part 
Number AM1700). Primers were designed according to the manufacturer’s instructions. A 
taq polymerase was used to amplify the PCR reaction. A 50μl reaction volume was cycled at 
an initial denaturation temperature of 98
0
C for 30 seconds, and then 35 cycles comprising 10 
seconds denaturation at 98
0
C, 30 seconds annealing at 60
0
C and 30 seconds elongation at 
72
0
C, and a final extension step at 72
0
C for 10 minutes. The PCR product was then purified, 
ligated into topo TA cloning vector (Invitrogen, USA) according to the manufacturer’s 
instructions and transformed into electro competent E-coli for miniprep and sequencing. The 
plasmid DNA was digested with EcoRI. Analysis of restriction enzyme digestions was 
performed via agarose gel electrophoresis.  The presence of the inserted gene was identified 
via sequencing.  
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2.2.17 Restriction digests 
Restriction enzyme digests were performed using enzymes from New England Biolabs at 
37
o
C in the buffers recommended by the manufacturer supplemented with 100x BSA where 
required. DNA was digested with excess of enzyme. For analysis of digestion products, 
reactions were terminated by the addition of 10x DNA loading buffer and analysed by gel 
electrophoresis. 
 
 2.2.18 PCR for cloning 
The KOD Hot Start DNA polymerase was used to amplify DNA. KOD polymerase is a high-
fidelity, proofreading and has 3‘to 5‘exonuclease activity, so PCR products are of high 
fidelity. In 0.2ml PCR tubes 1ng plasmid DNA or 200ng genomic DNA or 2μl of a 20μl 
reverse transcriptase reaction mix was mixed with 5μl of 10X PCR Buffer for KOD Hot Start 
DNA Polymerase, 3μl of each forward and reverse primers (at final concentration of 0.3μM), 
5 μl dNTPs (final concentration 0.2 mM), 2 μl MgSO4 (final concentration 1 mM), 1μl KOD 
Hot Start DNA Polymerase (1 U/μl) and PCR grade water to a final volume of 50μl. At the 
same time non-template control reactions were set up. PCR run conditions were set based on 
the size of the amplified fragment. 
 
2.2.19 DNA agarose gel electrophoresis 
Molecular biology agarose was dissolved in 1x TBE in a canonical flask to give the 
appropriate percentage gels around 1-2 % (w/v). The suspension was heated in a microwave 
oven until boiling. The solution was allowed to cool, 0.5μg/ml ethidium bromide or sybr safe 
was added, and poured into appropriate trays with combs. Once set, the gel was submerged in 
1x TBE buffer in a gel tank. DNA samples were mixed with 10x DNA loading buffer and 
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loaded into the wells along with the appropriate DNA ladder. Electrophoresis was carried out 
at 100V. DNA was visualised and photographed by illumination on a long wave UV light 
box. 
 
2.2.20 PCR purification 
2.2.20.1 Gel extraction of DNA 
Restriction fragments were purified from TBE agarose gels using GenElute DNA Gel 
Extraction kit according to manufacturer‘s protocol. DNA bands of the desired molecular 
weight were cut from the gel with a clean scalpel under UV light. The gel slice was weighed 
and 3 volumes of gel solubilisation solution were added. The gel mixture was incubated at 
50
o
C for 10 min with occasional mixing until the gel slice was completely dissolved. At the 
same time, the binding column was prepared by adding 500μl of column preparation solution 
and centrifuging at 13,000 rpm for 1min and discarding the flowthrough. 1 gel volume of 
100% isopropanol was added and mixed. The solubilized gel solution was loaded to the 
prepared binding column and centrifuged at 13,000rpm for 1min. DNA binds to silica 
membrane and was washed with 700μl of wash solution. Residual ethanol was removed by 
centrifugation for 1min. DNA was eluted by adding 30-50μl of elution buffer to the 
membrane, and the concentration of the eluted DNA was measured with the Nanodrop 
spectrophotometer (ND-1000, Ladtech International). 
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2.2.21 DNA sequencing 
Plasmid DNA was mixed with 3.2 pmol of sequencing primer to a total volume of 10μl. DNA 
sequencing carried out by Beckman Coulter Genomics, and the chromatographs were 
analysed with the 4Peaks software.  
 
2.2.22 siRNA transfection of IMBAT cells  
Undifferentiated or differentiated IMBAT cells were transiently transfected in 24 or 12-well 
plates using Lipofectamine RNAiMax reagent. Undifferentiated IMBAT cells were seeded 
into wells and grown in 10 % FBS and 1% L-glutamine in DMEM/F-12 without antibiotics 
until they were 80% confluent. The following day, the transfection mixes were prepared as 
follows: in an appropriate size tube siRNA was diluted in 50μl/100μl Opti-MEM® I reduced 
serum medium and mixed gently, whereas in a separate tube the appropriate volume of 
lipofectamine RNAiMax reagent was diluted in Opti-MEM® I reduced serum medium, 
mixed and incubated at room temperature for 5 minutes. The diluted siRNA and diluted 
lipofectamine were combined, gently mixed and incubated for 25 minutes to allow siRNA-
lipofectamine complexes to form. The transfection mix was then added to each well. After 
24h, transfection media was replaced with normal growth media and allowed a further 24 
hours before the cells were treated and harvested. 
For transfection of differentiated cells, following 7 days of differentiation cells in 6-well 
plates were washed with PBS and trypsinized (Trypsin added to cover cells then immediately 
removed; trypsin coated wells were kept in 37°C for one minute). Cells were resuspended in 
2ml medium (10% serum, 1% L-glutamine) without antibiotics. Cell were reverse transfected 
(while settling) with siRNA using Lipofectamine RNAiMAX diluted in OptiMEM reduced 
serum medium following manufacturers protocol, and the siRNA and lipofectamine complex 
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was incubated for 25 minutess.  Cells were left in transfection reagents overnight. Next day, 
each well was washed with DMEM/F-12 medium containing 10% FBS, 1% L-glutamine and 
1% Pen/strep. 2 mls of this media was then added to each well and left at 37°C for 24 hours. 
Cells were treated and harvested the following day (48h after transfection). 
 
2.2.23 Reporter Gene assays 
IMBAT cells were plated on 96-well plates washed with PBS and lysed in 25 μl 1x Reporter 
lysis buffer. The plates were then placed on a shaker for 5min and then placed at -80
o
C for 
storage or for a freeze-thaw step which is required for the appropriate lysis of the cells. Plates 
were then thawed and 10 μl of each lysate was transferred to a white 96-well plate. 50 μl of 
the luciferase assay reagent was then added to each well and immediately the luciferase 
activity was measured by reading luminescence on Victor2 plate reader (Perkin Elmer). The 
remaining lysates were used to measure luciferase activity to normalise firefly activity 
measurements. Thus, 10 μl of each lysate was transferred to a white 96-well plate together 
with 50 μl of Coelenterazine in Renilla buffer. Plates were incubated in dark at room 
temperature for 20 minutes and then read as described above. Each firefly luciferase activity 
was divided by Renilla activity to correct for variations in the transfection efficiency. 
 
2.2.24 Calcium mobilisation assay 
IMBAT cells were seeded into 35mm tissue culture treated dishes maintained in medium 
containing 10% FBS and 1% Penicillin/Streptomycin in DMEM/F-12 in an incubator (5% 
CO2 at 37°C) and grown to confluence. On the day of assay the Fluo4-AM dye was prepared 
according to the manufacturer‘s instructions. 2x calcium sensitive Fluo-4-AM was mixed 
with the same volume of culture medium, and cells were incubated for 30min in an incubator, 
 
 
94 
 
and a further 30min at room temperature. Plates were then placed for live cell imaging on the 
SP5 confocal microscope (Leica) using the LAS‐AF program. Cells were imaged with 20x 
objective at room temperature, capturing images every 1.2 sec for ~ 5min. DMSO was used 
to initially stimulate the cells to obtain a baseline control. Thereafter, the cells were 
stimulated with different ligands. The data exported from the program as values based on the 
fluorescence emitted by the experiment. These values were exported to Excel and the basal 
average intensity from the first 1min was subtracted. Ca
2+
 transient responses were reported 
as fold-change in Ca
2+
 dye fluorescence relative to the baseline signal. 
 
2.2.25 cAMP Accumulation Assays 
Undifferentiated IMBAT cells were seeded into 24 well plates. On reaching confluence the 
cells were serum starved overnight and pre-treated with 500μM IBMX, a phosphodiesterase 
inhibitor, for 5 min. Cells were then treated with 100μM GW9508, 10μM TUG891 or 10µM 
TUG1096 for 30min in the presence or absence of 3uM forskolin, an activator of adenyly 
cyclase. The experiment was terminated with the addition of 0.1 % HCl- Triton X-100. 
cAMP was measured using a competitive enzyme immunoassay (Enzo Life Sciences) 
according to the manufacturer‘s instructions, and normalised to protein concentration 
estimated using the BCA assay. 
 
2.2.26 β-arrestin recruitment assays 
IMBAT cells were plated on polyD-lysine coated cover slips in 24-well plates in 10% FBS 
and 1% Penicillin/Streptomycin in DMEM/F-12 media. On reaching 80 to 90% confluence 
cells were transfected with YFP-tagged β-arrestin-1 or β-arrestin-2 plasmid for 72 hours, 
using Lipofectamine 2000 as follows: In an appropriate size tube DNA was diluted in 
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50μl/100μl Opti-MEM® I reduced serum medium and mixed gently, whereas in a separate 
tube the appropriate volume of lipofectamine 2000 reagent was diluted in Opti-MEM® I 
reduced serum medium, mixed and incubated at room temperature for 5 minutes. The diluted 
DNA and diluted lipofectamine were combined, gently mixed and incubated for 20 minutes 
to allow DNA-lipofectamine complexes to form. The transfection mix was then added to each 
well and after 24h, transfection media was replaced with normal growth media and allowed a 
further 48 hours before the cells were treated ligands. The cells were treated with 100µM 
GW9508, 10µM TUG891 or 10µM TUG1096 for 1, 5 and 20 minutes. Another set was 
treated with DMSO and served as untreated control. Following treatment, the cells were 
immediately fixed in 4% paraformaldehyde (PFA) for 30 minutes. Fixed cells were washed 
three times in PBS and mounted on to coverslips with Fluoromount G. Images were taken via 
confocal microscopy (SP5 Leica microsystem) with 63x oil immersion objective.  
 
2.2.27 Phospho-kinase array  
Phospho-kinase array experiments were carried out using the Proteome Profiler, Human 
Phospho-Kinase Array Kit (R & D systems). Undifferentiated IMBAT cells were grown to 
confluence in DMEM/F-12, supplemented with 10 % FBS, 1% Pen/Strep and 1% L-
glutamine. Cells were then treated with various ligands for 5 minutes and harvested with 
buffer 6 according to manufacturer’s instructions. Protein estimation was carried out using 
the BCA assay, and membranes incubated with 20µg of protein.  The proteins of interest 
were detected with the chemiluminescent imager and the light emission was captured and 
visualized by exposing the blot to film. The positive signals seen on developed film were 
identified by placing the Transparency overlay, provided in the kit, on the developed 
membranes. Densitometry was carried out with ImageJ software. 
 
 
96 
 
2.2.28 Microarray experiments 
Global mRNA expression was measured in BAT depot using Illumina bead chip. Whole-
genome expression of wild-type and knockout samples were profiled using MouseWG-6 v2.0 
Expression BeadChips (Kuhn et al., 2004). The summary-level data was processed using the 
R packages lumi 2.10.0, lumiMouseAll.db 1.18.0 and lumiMouseIDMapping 1.10.0 using 
nuID annotations (Du et al., 2007, 2008). No background correction was used for a more 
sensitive analysis and the data was normalised using quantile normalisation. Differentially 
expressed genes (DEGs) between the wild-type and knockout samples were detected based 
on a moderated t-test using limma on the normalised data, removing unexpressed genes. The 
normalised expression data was filtered using logFC < 0.5 and q < 0.05, converted into z-
scores and heatmap 2 was used to visualise the data. DEGs with p < 0.05 were submitted to 
DAVID (Database for Annotation, Visualization and Integrated Discovery) for functional 
classification by submitting RefSeq mRNA accession numbers to DAVID.  Probe sets are 
coloured according to average expression levels across all samples, with green denoting a 
lower expression level and red denoting a higher expression level. Functional clusters were 
considered significant for FDR < 0.01 (Huang et al., 2009a, b). 
 
2.2.29 Statistical Analysis 
Data were analysed with GraphPad Prism5 software. ANOVA tests and T-tests were 
performed and only P values <0.05 were considered statistically significant. Results were 
given as mean ± standard error of mean. 
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Chapter 3 
Results 
 
Adipose Tissue: Cold-induced changes in gene expression 
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3.1 Introduction 
Adipose tissue is found in two forms: White Adipose Tissue (WAT) and Brown Adipose 
Tissue (BAT) (Cannon and Nedergaard, 2004). WAT stores energy and possesses endocrine 
properties whereas BAT, which is highly vascularized and possesses a high concentration of 
UCP1-containing mitochondria, provides heat to the body in response to cold stimulation. 
The primary molecule involved in this cold-induced thermogenesis in BAT is UCP1, a 
mitochondrial inner-membrane protein that uncouples proton entry from ATP synthesis. Both 
WAT and BAT are innervated by the sympathetic nervous system. Although all three known 
β-adrenoceptor subtypes (β 1-, β 2- and β3-adrenoceptor) are expressed in brown adipocytes 
β3-adrenoreceptor (β3-AR) seems to be most relevant for the acute activation of 
thermogenesis (Lafontan and Berlan, 1993). β1-AR and β2-AR do not mediate thermogenesis 
in rat brown fat cells even after cold acclimation (Zhao et al., 1998).  
How is the reduction in the environmental temperature sensed and translated into a 
thermogenic response in BAT? The activation of sympathetic nerves induces noradrenaline 
release from the nerve terminals. Upon cold exposure, efferent signals from the hypothalamus 
and brain stem control regions activating BAT thermogenesis and are relayed to the tissue by 
sympathetic innervation such that the release of norepinephrine activates β3-ARs in the 
membrane of brown adipocytes. This leads to increased lipolysis and β-oxidation of fatty 
acids and subsequently the activation of Ucp1 (Cannon and Nedergaard, 2004; Wu et al., 
2013).  
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3.2 Cold stimulation causes changes in gene expression 
Different fat depots vary in their response to cold. To understand the function of BAT, we 
have investigated the differences in gene expression profiles between BAT and WAT, 
induced by cold acclimation. We utilized microarray technology to investigate the differences 
in gene expression of mice kept at different temperatures. In doing this, we used female 
129Sv mice, a strain that has been reported to be resistant to both diabetes and obesity 
(Almind et al., 2007), and has a greater amount of adipocytes expressing Ucp1 in the 
different adipose tissues (Murano et al., 2009).  Gene expression from the interscapular BAT, 
subcutaneous WAT and mesenteric WAT was analysed by microarray from mice maintained 
for 10 days at either 28
0
C or 6
0
C. This analysis identified a number of genes that were 
regulated in a temperature-dependent manner and differentially expressed in one adipose 
depot than another. 
The origin of brown adipocytes arising in white adipose tissue (WAT) after cold 
acclimatization is unclear. It is well established that β-adrenergic stimulation, such as cold 
acclimatization, not only activates the brown adipocytes in interscapular BAT but also 
induces the appearance of brown adipocytes in WAT, termed ‘’brown in white (BRITE) or 
beige adipocytes (Nedergaard and Cannon, 2010; Zheng et al., 2014) . In showing these 
tissue remodelling properties, we compared the cold-induced genes in WAT to those enriched 
in BAT following cold exposure. Changes in gene expression identified by microarray were 
further investigated by q-RT-PCR in interscapular BAT, subcutaneous WAT, mesenteric 
WAT, and gonadal WAT at 28
0
C, 22
0
C or 6
0
C (Figures 3.1 and 3.2). Nrg4, Gpr120, Cidea 
and Rgs7 were highly expressed in BAT with moderate expression in the gonadal WAT. The 
expression of Nrg4 and Gpr120 was induced in BAT, subcutaneous and gonadal WAT 
following cold exposure (Figure 3.1). Nnat was preferentially expressed in gonadal WAT, 
followed by subcutaneous and mesenteric WAT and BAT, but was downregulated in all 
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depots following cold exposure (Figure 3.2). These results indicate that cold stimulation 
induces a series of changes in gene expression of BAT and WAT-associated genes. 
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Figure 3.1: mRNA expression levels of selected genes upregulated by cold exposure using q-RT-
PCR. A microarray analysis of BAT, subcutaneous WAT (sWAT), gonadal WAT (gWAT) and 
mesenteric WAT (mWAT) of mice exposed to 28, 22, or 6
0
C. Gene expression was normalized to 
beta-actin and depicted with reference to BAT at 28
0
C. All mRNAs are expressed as fold 
change. Error bars represent the mean ± SEM of at least 3 mice/groups in duplicates. 
Significant differences are shown. *P< 0.05, **P <0.005, ***P< 0.001. 
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Figure 3.2: mRNA expression levels of Nnat downregulated by cold exposure using q-RT-PCR. 
A microarray analysis of BAT, subcutaneous WAT (sWAT), gonadal WAT (gWAT) and 
mesenteric WAT (mWAT) of mice exposed to 28, 22, or 6
0
C. Gene expression was normalized to 
beta-actin and depicted with reference to BAT at 28
0
C. All mRNAs are expressed as fold 
change. Error bars represent the means ± SEM of at least 3 mice/groups in duplicates. 
Significant differences are shown. *P< 0.05, **P <0.005. 
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3.3 Validation of the gene expression on a mouse tissue panel  
Based on the results of the micro array-based gene expression analysis, we carried out q-RT-
PCR to validate the expression of the genes that were regulated in this temperature-dependent 
manner. A panel of mouse tissues from three sets of female FVBM mice was analysed for 
Ucp1, Nrg4, Gpr120, Rgs7, Nnat, Bmp8b, and Cidea, to determine their relative expressions. 
The expression of Cidea, a known brown fat gene (Seale et al., 2007), was used as a positive 
control. Following the analysis, it was observed that Ucp1, Nrg4, Gpr120, Rgs7, Bmp8b and 
Cidea were most highly expressed in BAT.  
Nnat, a member of the proteolipid family of amphipathic polypeptides, was downregulated by 
cold stimulus in BAT, mesenteric and subcutaneous WAT (Figure 3.2B). The expression of 
Rgs7 (Regulator of G-protein signalling 7), a negative regulator of GPCR signalling, was 
upregulated in BAT, subcutaneous WAT, gonadal WAT and mesenteric WAT following cold 
exposure (Figure 3.2A). Rgs7 was found to be highly expressed in the brain, BAT and 
pituitary, with its highest expression in BAT (Figure 3.3). Bone morphogenetic protein 8b 
(Bmp8b), is a member of the transforming growth factor-β (TGF-β) superfamily with a role 
to play in BAT’s sympathetic stimulation (Whittle et al., 2012). Bmp8b was found to be 
highly expressed in BAT (Figure 3.2A), and induced in BAT and subcutaneous WAT 
following cold stimulus, with little change in the mesenteric WAT (Figure 3.2A).  
The free fatty acid receptor, Gpr120 was most highly expressed in BAT (Figure 3.2A), and 
upregulated in BAT and gonadal WAT upon cold exposure (Figure 3.2A). Cidea, a known 
brown fat gene, was upregulated in all adipose depots following cold exposure (Figure 3.2A) 
and serves here as a positive control, thereby validating the result of other gene expression 
profiles seen (Figure 3.3). Nrg4 was highly expressed in BAT, with relatively low expression 
in the white adipose tissues, liver and mammary gland (Figure 3.2B). This expression was 
significantly induced in BAT, subcutaneous WAT and gonadal WAT upon cold exposure 
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(Figure 3.2A). Based on its high expression in BAT and its upregulation in BAT and WAT 
following cold acclimation, Nrg4 was selected for further studies.  
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Figure 3.3: mRNA levels of Nrg4, Bmp8b, Gpr120, Rgs7, Nnat, and Cidea across a panel of 
mouse tissues using q-RT-PCR. Tissue samples were obtained from FVB/N female mice kept 
under normal housing conditions. Total RNA was extracted with Trizol and cDNA was 
performed by using Moloney Murine Leukemia Virus Reverse transcriptase (M-MLV RT) 
following the manufacturer’s instructions. Gene expression was normalized to β-actin with 
kidney as the reference value. All data are expressed as the mean ± SEM of three samples in 
duplicate (n=3).  
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Table 3.1: Summary of gene expression profile of Nrg4, CIDEA, Bmp8b, Rgs7, Gpr129 
and Nnat across a panel of mouse tissues using q-RT-PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sub = Subcutaneous; Gon = Gonadal; NE = Not expressed 
 
 
 
 
 
 
 
 
 
Approximate fold change in mRNA expression with 
reference to the kidney 
Mouse 
tissues Nrg4 CIDEA Bmp8b Rgs7 Gpr120 Nnat 
Intestine 1 NE 13 NE 12 NE 
Spleen NE NE NE NE 7 NE 
Stomach NE 1 NE 1 76 NE 
Adrenal 2 4 NE 3 18 5 
Ovary 3 1 NE 2 3 9 
Mammary 39 221 NE 6 212 25 
Brain NE 3 NE 53 NE 54 
Lung 1 2 NE NE 435 1 
Brown 307 2409 21 73 1797 2 
Uterus 2 2 1 NE 2 1 
Pituitary 5 19 NE 40 245 829 
Kidney 1 1 1 1 1 1 
Pancreas 3 12 NE 1 138 19 
White Sub 6 14 1 4 180 44 
White Gon 52 104 NE 4 256 170 
Heart 2 19 NE 3 2 1 
Liver 25 1 1 NE 12 1 
Skeletal NE NE NE NE 2 1 
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3.4 Discussion  
The discovery of the existence of significant deposits of BAT in adult humans and its 
physiological response to cold and genetic activation (Cao et al., 2011) has opened new 
frontiers for therapeutic strategy for the treatment of obesity and related metabolic disorders.  
It has an enormous thermogenic function that will lead to increased energy expenditure. In 
fact, it has been estimated that 50g of brown adipose tissue would be sufficient to burn 20% 
of the daily energy intake (Cannon and Nedergaard, 2004). Since the major function of BAT 
is to dissipate energy, the potential to recruit and activate even a small amount of endogenous 
BAT via the induction of specific genes will be useful in the maintenance of energy 
homeostasis.  
To understand the function of BAT we have investigated the differences in gene expression 
between BAT and WAT with respect to temperature changes using microarray technology 
(Sun, 2007). From our microarray analysis we have identified a set of genes that are induced 
or downregulated following cold exposure in BAT and WAT. Previous studies have 
established preferential expression of genes involved in fatty acid metabolism in BAT 
compared to WAT following cold exposure (Shore et al., 2013). We were able to confirm the 
cold induced increase in Ucp1 and Gpr120, expression.  Our result identified Nrg4, Gpr120 
and Rgs7 to be cold induced, and Nnat was downregulated.  We confirmed that Nrg4 has its 
highest expression in BAT, with moderate expression levels in gonadal WAT, mammary 
gland and liver and low levels in the pituitary. Other studies have reported that Nrg4 had its 
highest expression in the pancreas (Harari et al., 1999).  However, a recent report supports 
our finding that Nrg4 is mainly a brown fat gene (Wang et al., 2014). Based on the findings 
that Nrg4 and Gpr120 were mostly expressed in BAT, and significantly upregulated 
following cold exposure, both Nrg4 and Gpr120 were selected for further studies in mice. 
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Chapter 4 
Results 
 
Neuregulin 4 (Nrg4) and its Functional Characterization 
in Brown Adipose Tissue 
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4.1 Introduction 
From the microarray-based gene expression data, Nrg4 was one of the genes that was 
identified to be regulated in a temperature-dependent manner. Furthermore, it was most 
highly expressed in BAT and this expression was increased upon cold exposure. It was also 
one of the very few genes that was cold regulated in the mesenteric WAT. Based on these 
findings, Nrg4 was selected for further study.  
Nrg4 is a member of a distinct subgroup of growth factors called the neuregulins (Nrg1–
Nrg4). They contain epidermal growth factor-like (EGF-like) domains and primarily signal 
through HER4, encoded by the gene ErbB4. The EGF protein family are involved in diverse 
biological processes involving normal development, and in the pathology of many diseases 
(Yarden and Sliwkowski, 2001). Neuregulins (NRGs) are signalling proteins that mediate 
cell-cell interactions in the nervous system, heart, breast, and other organ systems (Falls, 
2003). The neuregulin family of genes has four members: Nrg1, Nrg2, Nrg3, and Nrg4. Until 
recently, the role of Nrg4 in adipose tissue had not been studied. The primary structure and 
the pattern of expression of Nrg4, together with the strict specificity of this growth factor for 
ErbB4, suggest a physiological role distinct from that of the other known ErbB ligands 
(Harari et al., 1999). Nrg4 is highly expressed in BAT, with lower levels of expression in 
WAT, and its expression is induced by cold exposure. In order to understand the role of Nrg4 
in brown fat function we looked at its expression following brown adipocyte differentiation 
and Ucp1 induction, and the regulatory elements that are important for its role. An 
immortalized brown fat cell line was first created to test these function. Since the neuregulins 
interact with the nervous system, and Nrg4 was found to be expressed in brain, albeit a low 
level, it could have a role in BAT through interaction with the neurons innervating it. 
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4.2 Nrg4 is a brown fat–enriched adipokine  
Given the high mRNA level of Nrg4 in BAT (Figure 3.2A) , we decided to analyse its protein 
expression in vivo by a comprehensive immunohistochemistry staining with an anti-NRG4 
antibody. This confirmed the presence of NRG4 in the adipocytes of BAT and gonadal WAT, 
with BAT being much more immunoreactive than the Gonadal WAT (Figure 4.1) 
 
 
 
 
 
 
 
 
 
 
                                          
 
 
 
 
Figure 4.1: Immunohistochemical staining of BAT and gonadal WAT with of anti-127 NRG4 
antibody showing presence of Nrg4 in BAT and gonadal WAT. Fixed and paraffin-embedded 
BAT and gonadal WAT mouse samples were incubated with anti-127 NRG4 antibody (left 
panel/ brown colour) or blocking buffer alone as a negative control (right panel/ bluish colour). 
The samples were then incubated with Streptavidin Poly-HRP Conjugate and immunoreactivity 
was visualized by light microscopy (20X Magnification). Red arrows show brown adipocytes 
(with centrally placed nucleus) and the black arrows demonstrate show white adipocytes (with 
peripherally placed nucleus).  
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4.3 Immortalized brown adipocytes (IMBAT cells) system and Nrg4 expression  
Adipocyte differentiation is a complex process characterized by coordinated changes in cell 
morphology, hormone sensitivity, gene expression and secretory capacity (Perera et al., 
2006). This involves communication of extracellular signals to the nucleus, and is associated 
with the accumulation of triglycerides in lipid droplets, secretion of several hormones and 
changes in gene expression of certain genes (Spiegelman and Flier, 2001). This results in the 
mature adipocyte that is highly specialized for energy storage and homeostasis. A variety of 
agents influence adipocyte differentiation. At least two families of transcription factors, 
C/EBP and PPAR, are induced early during adipocyte differentiation.  
Until recently, studies using adipocyte cell lines have mostly relied on the 3T3-L1 line since 
these cells can be chemically induced to differentiate into adipocytes. However, these cells 
are fibroblastic and easily lose their adipogenic potential in culture (Wolins et al., 2006) 
especially with increasing passage (Poulos et al., 2010) and therefore not true preadipocytes. 
An immortalized brown adipose tissue (IMBAT) cell system was developed, which provides 
a model for adipocytes that are derived from bona fide preadipocytes rather than fibroblasts 
and provides an alternative system to primary preadipocytes for investigation of brown 
adipocyte functions.  
The immortalized protocol involved infection of brown adipocytes with SV40 large T antigen 
that has been genetically modified to express a mutated, temperature-sensitive SV40 large T-
antigen under the control of a major histocompatability complex class II promoter (Jat et al., 
1991). This was done prior to initial differentiation in order to prevent the sequestration of 
retinoblastoma protein thereby avoiding the risk of generating brown-like adipocytes from 
white preadipocytes (Rosell et al., 2014a; Scime et al., 2005).  These IMBAT cells are able to 
proliferate at permissive temperatures of 31-33
0
C in the presence of Geneticin (G418) but can 
also be induced to differentiate normally at 37
0
C in the absence of G418.  
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4.3.1 Immortalized brown adipocytes (IMBAT cells) system differentiate efficiently 
under standard differentiation protocol 
In testing the differentiation properties of our cell system, IMBAT cells were incubated with 
a standard differentiation cocktail comprising insulin, dexamethasone, triiodothyronine (T3), 
indomethacin, and IBMX. Lipid droplets became detectable within two days and following 
seven to eight days the cells were fully differentiated and could be visualized under the 
microscope (Figure 4.2.1B). To further demonstrate lipid droplets formation, the cells were 
stained with Oil Red O (ORO) a dye that stains lipids (Figure 4.2.1C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.1: IMBAT cells showing differentiation capacity (A) Undifferentiated cells stained 
with ORO (B) IMBAT Cells following 8 days of differentiation with standard differentiation 
cocktail showing lipid droplets-not stained with ORO. (C) IMBAT Cells following 8 days of 
differentiation with standard differentiation cocktail, and stained with ORO. To differentiate 
the cells, undifferentiated IMBAT cells cultured in 10% FBS and 1% L-glutamine and 1 % 
Pen/Strep were treated with 500µM IBMX, 250nM Dexamethasone, 170nM insulin, 125nM 
Indomethacin, and 1nM Triiodothyronine (T3) for the first 48hours. Thereafter the cells were 
maintained in 170nM insulin and 1nM T3 for next 6 days. For ORO staining, the culture 
medium from differentiated IMBAT cells was removed and cells were washed and fixed in 4% 
PFA at room temperature for 15 minutes, and washed again. Thereafter Oil Red O working 
solution (made up with isopropanol) was applied for 1h at room temperature. The cells were 
then rinsed with 60% isopropanol and PBS stained cells were visualized by light microscopy 
(20X Magnification). 
 
A 
B 
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4.3.2 Nrg4 expression increases during brown adipocyte differentiation 
It has previously demonstrated that Nrg4 was highly expressed in brown adipose tissue, and 
its expression enriched during cold acclimation (Chapter 3). It was hypothesised here that 
Nrg4 is associated with brown adipocyte differentiation. Adipocyte differentiation involves 
major changes in gene expression critical to its regulation such as PPARγ (Schoonjans et al., 
1996). In this present study, we carried out gene expression analysis to assess the changes in 
the expression of genes known to be upregulated during adipocyte differentiation. IMBAT 
cells were treated with insulin, triiodothyronine, IBMX, indomethacin, and dexamethasone 
for the first 2 days, and thereafter, cells were maintained on insulin and triiodothyronine for 
the next 6 days. Samples were taken at various time points for gene expressions (Figure 
4.2.2).  
 
The mRNA levels of the adipocyte marker aP2 became detectable within 12 hours of 
induction of differentiation and increased steeply and progressively over an 8 day period of 
differentiation validating an efficient differentiation of the IMBAT cells. The mRNA levels 
of PPARγ, a known regulator of adipogenesis, were detectable within hours of differentiation 
and rose rapidly to its peak during the induction period of differentiation. Glut4 expression 
followed a similar pattern to aP2, although the expression of aP2 was detectable within the 
first 12 hours following differentiation. PPARγ and PPARα mRNA were observed early, 
although while mRNA levels of PPARα remained low until 4 days following differentiation, 
PPARγ mRNA levels rose steeply from the second day peaking 4 days following 
differentiation. The expression pattern of C/EBPα and HSL appeared to follow a similar 
pattern, however the mRNA levels of C/EBPα was relatively higher. The metabolic genes, 
HSL and SREBP1c showed rapid induction after 24 hours of differentiation achieving their 
highest induction on day 4. Cidea showed a rapid induction after 2 days of differentiation. 
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Although Ucp1 expression was observed early during IMBAT cells differentiation, its mRNA 
levels fluctuated throughout differentiation, peaking at 12 hours of differentiation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.2: mRNA levels of BAT associated genes following a differentiation time-course using 
q-RT-PCR. Undifferentiated IMBAT cells cultured in 10% FBS and 1% L-glutamine and 1 % 
Pen/Strep were treated with 500µM IBMX, 250nM Dexamethasone, 170nM insulin, 125nM 
Indomethacin, and 1nM Triiodothyronine (T3) for the first 48hours. Thereafter the cells were 
maintained on 170nM insulin and 1nM T3 for next 6 days. Samples were taken at 12 hours, 24 
hours, 2 days, 4 days and at the 8
 
day time-points. Total RNA was extracted and cDNA were 
prepared as already described in materials and method. Gene expression was normalized to β-
actin with the untreated (0h) cells as the reference value. All data are expressed as the mean ± 
SEM of three independent samples in duplicate.  
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4.3.3 Nrg4 is expressed early during brown adipocyte differentiation. 
Based on the dynamics of gene expression observed following IMBAT cell differentiation, 
another experiment was carried out to compare changes in the Nrg4 expression with the 
changes in aP2 expression following brown adipocyte differentiation. To do this IMBAT 
cells were differentiated using the standard differentiation protocol as previously described. 
Here it was observed that both aP2 and Nrg4 mRNAs became detectable within 2 days of 
differentiation and rose steadily afterwards. However, the induction level of aP2 was higher 
(Figure 4.2.3).  
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Figure 4.2.3: mRNA levels of aP2 and Nrg4 in IMBAT cells throughout differentiation using q-
RT-PCR. IMBAT cells were differentiated for 8 days using the standard differentiation 
protocol, and total RNA and cDNA were carried out as already described. Gene expression was 
normalized to β-actin with the untreated (0h) cells as the reference value. All data are expressed 
as fold induction compared with time 0h. Error bar represent the mean ± SEM of three 
independent samples in duplicate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0h 4h 24h 2d 4d 6d 8d
0
500
1000
1500
2000
N
rg
4
 m
R
N
A
 
(F
o
ld
 c
h
a
n
g
e
)
0h 4h 24h 2d 4d 6d 8d
0
2000
4000
6000
8000
10000
a
P
2
 m
R
N
A
 
(F
o
ld
 c
h
a
n
g
e
)
aP2 Nrg4 
 
 
120 
 
4.3.4 Nrg4 expression in IMBAT cells is activated by β3-AR. 
In rodents, prolonged cold exposure or adrenergic signalling can provoke the appearance of 
clusters of Ucp1 positive cells with a multilocular brown adipocyte-like morphology in WAT 
(Rosen and Spiegelman, 2014). The Ucp1 mRNA and protein are found in “brown” and to a 
lesser extent in “white” adipose tissue; however, its expression is confined to brown 
adipocytes (Ricquier and Bouillaud, 2000) The β3-AR exerts a central role in the 
transduction of catecholamine effects in WAT and BAT. In the absence of β-AR signalling, 
mice are unable to maintain their core temperature (Bachman et al 2002). Therefore, 
exposure to temperatures below thermoneutrality activates BAT through the activation of 
adrenergic fibres since nor-adrenaline acts via β3-AR which have similar pharmacological 
effect as cold exposure (Cinti et al., 2002). The factors that mediate β3 signalling in WAT 
have yet to be fully determined.  
To address whether Nrg4 expression is regulated by β3-AR activation, differentiated IMBAT 
were treated with a selective β3-AR agonist (CL-316,243) for 5 hours. Nrg4 levels in 
undifferentiated IMBAT cells and its induction following IMBAT cell differentiation for 8 
days was first assessed. Given that Ucp1 expression is under the control of NE released from 
the sympathetic nerve terminals innervating the BAT cells and activated by β3-AR 
stimulation (Bartness et al., 2010b; Vaughan et al., 2014), it was also of interest to compare 
Nrg4 induction with that of Ucp1 (Figure 4.2.3B). A significant increase in the expression of 
Ucp1, aP2 and Nrg4 occurred following IMBAT differentiation. Both Ucp1 and Nrg4 
mRNAs levels, but not aP2, were significantly increased upon β3-AR stimulation.  The 
induction of Ucp1 was however much greater than that for Nrg4 (Figure 4.2.4B). The 
induction of Ucp1 was approximately 100-fold as compared to that of Nrg4 which was 
approximately 2.5-fold. Put together, Nrg4 expression increases with IMBAT cells 
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differentiation, and in brown adipocytes is sensitive to regulation downstream of β3-AR 
activation. 
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Figure 4.2.4: (B) mRNA levels of Ucp1, aP2 and Nrg4 in undifferentiated (U), differentiated (D), 
and β3-AR agonist-treated (D + CL) IMBAT cells. Cells were differentiation using standard a 
protocol that was already described. Thereafter the cells were maintained in 170nM insulin and 
1nM T3 for next 6 days. A set of the differentiated cells was then treated with a selective, β3-AR 
agonist (10μM CL 316,243) for 5 hours. All data are expressed as the mean ± SEM of three 
samples in duplicate. *p<0.05, **p˂0.005. 
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4.4 Functional role Nrg4 in BAT 
4.4.1 Nrg4 is secreted by brown adipocytes. 
Nrg4 was identified to be a brown fat gene. To test if Nrg4 was secreted into the culture 
media by mature brown adipocytes, conditioned medium from undifferentiated and 
differentiated IMBAT cells was subjected to ELISA. Nrg4 was detected in the conditioned 
medium from the differentiated adipocytes but not in the unconditioned medium or medium 
from undifferentiated IMBAT cells. This, confirms Nrg4 to be present in BAT and secreted 
by mature brown adipocytes (Figure 4.3.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.1:  Nrg4 levels in unconditioned medium (control), conditioned medium from 
undifferentiated IMBAT cells (Undifferentiated Conditioned), and 4-wk-differentiated IMBAT 
cells (Differentiated Conditioned), determined by ELISA. DNA content was 28.65 ± 
1.3896μg/well and 26.04 ± 1.96μg/well, for differentiated and undifferentiated cells respectively. 
ND=not detectable. 
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4.4.2 Nrg4 promotes neurite outgrowth 
Since Nrg4 was found to be highly expressed in brown adipose tissue, enriched in brown fat 
and markedly increased during brown adipocyte differentiation, what then are its functions in 
BAT? To provide insight into the potential role of Nrg4 in BAT we decided to investigate the 
possible communication of brown adipocytes with sympathetic nervous system via Nrg4 
induction. It has been shown that a synthesized form of NRG4 stimulated neurite outgrowth 
in PC12/HER4 cells (Hayes et al., 2008). PC12 cells are a cell line derived from a 
pheochromocytoma of the rat adrenal medulla (Greene and Tischler, 1976). It is an 
established cell line for the study of neurons (Das et al., 2004). Conditioned medium from 
differentiated IMBAT cells was used to treat PC12 cells that had been transfected with 
HER4. Differentiation of PC12 cells is most often assessed by semiquantitative or 
quantitative morphological methods. These methods can include determination of cell size, 
the number of cells exhibiting processes (neurites), and the extent of neurite growth or neurite 
length (Das et al., 2004). Since all the cells treated with the conditioned medium from 
differentiated IMBAT cells had neurite outgrowths (Figure 4.5), the neurite lengths with 
different concentrations of conditioned medium was measured. Conditioned media was used 
at 100%, 50%, or 25%, diluted in normal medium, to treat PC12/HER4 cells for 24 hours and 
the average neurite length determined. In comparison to unconditioned medium, significant 
increase in the neurite lengths of the PC12/HER4 cells in a dose dependent manner was 
observed. The cells treated with 100% differentiation medium had the most numerous and 
longest outgrowths. The unconditioned medium showed no outgrowth (Figure 4.3.2A and B).  
In order to determine if NRG4 was the secreted factor in the conditioned medium that 
stimulated neurite formation, we knocked down Nrg4 in IMBAT cells with shRNA and used 
conditioned medium from differentiated IMBAT cells to treat PC12/HER4 cells. The 
conditioned medium following approximately 75% Nrg4 knockdown (Figure 4.3.2E) was 
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unable to stimulate neurite formation in the PC12/HER4 cells compared to the control (figure 
4.3.2C and D), suggesting that brown adipocyte-derived NRG4 is involved in the control of 
sympathetic neurons activating BAT. Thus, NRG4 appears to be involved in a crosstalk 
between brown adipose tissue and their innervation, and may also enhance the sympathetic 
innervation of WAT during browning. 
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Figure 4.3.2: (A) PC12/HER4 cells showing neurite outgrowth (white arrows) following 
treatment with different concentrations of conditioned medium from differentiated IMBAT 
cells (20X Magnification). IMBAT cells were differentiated using standard differentiation 
cocktail, and on the 8th day of differentiation conditioned medium was collected. A part of this 
was serially diluted with normal media to give 50% and 25% concentration; the control was the 
unconditioned media. The collected media were used to treat PC12/HER4 cells. The treated 
PC12/HER4 cells were then fixed and immunostained with Tuj1 antibody (a neuron-specific 
class II beta-tubulin). (B) Neurite outgrowth measured in µm and expressed as fold induction 
over control cells. (C) Effect of the knockdown of Nrg4 in the cell system (20X Magnification). 
The IMBAT cells stably expressing shNrg4 cells were differentiated for 8 days using standard 
differentiation cocktail, and the conditioned medium was used to treat PC12/HER4 cell. The 
cells were fixed and immunostained with Tuj1 antibody (D) Graph of average neurite length of 
PC12/HER4 cells following knockdown of Nrg4 in IMBAT cells. (E) mRNA expression of Nrg4 
in the IMBAT cells following Nrg4 knockdown. For all of the data, error bars represent means 
± SEM, and significant differences are shown as *P < 0.05.  
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4.4.3 HER4 receptor is expressed in BAT and upregulated in differentiated IMBAT 
cells 
The Nrg4 receptor, HER4 has been associated with cellular processes including the 
regulation of cell division, survival, chemotaxis and differentiation (Maatta et al., 2006; 
Sundvall et al., 2008). Driven by our result that NRG4 promotes neurite outgrowth in PC12 
cells stably expressing the HER4 (Figure 4.5A), we investigated the potential for a specific 
autocrine action of NRG4 in BAT. We carried out a q-RT-PCR on a mouse tissue panel that 
we had earlier used to validate our micro array data to determine the expression of HER4. We 
observed a relatively low expression of HER4 in BAT, with undetectable levels in WAT 
(Figure 4.3.3A). Its expression was high in the brain, pituitary, kidney and heart. However, in 
the IMBAT cell system, its expression which was low in pre-adipocytes was induced 
approximately 20-fold following differentiation for 8 days (Figure 4.3.3B).  
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Figure 4.3.3: (A) mRNA levels of HER4 across a panel of mouse tissues using q-RT-PCR. Tissue 
samples were obtained from FVB/N female mice kept under normal housing conditions. Total 
RNA was extracted with TRIzol and cDNA was performed by using Moloney Murine Leukemia 
Virus Reverse transcriptase (M-MLV RT) following the manufacturer’s instructions. Gene 
expression was normalized to β-actin with kidney as the reference value. All data are expressed 
as the mean ± SEM of three samples in duplicate (n=3). (B) mRNA levels of HER4 measured via 
q-RT-PCR in undifferentiated and differentiated IMBAT cells. Cell differentiation was done 
using standard differentiation cocktail for 8 days. Gene expression was normalized to β-actin 
with undifferentiated cells as the reference value. All data are expressed as the mean ± SEM of 
three samples in duplicate. *p<0.05 
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4.4 Regulation of Nrg4 expression 
4.4.1 Nrg4 expression in IMBAT cells is regulated by PPARγ. 
The transcriptional regulation of Nrg4 in brown adipocytes remains unknown. The PPAR and 
CEBP families of transcription factors are known to be the major regulators of adipocyte 
function, and PPARγ is the key regulator of adipocyte differentiation in both white and 
brown adipocytes (Rosen et al., 2000; Tontonoz et al., 1994). The activation of PPARγ by 
synthetic ligands has been shown to promote the differentiation of brown fat precursor cells 
(Tai et al., 1996). To investigate the role of PPARγ in Nrg4 regulation of BAT function, we 
treated undifferentiated IMBAT cells for 5 days with PPARγ agonists (rosiglitazone or 
GW1929), PPARγ antagonist (GW9662), PPARα agonist (GW7647) or PPARδ agonist 
(GW1516). mRNA levels of Nrg4 and aP2 were then determined by q-RT-PCR.  
In the undifferentiated IMBAT cells, both Nrg4 and aP2 expression was induced following 
treatment with rosiglitazone, although the induction of aP2 was higher (Figure 4.2.1A). 
Treatment with GW9662 (PPARγ antagonist) alone had no effect on the expression of Nrg4 
and aP2. However, when undifferentiated IMBAT cells were incubated with Rosiglitazone 
for 5 days, followed by the GW9662 for 24 hours, there was an attenuation of rosiglitazone-
induced expression of Nrg4 and aP2 (Figure 4.4.1A). Whereas treatment with another 
selective PPARγ agonist, GW1929 induced over 100-fold induction in the expression of Nrg4 
and aP2, there was no effect with either PPARα (GW7647) or PPARδ agonists (GW1516). 
The similar pattern of Nrg4 and aP2 induction following treatment with PPARγ agonists 
(rosiglitazone and GW1929), indicates that these factors may share common modes of 
transcriptional regulation during brown adipocyte differentiation (Figure 4.4.1A). 
Based on the above results that Nrg4 and aP2 exhibit similar responses to various PPAR 
ligands stimuli in undifferentiated IMBAT cells, the responses of Nrg4 and aP2 were also 
analysed in fully differentiated IMBAT cells stimulated with the same PPAR ligands. 
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IMBAT cells were differentiated for 7 days, followed by stimulation with PPAR ligands for 
24 hours. There was an induction in the expression of Nrg4 and aP2 following PPARγ 
agonist stimulation but this was not significant (Figure 4.4.1B). However, Nrg4 and aP2levels 
were undetectable following addition of GW9662 (Figure 4.4.1B). Overall, these results 
indicated that Nrg4 is regulated by PPARγ in a manner similar to aP2. 
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Figure 4.4.1: mRNA levels of aP2 and Nrg4, measured via q-RT-PCR in undifferentiated and 
differentiated IMBAT cells treated with PPARƴ agonist and antagonist. (A) Undifferentiated 
IMBAT Cells were treated for 5 days with 100nM rosiglitazone (in the presence or absence of 
10µM GW9662), 2.5µM GW1929, 100nM GW7647, and 1µM GW1561. Gene expression was 
normalized to β-actin with DMSO as the reference value. (B) IMBAT cells were differentiated 
using standard differentiation protocol for 7 days.  Thereafter they were treated 12 hourly for 
24 hours with PPARγ agonists, 100nM rosiglitazone, 10µM GW9662, 2.5µM GW1929, 100nM 
GW7647, and 1µM GW1561. Gene expression was normalized to β-actin with DMSO as the 
reference value. All data are expressed as the mean ± SEM of two independent samples in 
triplicate.  
A 
B 
Rosiglitasone (Rosi): PPARγ agonist  
GW9662:  PPARγ antagonist 
GW1929  PPARγ agonist  
GW7647:  PPARα agonist    
GW1516:  PPARδ agonist    
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4.4.2 Nrg4 expression in IMBAT cells is regulated by PPARγ. 
To further characterize the regulation of Nrg4 the accurate identification of transcription start 
sites (TSSs) and promoter regions is an important step that enables targeted searching for 
regulatory-protein binding motifs in the promoter regions of genes with similar expression 
patterns (McGrath et al., 2007). Therefore, to localize the important control regions that 
activate Nrg4 gene expression, we decided to clone its promoter region and identify its 
regulatory elements. We first determined the transcription start site of the Nrg4 transcripts.  
The full length cDNA sequence of Nrg4 was acquired by performing 5’ RACE reaction.  
A   
 
(B) -2000….GTTCCCCTGGCTGCTTGCGACCTCTGCTCACACCTTGGTCTGCCTTGACCTCG    
CCCACACTGAAGTGACATAAATCCGATTTTTGACACGTTGTAAAGTTCGAGTCACAGTT
GCTGAAGTCCTCAGTGTTCAAACACTTGTGAAACGCTGCATGTCTAGC…..+60 
Figure 4.4.2 (A): Electrophoretic image showing 200bp purified PCR product from 5’ RACE 
experiment with Nrg4 gene. Specific inner and outer reverse primers were designed using the 
Primer Blast software. A taq polymerase was used to amplify the PCR reaction. The PCR 
product was separated using a 2% agarose gel electrophoresis and the purified PCR product 
was cloned into PCR 4.0 vector. (B) Genomic sequence showing regions around the 
transcription start site (TSS). Red arrow (+1) indicates the transcription start site detected by 
genomic analysis.  
 
 
 
 
+1 
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Having identified a single Nrg4 transcription start site the promoter regions within 2000 base 
pairs upstream and 60 base pairs downstream of the primers was assessed. This region was 
subcloned into pGL3-Basic vector and the obtained plasmid transfected into HEK293 cells. 
Unfortunately the result was inconclusive indicating that the 2kb Nrg4 promoter is not the 
full promoter that is necessary for Nrg4 transcription activation. However, comparing the 
expression of Nrg4 expression with that of the PPARγ–regulated aP2 in brown adipocytes 
exposed to PPAR ligands (Figure 4.4.1) strongly support a regulatory role for PPARγ.  
An analysis of open access chromatin immunoprecipitation (ChIP) sequencing data in 3T3-
L1 cells shows PPARγ, C/EBPβ and Stat5a binding sites within introns of the Nrg4 gene. 
These data raise the possibility that the key regulatory region for Nrg4 expression in brown 
adipocytes is intronic rather than within the promoter 5’ of the transcription start site (Figure 
4.4.3A and 4.4.3B).  
 
 
 
 
 
 
 
 
Figure 4.4.3A: Binding sites for Nrg4 regulatory regions in the early and late stages of 
differentiation of 3T3-L1 cells. Data from (Siersbaek et al., 2011). (Track were displayed on the 
UCSC genome browser: genomes.ucsc.edu) 
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Figure 4.4.3B: Binding sites for PPARγ, C/EBPβ and Stat5a in the Nrg4 regulatory regions in 
the early stages of 3T3-L1 differentiation and PPARγ binding sites in the late stages of 
differentiation of 3T3-L1 cells. Data from (Siersbaek et al., 2011). (Track were displayed on the 
UCSC genome browser: genomes.ucsc.edu) 
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4.5 Discussion 
Nrg4 is a member of the neuregulin family comprising of 4 ligands that activate ErbB 
tyrosine kinase receptors. We have reported that Nrg4 was highly expressed in brown adipose 
tissue, with low expression in WAT, and this expression was increased by temperature 
reduction, indicating that Nrg4 may have a role to play in brown adipose tissue 
thermogenesis or the transition from white to beige fat. Next, we looked to see if NRG4 
protein was expressed in the adipose tissue. Based on an immunohistochemical staining with 
a specific antibody, NRG4 was detected in BAT and gonadal WAT. A subsequent report has 
confirmed that Nrg4 is expressed in adipose tissue (Wang et al., 2014). The significance of 
the presence of Nrg4 in the WAT may be relevant to WAT remodelling given the paucity of 
BAT compared to WAT. 
How does Nrg4 affect the function of brown adipocytes? The differentiation of adipocyte is 
associated with its maturity and the expression of certain specific genes, notably aP2.  A 
number of genes whose expression levels changed throughout brown adipocyte 
differentiation process were identified. aP2, a known differentiation marker became 
detectable in the early period of differentiation, and its expression levels increased steadily 
throughout. This finding was in line with other reports showing aP2 to be expressed early 
following differentiation (Matsubara et al., 2005). Nrg4 was observed to have a similar 
mRNA profile with aP2 throughout differentiation. This observation suggests that Nrg4 is 
more likely subject to similar regulatory mechanisms as aP2. Given that Ucp1 expression, 
which is central to brown fat heat production in response to cold exposure, is under the 
control of BAT sympathetic innervations, it was therefore of interest to compare its 
expression with that of Nrg4 in adipocytes. Increased mitochondrial uncoupling is associated 
with increased BAT thermogenic activity. Both Nrg4 and Ucp1 were induced upon IMBAT 
cells differentiation. When the differentiated brown adipocytes were challenged with a β3-AR 
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agonist, there was a significant induction in the Nrg4 and Ucp1 mRNA levels. This induction 
was however not observed in aP2 mRNA 
The presence of Nrg4 in BAT and the differential expression pattern observed in BAT versus 
WAT was confirmed by an immunohistochemical staining using anti-NRG4 antibody. BAT 
showed a much higher immunoreactivity to the presence of NRG4 protein than the Gonadal 
WAT. The most recently described member of the ErbB receptor tyrosine kinase family is 
ErbB4 (HER4). Although related in sequence to other ErbB family members and organized in 
a similar fashion, ErbB4 has a larger spectrum of ligands that activate it. A recent report has 
indicated that NRG4 binds both ErbB-3 and ErbB-4 (Wang et al., 2014). However, the 
experiments were concluded before this and based on several other reports on the specificity 
of NRG4 to HER4 (Harari et al., 1999; Hayes et al., 2007; Hayes et al., 2008). Not much is 
known about the role of ErbB4 in adipose tissue. ErbB4 was been determined to be present in 
BAT and neuronal tissues, and its expression was induced upon IMBAT cell differentiation. 
In deciphering the function of Nrg4 in BAT, the ability of NRG4 to activate HER4 in a 
paracrine fashion was determined, by exposing PC12 cells stably expressing HER4 
(PC12/HER4 cells) to conditioned medium from differentiated brown adipocytes. The 
conditioned medium from differentiated brown adipocytes was found to contain detectable 
levels of NRG4 protein. Following the treatment, there was an extensive neurite formation in 
the PC12/HER4 cells. Although other researchers have reported that recombinant NRG4 
activates PC12 cells transfected with HER4 following a direct biochemical assay (Hayes et 
al., 2007), this is the first time it was demonstrated that endogenously derived secreted NRG4 
from brown adipocytes leads to extensive neurite formation. It was confirmed via shRNA 
knockdown in IMBAT cells that the neurite outgrowths observed in PC12/HER4 cells were 
caused directly by Nrg4. This suggests a novel role of Nrg4 in the function of brown fat. The 
ability of conditioned medium from differentiated IMBAT cells to stimulate extensive neurite 
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outgrowth in PC12/HER4 cells and the significant induction of Nrg4 in differentiated 
IMBAT cells have important implications for neuronal signalling in BAT. Since enhanced 
sympathetic innervation will increase the potential to upregulate Ucp1 and promote 
uncoupling, the NRG4-ErbB-4 axis could therefore represent an important signalling 
mechanism in BAT for increasing the sensitivity of BAT to sympathetic stimuli. 
Peroxisome proliferator-activated receptors (PPARγ, PPARα, and PPARδ) are important 
regulators of lipid metabolism. Although they share significant structural similarity, the 
biological effects associated with each PPAR isotype are distinct (Hummasti and Tontonoz, 
2006). To determine the possible factors that may be involved in the regulation of Nrg4 in 
BAT, we used a number of PPAR ligands to stimulate both undifferentiated and 
differentiated brown adipocytes. Both Nrg4 and aP2 were induced by PPARγ activation and 
inhibited by a potent and selective PPARγ antagonist (GW9662), while excluding the role of 
both PPARδ and PPARα in the regulation of Nrg4 function in BAT.  
A detailed understanding of the process regulating brown adipose tissue function is essential 
for the control of obesity and its associated conditions. PPARγ has been identified as a 
possible transcriptional regulator of Nrg4 in adipocytes. The Nrg4 promoter was cloned into a 
reporter gene plasmid as a first step to define its regulatory motifs and determine the role of 
PPARγ. Although brown fat-selective transcription factors have not been identified, the 
binding of PPARγ is essential for the function of the Ucp1 enhancer (Sears et al., 1996) 
indicating that PPARγ could represent key components of the selectivity and thermogenic 
response of brown adipose tissue. There was an induction in the expression of Nrg4 and aP2 
following PPARγ agonist stimulation but this was not significant (Figure 4.4.1B).  The 
inability to detect PPARγ-dependent induction of a reporter construct containing the Nrg4 5’-
untranslated region is likely due to key regulatory regions being further upstream, 
downstream or within the gene. In support of this, analysis of available ChIP seq data reveals 
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significant binding of PPARγ to Nrg4 intronic regions. Although we do not exclude other 
regulatory motifs that may be interacting with Nrg4 to induce BAT function, the overall data 
indicates that Nrg4 is a PPARγ-regulated brown fat adipokine that can signal to neuronal 
cells. PPARγ has been reported to interact with β3-AR in obese people (Yoshihara et al., 
2015), and its agonist have been used for the treatment of diabetes in humans (Hsu and Pan, 
2014). Since HER4 is present in BAT and upregulated in mature brown adipocytes, NRG4 
appears to be involved in a crosstalk between brown adipose tissue and their innervation, and 
may also enhance the sympathetic innervation of WAT during browning.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
139 
 
Chapter 5 
Results 
 
Gpr120: Regulation of Expression in BAT 
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5.1 Introduction 
Gpr120 is a member of the family of G protein-coupled receptors (GPCRs). It binds both 
saturated and unsaturated fatty acids (Hirasawa et al., 2005), where it has a critical role in 
various physiological homeostatic mechanisms such as adipogenesis, regulation of appetite 
and food preference (Gotoh et al., 2007a). Stimulation of Gpr120 with ω-3 fatty acids also 
causes broad anti-inflammatory effects in monocyte 264.7 cells and in primary intraperitoneal 
macrophages (Oh et al., 2010). Gpr120 is the only lipid sensing GPCR which is highly 
expressed in adipose tissue, proinflammatory CD11c
+
 macrophages (BMDCs), mature 
adipocytes, and monocytic RAW 264.7 cells (Oh et al., 2010).  Gpr120-deficient mice fed a 
high-fat diet developed obesity, glucose intolerance, and fatty liver with decreased adipocyte 
differentiation and lipogenesis and enhanced hepatic lipogenesis (Ichimura et al., 2012b). It 
has also been reported that the R270H variant of human Gpr120 enhances inflammation in 
adipose and hepatic tissue, and carriers of this gene, irrespective of geographical origin, 
developed obesity (Ichimura et al., 2012b; Marzuillo et al., 2014). 
Adipose tissue metabolism exerts an impact on whole-body metabolism, playing a critical 
role in glucose homeostasis by releasing adipocytokines that regulate insulin sensitivity in 
other organs (Coelho et al., 2013). The energy burning property of BAT is a promising target 
for the treatment of obesity and its associated complications. This property is conferred to 
BAT by its expression of Ucp1 whose uncoupling is achieved by its ability to transport 
protons across the inner mitochondria membrane (Brondani et al., 2012). Based on the 
potential role of Gpr120 in inflammation, obesity and insulin resistance, and the thermogenic 
property of BAT, the roles of Gpr120 in BAT function was assessed. Its expression in BAT 
was therefore determined. 
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5.2 Gpr120 is regulated in a temperature-dependent manner 
To decipher the factors that could be responsible for the switch from one form of adipose 
tissue to the other in response to temperature changes, our group had earlier performed a 
microarray-based gene expression analysis of mice placed at different temperatures (Figure 
5.1). Gpr120 was identified to be highly expressed in BAT and upregulated in BAT and 
selective WAT depots following cold exposure (Figure 5.1).  Although there was no 
significant change in its expression in the mesenteric WAT in response to cold, Gpr120 
expression was significantly upregulated in the subcutaneous and gonadal WAT (Figure 5.1).   
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Figure 5.1: q-RT-PCR showing gene expression of Gpr120 induced by cold exposure following a 
microarray analysis of BAT, subcutaneous WAT (sWAT), gonadal WAT (gWAT) and 
mesenteric WAT (mWAT) of mice exposed to 28, 22, or 6
0
C. All mRNAs are expressed as fold 
induction relative to BAT at 28
0
C. Bars represent the means ± SEM of at least 3 mice/groups, 
and significant differences are shown. *P< 0.05, **P <0.005, ***P< 0.001. 
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5.3 Gpr120 is more highly expressed in Brown Adipose Tissue 
Based on its high expression in BAT and upregulation with respect to cold acclimation in 
adipose tissue, we decided to validate the expression of Gpr120 on a panel of mouse tissues 
while comparing its expression profile with that of Gpr40, Gpr41, and Gpr43 which are fatty 
acid receptors (Figure 5.2). Gpr120 had its highest expression in BAT, with lower levels in 
white adipose tissues as well as in pancreas, lung, stomach and mammary gland (Figure 5.2). 
Levels were very low in the liver, skeletal muscle, heart, intestine, spleen and brain. Gpr40 
was undetectable in brown adipose tissues, with low expression in subcutaneous WAT. 
Gpr43, which is known to be abundantly expressed in WAT (Kimura et al., 2013), was the 
most highly expressed in the white subcutaneous and gonadal adipose tissues depots with low 
levels in BAT. Gpr41 mRNA expression was highest in the adrenal and undetectable in BAT. 
Overall, this data indicates that Gpr120 is the most highly expressed and predominant free 
fatty acid receptor in BAT. 
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Figure 5.2: mRNA levels of Gpr120, Gpr40, Gpr41, and Gpr43 across a panel of mouse tissues 
using q-RT-PCR. Tissue samples were obtained from FVB/N female mice kept under standard 
housing conditions. Total RNA was extracted with TRIzol and cDNA was prepared as described 
in materials and methods. Gene expression was normalized to β-actin with kidney as the 
reference value. All data are expressed as the mean ± SEM of three samples in duplicate (n=3).  
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Table 5.1: Summary of gene expression profile of Gpr120, Gpr40, Gpr41 and Gpr43 
across a panel of mouse tissues using q-RT-PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sub = Subcutaneous; Gon = Gonadal; NE = Not expressed 
 
 
 
 
 
 
 
 
 
 
 
Approximate fold change in mRNA expression with reference 
to the kidney 
Mouse 
tissues Gpr120 Gpr40 Gpr41 Gpr43 
Intestine 12 7 NE 3 
Spleen 7 159 1 73 
Stomach 76 4 NE 7 
Adrenal 18 1 3 6 
Ovary 3 1 NE 5 
Mammary 212 95 NE 56 
Brain NE NE 1 NE 
Lung 435 3 NE 3 
Brown 1797 1 NE 15 
Uterus 2 NE NE 1 
Pituitary 245 5 1 1 
Kidney 1 1 1 1 
Pancreas 138 212 1 12 
White Sub 180 18 NE 161 
White Gon 256 1 NE 212 
Heart 2 1 NE 2 
Liver 12 1 1 1 
Skeletal 2 NE NE 2 
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5.3 Regulation of Gpr120 expression in brown adipocytes 
5.3.1 Gpr120 expression is detectable in early phase of brown adipocyte differentiation 
Gpr120 has been implicated as playing an important role in the control of lipid and glucose 
metabolism (Miyauchi et al., 2009a). Based on its significant expression level in BAT, and its 
property of being cold-regulated, a q-RT-PCR was carried out to determine its expression 
levels during adipocyte differentiation, and potential mechanism of regulation. IMBAT cells 
were differentiated over a time course of 8 days (Figure 5.3.1). Gpr120 levels were compared 
to that of aP2 (an adipocyte differentiation marker) following treatment of differentiated 
IMBAT cells with a β3-AR agonist (CL-316,243) for 5 hours (Figure 5.3.2). Gpr120 mRNA 
became detectable on the second day of differentiation and increased steeply till full 
differentiation. Although aP2 expression was detected earlier than Gpr120, they both showed 
similar pattern of increase in their mRNA expression with differentiation.  
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Figure 5.3.1: q-RT-PCR showing gene expression of Gpr120 and aP2 following a differentiation 
time-course. IMBAT Cells were treated with standard differentiation cocktail on reaching full 
confluence. The cells were harvested following differentiation over a time course for 8 days as 
indicated. Total RNA was extracted with Trizol and cDNA was prepared as described in 
materials and methods. Gene expression was normalized to β-actin with the untreated (0h) cells 
as the reference value. All data are expressed as the mean ± SEM of three independent samples 
in duplicate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
149 
 
5.3.2 Gpr120 expression in brown adipocyte is regulated by β3-AR activation   
When fully differentiated, IMBAT cells were treated with β3-AR agonist (CL-316,243). 
There was a significant induction in the levels of Gpr120 (Figure 5.3.2There was 
approximately a thousand fold increase in Gpr120 expression following differentiation. 
Expression was induced a further 2-fold upon treatment with β3-AR agonist. There was Ucp1 
induction which was over 100-fold upon β3-AR agonist treatment.  However, there was no 
change in aP2 mRNA upon β3-AR agonist stimulation. This result reveals that both 
differentiation and β3-AR signalling pathway are involved in the regulation of Gpr120 in 
brown adipocytes. 
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Figure 5.3.2: mRNA levels of Ucp1, aP2 and Gpr120 in undifferentiated (U), differentiated (D), 
and β3-AR agonist-treated differentiated (D+CL) IMBAT cells, using q-RT-PCR. 
Undifferentiated IMBAT cells were harvested 2 days after confluence. A second set of IMBAT 
cells was differentiated using the standard differentiation protocol as already described, and 
another set of cells was fully differentiated and treated with a selective β3-AR agonist (10μM CL 
316,243) for 5 hours. Total RNA was extracted with TRIzol and cDNA was prepared as 
described in materials and methods. Gene expression was normalized to β-actin with 
undifferentiated (U) as the reference value. All data are expressed as the mean ± SEM of three 
samples in duplicate (n=3). *p<0.05 and **p<0.005. 
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5.4 Gpr120 agonist, GW9508, induced lipid droplet formation in IMBAT cells 
As Gpr120 is highly expressed in BAT and induced upon adipocyte differentiation, the role 
of Gpr120 on adipocyte differentiation was assessed via ability of a Gpr120 ligand to induce 
lipid droplet formation. Lipid accumulation is a characteristic of adipocyte maturation to a 
functional state (Seale and Lazar, 2009). Undifferentiated IMBAT cells were treated with 
DMSO or a Gpr120 agonist, GW9508. Although this agonist is known to bind and activate 
both Gpr120 and Gpr40 (Briscoe et al., 2006b), the ligand was used as Gpr120 agonist since 
Gpr40 was not expressed in BAT (Figure 5.2). Interestingly, compared to the undifferentiated 
cells (Figure 5.4A), the agonist-treated cells developed lipid droplet (Figure 5.4B), with 
morphological features indicative of cell differentiation (figure 5.4C). 
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Figure 5.4: GW9508 induces lipid droplet formation. Oil Red O (O Red O) staining of IMBAT 
cells following treatment with GPR120 ligand, GW9508. (A) Undifferentiated cells stained with 
ORO (B) Undifferentiated IMBAT cells treated with 100μM GW9508 12 hourly for 8 days, and 
stained with O Red O (C) IMBAT Cells following 8 days of differentiation with standard 
differentiation cocktail, and stained with O Red O. To differentiate the cells, undifferentiated 
IMBAT cells cultured in 10% FBS and 1% L-glutamine and 1 % Pen/Strep were treated with 
500µM IBMX, 250nM Dexamethasone, 170nM insulin, 125nM Indomethacin, and 1nM 
Triiodothyronine (T3) for the first 48hours. Thereafter the cells were maintained on 170nM 
insulin and 1nM T3 for next 6 days. Lipid droplets were visualized with the aid of a light 
microscope (20X Magnification). 
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5.5 Discussion 
Gpr120 was one of the genes regulated in a temperature-dependent manner. Following a gene 
expression profile experiment on a panel of mouse tissue (figure 5.2), our validated result 
showed that Gpr120 was more highly expressed in BAT than other tissues assessed. Another 
group had demonstrated that its expression was high in  mature adipocytes, with negligible 
expression in muscle, pancreatic cell and hepatocytes (Gotoh et al., 2007a), they did not 
however discriminate between BAT and WAT. Gpr120 is upregulated in BAT and some 
WAT depots following cold exposure, implying that this gene may be involved in recruitment 
of more BAT on appropriate stimulation and WAT remodelling. Gpr40 was found to be 
predominantly expressed in the pancreas, corroborating the works of Briscoe et al., 2003; 
and Itoh et al., 2003. The finding that Gpr43, a known white fat gene, was more highly 
expressed in WAT than other tissues validated our results. 
When undifferentiated IMBAT cells were treated with a Gpr120 agonist (GW9508), there 
was lipid droplet formation and development of a mature phenotype. This induction of 
differentiation suggests a major function of Gpr120 in adipocyte function especially in terms 
of differentiation and maturity. Gotoh et al., 2007 had demonstrated that loss of function of 
Gpr120 by RNA interference led to the inhibition of adipocyte differentiation of 3T3-L1 
cells.  
The anti-obesity effect of β3-AR stimulation is largely attributable to Ucp1 (de Souza and 
Burkey, 2001) and treatment of obese animals with β3-AR agonists is known to increase lipid 
mobilization, induce Ucp1, improve insulin action, and reduce body fat content (de Souza 
and Burkey, 2001; Inokuma et al., 2006). Gpr120 has been demonstrated to be highly 
expressed in brown fat, induced upon cold exposure and involved in the differentiation 
property of BAT by its ligand-induced lipid droplet formation, and induced by β3-AR 
agonists. Gpr120 is a lipid sensor whose dysfunction has been reported to cause obesity in 
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both mice and human (Ichimura et al., 2014; Ichimura et al., 2012b). Based on our findings 
Gpr120 may be involved in β3-AR regulation of BAT function. This suggests a putative 
mechanism for Gpr120 involvement in BAT thermogenic, anti-obesity and anti-diabetic 
activities through its effect on β3-AR pathway.  
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Chapter 6 
Results 
 
The role of Gpr120 in BAT via Gpr120 knockout models 
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6.1 Introduction 
Gpr120 is known to be a nutrient-sensing receptor, which may have an important role in the 
activation of metabolic pathways that control energy utilisation of adipocytes, including β-
oxidation and glucose uptake (Gotoh et al., 2007). It has been found to promote secretion of 
cholecytokinin and glucagon-like peptide from intestinal luminal cells in response to 
stimulation by unsaturated long chain fatty acids (Tananka et al 2008a/b). Gpr120 activation 
in primary white adipose tissue and 3T3-L1 adipocytes led to an increase in glucose transport 
and translocation of GLUT4 to the plasma membrane, and this effect was abolished upon 
Gpr120- and Gαq/11 knock-out (Talukdar et al., 2011). Gpr120 KO mice developed obesity, 
increased inflammation, and insulin resistance, consistent with a role for Gpr120 signalling in 
the metabolic syndrome and diabetes mellitus (Oh et al., 2010). However, the role of Gpr120 
in brown adipose tissue is unknown, and whether it has a role to play in directly modulating 
the metabolic and inflammatory conditions is yet to be determined. 
BAT has been shown to be activated by cold, and brown adipocyte maturity can be induced 
by ligands that activate Gpr120 (Chapter 5). To evaluate the role of Gpr120 in glucose 
metabolism and inflammation, BAT from Gpr120 knockout (KO) and wild type (WT) 
(provided by Dr Sami Damak, Nestle, Switzerland) were obtained. The effect of Gpr120 
knockout on genes central to these functions and the potential to identify novel functional 
roles within brown fat was determined. This would aid in determining the impact of 
pharmacological interventions that target Gpr120 to activate and/or expand BAT.  
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6.2 Gene expression analysis of BAT in Gpr120 KO mice 
Tissues from Gpr120 KO mice and WT littermates with similar body weights and on normal 
chow diet were evaluated. We carried out a microarray to monitor global changes in 
expression of genes that were either upregulated or downregulated in the Gpr120 knockout 
mice tissues. 101 gene sets were differentially expressed (Figure 6.1). We identified 27 
upregulated genes and 74 downregulated genes (Table 6.1). The majority of downregulated 
genes (Table 6.3) were involved in energy expenditure (example, O3far1), lipid metabolism 
(for example, Apoc1 and Acsl1) and glucose metabolism (for example, Gys2), while the 
upregulated genes (Table 6.2) were those implicated in inflammation (for example the 
chemokine ligands) and certain forms of cancer (for example, melanoma antigen). 
Based on the analysis of differentially expressed genes identified in BAT from Gpr120 
knockout mouse, q-RT-PCR was carried out to validate certain key genes identified and to 
determine role of BAT Gpr120 in additional genes known to be involved in adipogenesis, 
inflammation , lipolysis, lipogenesis, and in glucose metabolism. 
 
Table 6.1: Summary of up and downregulated genes in Gpr120 knockout BAT. 
 
 
 
FC: Fold change 
DE: Differentially expressed 
nuID: Nucleotide universal IDentifier 
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Figure 6.1 Global expression analysis of brown adipose tissue (BAT) in Gpr120 knockout mice. 
Global mRNA expression was measured in BAT depot using Illumina bead chip. Whole-genome 
expression of wild-type and knockout samples were profiled using MouseWG-6 v2.0 Expression 
BeadChips (Kuhn et al., 2004). The summary-level data was processed using the R packages 
lumi 2.10.0, lumiMouseAll.db 1.18.0 and lumiMouseIDMapping 1.10.0 using nuID annotations 
(Du et al., 2007, 2008). No background correction was used for a more sensitive analysis and the 
data was normalised using quantile normalisation. Differentially expressed genes (DEGs) 
between the wild-type and knockout samples were detected based on a moderated t-test using 
limma on the normalised data, removing unexpressed genes. The normalised expression data 
was filtered using logFC < 0.5 and q < 0.05, converted into z-scores and heatmap.2 was used to 
visualise the data. DEGs with p < 0.05 were submitted to DAVID (Database for Annotation, 
Visualization and Integrated Discovery) for functional classification by submitting RefSeq 
mRNA accession numbers to DAVID.  Probe sets are coloured according to average expression 
levels across all samples, with green denoting a lower expression level and red denoting a higher 
expression level. Functional clusters were considered significant for FDR < 0.01 (Huang et al., 
2009a, b). 
 
 
Heatmaps, normalised 
q = 0.05 
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6.2.1 Differentially expressed genes 
Table 6.2: Genes Upregulated in Gpr120 KO BAT 
Gene Symbol Gene Name Fold 
Change 
Adjusted 
P Value 
Sncg synuclein, gamma 1.99 0.037 
Xlr4a X-linked lymphocyte-regulated 4A 1.86 0.047 
Npm3-ps1 nucleoplasmin 3, pseudogene 1 1.75 0.039 
Cd52 CD52 antigen 1.71 0.014 
Rarres2 retinoic acid receptor responder (tazarotene induced) 2 1.71 0.021 
Hist1h2ap histone cluster 1, H2ap 1.68 0.011 
Wdfy1 WD repeat and FYVE domain containing 1 1.67 0.021 
Cxcl9 chemokine (C-X-C motif) ligand 9 1.65 0.011 
Hist1h2ad histone cluster 1, H2ad 1.62 0.011 
Ccl11 chemokine (C-C motif) ligand 11 1.62 0.023 
Npm3 nucleoplasmin 3 1.52 0.040 
Hebp1 heme binding protein 1 1.52 0.013 
Coro1a coronin, actin binding protein 1A 1.52 0.008 
Hn1 hematological and neurological expressed sequence 1 1.50 0.023 
Gm10063 predicted gene 10063 1.49 0.028 
Cd74 
CD74 antigen (invariant polypeptide of major 
histocompatibility complex, class II antigen-associated) 
1.48 0.045 
Hist1h2ai histone cluster 1, H2ai 1.48 0.022 
Sae1 SUMO1 activating enzyme subunit 1 1.48 0.009 
Gm11425 predicted gene 11425 1.46 0.034 
Psmb9 
proteasome (prosome, macropain) subunit, beta type 9 (large 
multifunctional peptidase 2) 
1.45 0.005 
Slamf9 SLAM family member 9 1.45 0.031 
Pigp phosphatidylinositol glycan anchor biosynthesis, class P 1.45 0.034 
Maged2 melanoma antigen, family D, 2 1.45 0.011 
H2-Eb1 histocompatibility 2, class II antigen E beta 1.44 0.034 
Hist1h2af histone cluster 1, H2af 1.44 0.027 
Dus4l dihydrouridine synthase 4-like (S. cerevisiae) 1.43 0.029 
Wbp5 WW domain binding protein 5 1.42 0.037 
Rpl12 ribosomal protein L12 1.41 0.031 
Rps5 ribosomal protein S5 1.41 0.046 
1110059E24Ri
k 
RIKEN cDNA 1110059E24 gene 1.41 0.003 
4833442J19Ri
k 
RIKEN cDNA 4833442J19 gene 1.41 0.025 
Anxa2 annexin A2 1.40 0.004 
Mgst3 microsomal glutathione S-transferase 3 1.39 0.026 
Nsmce1 non-SMC element 1 homolog (S. cerevisiae) 1.39 0.021 
Hist1h2an histone cluster 1, H2an 1.39 0.027 
Lsm5 
LSM5 homolog, U6 small nuclear RNA associated (S. 
cerevisiae) 
1.38 0.034 
Mpeg1 macrophage expressed gene 1 1.38 0.025 
Ubxn6 UBX domain protein 6 1.38 0.023 
Rps12 ribosomal protein S12 1.38 0.026 
Evi2a ecotropic viral integration site 2a 1.38 0.034 
Arhgdib Rho, GDP dissociation inhibitor (GDI) beta 1.38 0.036 
Fbn1 fibrillin 1 1.37 0.049 
Rps26 ribosomal protein S26 1.37 0.034 
Rhoj ras homolog gene family, member J 1.37 0.015 
Ugt1a10 UDP glycosyltransferase 1 family, polypeptide A10 1.37 0.034 
Mgst3 microsomal glutathione S-transferase 3 1.36 0.009 
Tyrobp TYRO protein tyrosine kinase binding protein 1.36 0.031 
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Ebpl emopamil binding protein-like 1.36 0.016 
Arpc3 actin related protein 2/3 complex, subunit 3 1.36 0.033 
Siva1 SIVA1, apoptosis-inducing factor 1.35 0.040 
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Table 6.3: Genes Downregulated in Gpr120 KO BAT 
Gene Symbol Gene Name Fold 
Change 
Adjusted 
P Value 
O3far1 omega-3 fatty acid receptor 1 0.35 0.002 
Pnpla3 patatin-like phospholipase domain containing 3 0.38 0.016 
Hspa8 heat shock protein 8 0.41 0.001 
Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 0.43 0.038 
Adrbk2 adrenergic receptor kinase, beta 2 0.55 0.004 
Vegfa vascular endothelial growth factor A 0.55 0.003 
Apoc1 apolipoprotein C-I 0.55 0.004 
Mlxipl MLX interacting protein-like 0.56 0.007 
Hspd1 heat shock protein 1 (chaperonin) 0.56 0.017 
Luc7l3 LUC7-like 3 (S. cerevisiae) 0.58 0.015 
Per2 period homolog 2 (Drosophila) 0.60 0.011 
Atl2 atlastin GTPase 2 0.60 0.034 
Neat1 nuclear paraspeckle assembly transcript 1 (non-protein coding) 0.61 0.050 
Acsl1 acyl-CoA synthetase long-chain family member 1 0.61 0.041 
Ggnbp1 gametogenetin binding protein 1 0.61 0.011 
Slc4a4 solute carrier family 4 (anion exchanger), member 4 0.61 0.014 
Per2 period homolog 2 (Drosophila) 0.61 0.021 
Rnf44 ring finger protein 44 0.62 0.023 
Flcn Folliculin 0.62 0.028 
Slc25a20 solute carrier family 25 (mitochondrial carnitine/acylcarnitine 
translocase), member 20 
0.62 0.025 
Atl2 atlastin GTPase 2 0.62 0.047 
Hnrpdl heterogeneous nuclear ribonucleoprotein D-like 0.62 0.011 
Srsf2 serine/arginine-rich splicing factor 2 0.63 0.016 
Slc38a2 solute carrier family 38, member 2 0.63 0.016 
Gys2 glycogen synthase 2 0.63 0.023 
Ddx17 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 0.63 0.014 
Gm3308 predicted gene 3308 0.64 0.021 
Gm10621 predicted gene 10621 0.64 0.004 
Ccrn4l CCR4 carbon catabolite repression 4-like (S. cerevisiae) 0.64 0.024 
Actb actin, beta 0.64 0.021 
Aspg asparaginase homolog (S. cerevisiae) 0.64 0.021 
Clasrp CLK4-associating serine/arginine rich protein 0.64 0.013 
Ppargc1b peroxisome proliferative activated receptor, gamma, coactivator 
1 beta 
0.64 0.029 
Apoc1 apolipoprotein C-I 0.65 0.034 
Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 0.65 0.017 
Adhfe1 alcohol dehydrogenase, iron containing, 1 0.65 0.028 
Klf9 Kruppel-like factor 9 0.65 0.029 
Aacs acetoacetyl-CoA synthetase 0.66 0.039 
Vegfa vascular endothelial growth factor A 0.66 0.003 
Srrm2 serine/arginine repetitive matrix 2 0.66 0.013 
2810403A07R
ik 
RIKEN cDNA 2810403A07 gene 0.67 0.011 
Hsp90ab1 heat shock protein 90 alpha (cytosolic), class B member 1 0.67 0.046 
Gtf3c2 general transcription factor IIIC, polypeptide 2, beta 0.67 0.011 
Lgals4 lectin, galactose binding, soluble 4 0.67 0.011 
Paqr9 progestin and adipoQ receptor family member IX 0.67 0.030 
Arap3 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 
3 
0.68 0.030 
Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 
5 
0.68 0.001 
Fam126b family with sequence similarity 126, member B 
 
0.68 0.022 
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Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 
5 
0.68 0.003 
Gm2589 predicted gene 2589 0.68 0.012 
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6.2.2 Effect of Gpr120 KO on brown fat associated genes 
We carried out preliminary gene expression studies to determine the effects of Gpr120 KO on 
the expression of specific brown fat genes aP2, Ucp1, and CIDEA. Also the expression of 
Adrbk2 and Sncg, genes that were highly downregulated or upregulated respectively within 
the microarray, were determined. As expected, there was no detectable Gpr120 mRNA in the 
KO BAT. However, in these samples, Gpr40 was detected at low level in BAT, but not 
significantly affected by Gpr120 KO. There was no significant change in the expression of 
aP2, Ucp1 or CIDEA in the KO compared to the WT (Figure 6.2.1). However, there was a 
significant reduction in the mRNA levels of Adrbk2 in Gpr120 KO BAT compared to WT, 
confirming the observation. The most upregulated gene in Gpr120 KO BAT, Sncg, a member 
of the synuclein family of genes, exhibited a significant increase in Gpr120 KO BAT 
compared to the WT (Figure 6.2.1).  
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Figure 6.2.1: mRNA expression levels of Gpr120, aP2, Ucp1, Gpr40, CIDEA, Sncg, and Adrbk2 
in brown adipose tissue (BAT) from either GPR120 knockout (KO) or wild type (WT) mice 
using q-RT-PCR. BAT samples were obtained from five pairs of Gpr120 KO and WT 
littermates kept in the same housing condition. Total RNA was extracted with TRIzol and 
cDNA was prepared as described in materials and methods. Gene expression was normalized to 
β-actin with GPR120 WT as the reference value. All data are expressed as the mean ± SEM of 
five samples in duplicates (n=5). *p<0.05 
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6.2.2 The role of Gpr120 in inflammation in BAT  
It is now recognized that chronic tissue inflammation is a major component of obesity-
induced insulin resistance, and this is due to the accumulation of proinflammatory immune 
cells (Oh and Olefsky, 2012), and adipocytes are capable of contributing to this inflammation 
by their production of inflammatory mediators (Vielma et al., 2013) such as TNF-α, IL-1β, 
IL-6, and/or BDNF, and by playing a significant role in initiating the inflammatory cascade 
(Deshmane et al., 2009). The effect of Gpr120 knockout on BAT inflammatory genes was 
therefore assessed. The mRNA expression levels of IL-6, TNFα, RANTES, CD36, and MCP-
1 in Gpr120 KO BAT was compared to WT BAT. There was a trend towards upregulation of 
IL-6, and RANTES in the Gpr120 knockout BAT compared to WT (Figure 6.2.2) although 
this was not significant. 
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Figure 6.2.2: mRNA expression levels of IL-6, TNFα, CD36, RANTES, and MCP-1 in brown 
adipose tissue from either GPR120 knockout (KO) or wild type (WT) mice using q-RT-PCR. 
BAT samples were obtained from five pairs of Gpr120 KO and WT littermates kept in the same 
housing condition. Total RNA was extracted with TRIzol and cDNA was prepared as described 
in materials and methods. Gene expression was normalized to β-actin with GPR120 WT as the 
reference value. All data are expressed as the mean ± SEM of five samples in duplicates (n=5).  
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6.2.3 Gpr120 is essential for lipogenesis  
Fatty acid synthesis is an important component of the metabolic regulation of adipose tissue. 
Thermogenesis in BAT has been attributed predominantly to activation of mitochondrial 
uncoupling via Ucp1, resulting in heat production. Increased adipose tissue lipogenesis is 
associated with enhanced insulin sensitivity (Yore et al., 2014) and improved thermogenesis 
(Diaz et al., 2014). To determine the effect of Gpr120 KO on lipogenesis, mRNA levels of 
known genes involved in lipogenesis were examined. Specifically Acc1, Acc2, Fasn, Scd1, 
Scd2, Aacs, and Srebp1c were analysed in Gpr120 KO BAT compared to WT BAT. A 
significant reduction in the expression of Acc1, Acc2, Fasn, and Scd2, in the Gpr120 
knockout BAT as compared to the WT was observed (Figure 6.2.3). This suggests that 
downregulation of Gpr120 may cause an impairment in BAT lipogenic activity, through the 
inhibition of key genes that control this process. 
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Figure 6.2.3: mRNA expression levels of Acc1, Acc2, Scd1, Scd2, Aacs, and Srebp1c in brown 
adipose tissue from either GPR120 knockout (KO) or wild type (WT) mice using q-RT-PCR. 
BAT samples were obtained from five pairs of Gpr120 KO and WT littermates kept in the same 
housing condition. Total RNA was extracted with TRIzol and cDNA was prepared as described 
in materials and methods. Gene expression was normalized to β-actin with GPR120 WT as the 
reference value. All data are expressed as the mean ± SEM of five samples in duplicates (n=5). 
*p<0.05 
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6.2.4 Gpr120 KO impairs lipolysis in BAT 
The hydrolysis of stored triacylglycerol (TAG) in adipocytes results in the release of free 
fatty acids and glycerol into the bloodstream. Complete TAG hydrolysis depends on the 
activity of certain key enzymes such as adipose triglyceride lipase (ATGL) and hormone-
sensitive lipase (HSL). Therefore in order to assess the effects of Gpr120 knockout on genes 
involved in the lipolytic pathway, we analysed mRNA levels of ATGL, HSL, Acsl1, Pnpla3, 
Adhfe1, and Apoc1 in the Gpr120 KO BAT compared to the WT. A reduction in mRNA 
levels of all the genes was observed. However, ATGL, HSL, and Apoc1 were the only genes 
with significantly reduced mRNA levels (Figure 6.2.4). This suggests that Gpr120 KO is 
associated with reduction of lipolytic genes and impairment of fatty acid metabolism. 
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Figure 6.2.4: mRNA expression levels of HSL, ATGL, Acsl1, Pnpla3, Adhfe1, and Apoc1 in 
brown adipose tissue from either GPR120 knockout (KO) or wild type (WT) mice using q-RT-
PCR. BAT samples were obtained from five pairs of Gpr120 KO and WT littermates kept in the 
same housing condition. Total RNA was extracted with TRIzol and cDNA was prepared as 
described in materials and methods. Gene expression was normalized to β-actin with GPR120 
WT as the reference value. All data are expressed as the mean ± SEM of five samples in 
duplicates (n=5). *p<0.05 
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6.2.5 Gpr120 is involved in the regulation of glucose metabolism 
Brown adipose tissue activation is reported to play a physiologically significant role in 
whole-body energy expenditure, glucose homeostasis and insulin resistance (Chondronikola 
et al., 2014). Therefore the requirement of Gpr120 in regulation of key genes in glucose 
metabolism was next evaluated.  The mRNA levels of genes known to be constitutively 
involved in the metabolism of glucose, some of which were identified by the microarray 
experiments (Gys2, Paqr9) were analysed. We compared the expression of Glut4, Insulin 
receptor, Adcy4, Mlxip1, Glut1, Gys2, Vldlr, Paqr9, and Aldh2 in Gpr120 KO BAT to WT 
BAT. A significant reduction in the mRNA expression levels of Glut4, Insulin receptor, 
Adcy4 and Mlxip1in the Gpr120 KO BAT as compared to the WT BAT (Figure 6.2.5). This 
result suggests that BAT Gpr120 has a role to play in adipose tissue glucose homeostasis. 
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Figure 6.2.5A: mRNA expression levels of Glut1, Glut2, Insulin receptor, Gys2, and Adcy4 in 
brown adipose tissue from either GPR120 knockout (KO) or wild type (WT) mice using q-RT-
PCR. BAT samples were obtained from five pairs of Gpr120 KO and WT littermates kept in the 
same housing condition. Total RNA was extracted with TRIzol and cDNA was prepared as 
described in materials and methods. Gene expression was normalized to β-actin with GPR120 
WT as the reference value. All data are expressed as the mean ± SEM of five samples in 
duplicates (n=5). *p<0.05 
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Figure 6.2.5B: mRNA expression levels of Vldlr, Mlxip1, Adrbk2, Paqr9, and Aldh2 in brown 
adipose tissue from either GPR120 knockout (KO) or wild type (WT) mice using q-RT-PCR. 
BAT samples were obtained from five pairs of Gpr120 KO and WT littermates kept in the same 
housing condition. Total RNA was extracted with TRIzol and cDNA was prepared as described 
in materials and methods. Gene expression was normalized to β-actin with GPR120 WT as the 
reference value. All data are expressed as the mean ± SEM of five samples in duplicates (n=5). 
*p<0.05 
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Table 6.4: Summary of genes found to be downregulated in Gpr120 knockout BAT 
using q-RT-PCR. 
Downregulated 
genes Gene name p-value 
Adrbk2 adrenergic receptor kinase, beta 2 <0.05 
Gpr40 omega-3 fatty acid receptor 1 >0.05 
Acc1 Acetyl-CoA carboxylase 1 <0.05 
Acc2 Acetyl-CoA carboxylase 2 <0.05 
Fasn Fatty acid synthase <0.05 
Scd1 Stearoyl-CoA desaturase 1 >0.05 
Scd2 Stearoyl-CoA desaturase 2 <0.05 
Aacs acetoacetyl-CoA synthetase >0.05 
Srebp1c sterol regulatory element-binding protein 1c >0.05 
HSL Hormone sensitive lipase <0.05 
ATGL Adipose triglyceride lipase  <0.05 
Acsl1 
acyl-CoA synthetase long-chain family 
member 1 >0.05 
Pnpla3 patatin-like phospholipase domain containing 3 <0.05 
Adhfe1 Alcohol dehydrogenase, iron containing,1  >0.05 
Apoc1 apolipoprotein C-I <0.05 
Glut1 Glucose transporter 1 >0.05 
Glut4 Glucose transporter 4 <0.05 
Insulin receptor Insuline receptor <0.05 
Gys2 Glycogen Synthase 2 >0.05 
Adcy4 Adenylate cyclase 4 <0.05 
Vldlr Very low density lipoprotein lipase receptor >0.05 
Mlxip1 MLX interacting protein-like <0.05 
Paqr9 
progestin and adipoQ receptor family member 
IX >0.05 
Aldh2 Aldehyde dehydrogenase 2  >0.05 
 
Note: only those with p-value <0.05 were found to be significantly downregulated 
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Table 6.5: Summary of genes found to be upregulated in Gpr120 knockout BAT using 
q-RT-PCR. 
Upregulated 
genes Gene name p-value 
Sncg synuclein, gamma <0.05 
IL6 Interleukin-6  >0.05 
TNFα Tumour necrosis factor-α  >0.05 
CD36 Thrombospondin Receptor >0.05 
RANTES Chemokine ligand 5 (CCL5) >0.05 
MCP-1 Monocyte chemoattractant protein-1 (CCL2) >0.05 
 
Note: only those with p-value <0.05 were found to be significantly upregulated  
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6.3 siRNA-mediated Gpr120 Knockdown in IMBAT cells is associated with increase in 
inflammatory gene expression and reduction in metabolic gene expression 
In order to further confirm a direct impact of the loss or the absence of Gpr120 in BAT, 
Gpr120 levels were reduced by siRNA in the IMBAT cell system. Noting that Gpr120 is only 
expressed at the basal level in brown preadipocytes but upregulated in mature adipocytes, 
IMBAT cells were differentiated for 6 days to allow expression of Gpr120. Thereafter the 
cells were transfected for 48 hours with Gpr120 siRNA and the mRNA expression levels of 
Gpr120, aP2, Ucp1, IL-6, Glut4, Sncg, Mlxipl, and Scd2 were determined using q-RT-PCR. 
The validity of the knockdown was provided by over 70% downregulation of Gpr120 
expression (Figure 6.3). Similar to the effects observed with the KO BAT, there was a 
significant increase in expression of Sncg. Ucp1 levels were lower in IMBAT cells treated 
with Gpr120 siRNA as compared to the control, although this did not reach significance.  IL-
6, aP2, Glut4, and Mlxipl levels, however, were not significantly altered. 
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Figure 6.3: Regulation of expression of aP2, Ucp1, Mlxip1, Sncg, IL-6, and Glut4 in IMBAT 
cells by Gpr120 using q-RT-PCR. IMBAT cells were differentiated for 48 hours with 500µM 
IBMX, 250nM Dexamethasone, 170nM insulin, 125nM Indomethacin, and 1nM 
Triiodothyronine (T3). Thereafter, they were transfected with either Gpr120 siRNA or 
siControl for 48hours. Total RNA was extracted with TRIzol and cDNA was prepared as 
described in materials and methods. Gene expression was normalized to β-actin and depicted 
with reference to siControl. All data are expressed as the mean ± SEM of three samples in 
duplicates (n=3). *p<0.05 
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6.4 Discussion 
In the search for genes that may be potentially involved in the regulation of brown adipose 
tissue function with respect to Gpr120, a microarray study, in addition to study of known 
candidate genes, in BAT from WT and Gpr120 KO mice, was carried out. These two 
approaches were used to investigate the importance of Gpr120 as a fatty acid receptor in BAT 
function.  
Obesity is a chronic inflammatory state associated with elevated levels of pro-inflammatory 
cytokines and chemokines in tissues and in the circulation. Adipocytes are capable of 
contributing to this inflammation by production of inflammatory mediators. Certain genes are 
traditionally associated with inflammation, such as Interleukin-6 (IL-6), Tumour necrosis 
factor-α (TNFα) and some chemokines. Together with TNFα, the expression of IL-6 in 
adipose tissue is known to be associated with obesity-linked insulin resistance (Kern et al., 
2001). Gpr120 has been reported to have anti-inflammatory and anti-diabetic effects (Oh et 
al., 2010). Following knockout of Gpr120 in BAT, there was an upregulation of IL-6, and 
MCP-1, albeit not significant. IL-6 is an interleukin that acts as both a pro-inflammatory 
(Bastard et al., 1999) and anti-inflammatory cytokine (Pedersen, 2013) to modulate immune 
response.  Despite the high variability in levels of IL-6 in KO tissue, which may indicate a 
larger sample size is required, Gpr120 may have an anti-inflammatory function but the 
current study suggests that there may be more key functions of this receptor in BAT, and 
possibly Gpr120 in other cell types/tissues may be more anti-inflammatory.  
Immune response and metabolic regulation are highly integrated and this interface maintains 
a central homeostatic system, dysfunction of which can cause obesity-associated metabolic 
disorder such as type 2 diabetes, fatty liver disease, and cardiovascular disease (Hotamisligil, 
2006). Certain molecular pathways have linked obesity to insulin resistance (Shoelson et al., 
2006). Furthermore, there may be regulatory links between BAT thermal plasticity and 
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glucose metabolism in humans (Lee et al., 2014a). Since Gpr120 was highly expressed in 
BAT and upregulated by cold exposure, it was hypothesized that Gpr120 had a role in the 
maintenance of glucose homeostasis. Expression of genes that are constitutively involved in 
the metabolism of glucose was assessed in the Gpr120 KO compared to WT BAT. Glucose 
transporter type 4, (Glut4) is involved in insulin-regulated trafficking of glucose, and whole 
body energy homeostasis.  It is expressed in tissues that exhibit insulin-stimulated glucose 
uptake (heart and skeletal muscle and adipose tissue). One of the main acute effects of insulin 
is to regulate the disposal and storage of dietary glucose by stimulating the uptake of glucose 
into muscle and fat. Mice overexpressing Glut4 in adipocytes have elevated lipogenesis and 
increased glucose tolerance despite being obese with elevated circulating fatty acids (Yore et 
al., 2014).  In Gpr120 KO BAT, a significant reduction in the mRNA levels of Glut4, Insulin 
receptor and Mlxipl was observed. Although other studies have reported similar findings in 
adipose tissue as a whole (Oh et al., 2010), this is the first study to identify a potential role of 
Gpr120 in glucose and lipid metabolism in BAT. Although downregulation of Gpr120 in 
IMBAT cells did not corroborate these findings, this may reflect that a more complete 
knockdown is required, as in the tissue from the KO mice. Mlxipl, also known as MLX-
interacting protein-like is a carbohydrate-responsive element-binding protein (ChREBP). 
ChREBP and peroxisome proliferator-activated receptor alpha (PPARα) plays an important 
role in the regulation of lipid metabolism in the liver (Iizuka et al., 2013). 
BAT is a thermogenic organ involved in energy balance and maintenance of healthy body 
weight. There was a significant reduction in the levels of enzymes involved in lipolysis, HSL 
and ATGL in Gpr120 KO compared to WT BAT. The primary action attributed to HSL is 
hydrolysis of stored triacylglycerols in adipose tissue. Since activation of HSL leads to the 
release of free fatty acids which are taken up by mitochondria, the interaction with Ucp1 
results in increased energy expenditure (Djouder et al., 2010).  ATGL, Adipose triglyceride 
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lipase (ATGL), an enzyme that catalyzes the rate limiting hydrolytic step of triglycerides in 
the triacylglycerol lipolysis cascade, is expressed predominantly in adipose tissue. There was 
also significant downregulation of Pnpla3 and Apoc1 in the Gpr120 KO BAT compared to 
WT BAT. Human patatin-like phospholipase (Pnpla) is an enzyme involved in the regulation 
of adipocyte differentiation. Members of this new enzymatic family displaying lipase and 
transacylase properties appear to have major roles in the regulation of lipid metabolism and 
that it participates in the restoration of lipid homeostasis upon aberrant intracellular lipid 
accumulation (Chamoun et al., 2013). Apoc1 is secreted in plasma where it is a component of 
very low density lipoproteins (VLDL) and chylomicrons. This protein activates the enzyme 
lipoprotein lipase which hydrolyzes triglycerides and thus provides FFAs to cells. 
Apolipoprotein C-I binds FFAs and reduces their intracellular esterification. Interestingly, 
expression of Apoc1 in mice has been linked to protection against obesity (Westerterp et al., 
2007), thus its reduction in the absence of Gpr120, which results in obese animals when fed a 
high fat diet (Jong et al., 2001),  is consistent with these observations.  
Acsl1 is a member of the ligase family of enzymes. It plays a key role in lipid biosynthesis 
and fatty acid degradation. By directing fatty acids toward beta-oxidation Acsl1 is required 
for cold thermogenesis (Ellis et al., 2010). Alcohol dehydrogenase, iron containing,1 
(Adhfe1) is responsible for the oxidation of 4-hydroxybutyrate in mammalian tissues (Kardon 
et al., 2006) and has been shown to be upregulated during brown adipocytes differentiation 
(Kim et al., 2007). Although there was a mild reduction in the mRNA levels of Adhfe1 and 
Acsl1 in the Gpr120 KO compared to WT, Gpr120 does not seem to have a role in the 
regulation of these genes. 
In addition to lipolysis, genes associated with lipogenesis also seem to require Gpr120. Two 
stearoyl-CoA desaturase (Scd1 and Scd2) isoforms can be expressed during the 
differentiation of 3T3-L1 preadipocytes into adipocytes. Stearoyl-CoA desaturase (SCD) is a 
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key rate-limiting enzyme in the synthesis of unsaturated fatty acids. Scd1 and Scd2 are 
enzymes involved in fatty acid metabolism required for diet-induced insulin resistance 
(Gutierrez-Juarez et al., 2006). The significant downregulation of Scd2 following Gpr120 
knockout in BAT also suggests a role for Gpr120 in brown fat lipogenesis. Acetyl-CoA 
carboxylase (Acc1 and Acc2) are enzymes whose functions involve the generation of 
malonyl-CoA which is a precursor in fatty acid synthesis. Both Acc1 and Acc2 mRNA levels 
were significantly reduced in Gpr120 KO BAT compared to WT BAT. Adipocyte lipogenic 
pathway encompasses fatty acid synthesis and subsequent triacyl glyceride synthesis 
catalysed by FAS. Inhibiting lipogenic enzymes could therefore potentially reduce obesity. 
Our result showed a significant reduction in the Level of Fasn in the Gpr120 KO BAT 
compared to WT. (Lodhi et al., 2012) had reported that Fasn deficiency resulted in reduced 
PPARγ activation and reduced adipogenesis. 
Loss of Gpr120 also affected the levels of GPCR-associated signalling molecules. Adcy4 
encodes a member of the family of adenyly cyclases, which are membrane-associated 
enzymes that catalyse the formation of the second messenger cyclic adenosine 
monophosphate (cAMP). The significant reduction in the mRNA levels of Adcy4 observed in 
Gpr120 KO suggests that Gpr120 may regulate the ability of distinct GPCRs to activate 
(Gαs-coupled) or inhibit (Gαi-coupled) the cAMP pathway such as the β-ARs, in BAT.  
Adrbk2 (adrenergic, beta, receptor kinase 2), also known as G-protein-coupled receptor 
kinase 3(GRK3) is a serine/threonine kinase specifically involved in the phosphorylation of 
activated GPCRs, contributing to receptor desensitization and recruitment of β-arrestins. 
Although GRK6 is implicated in phosphorylation of human Gpr120 in heterologous cell lines 
(Burns et al., 2014), its downregulation in Gpr120 KO BAT may suggest a role for this 
kinase in Gpr120 signal regulation and/or a role for Gpr120 in regulating activity of distinct 
receptors in this tissue. 
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Synuclein (Sncg) was the most upregulated gene identified in the microarray in the Gpr120 
KO BAT compared to WT. This gene is known to be expressed in WAT, with mild 
expression in BAT and neuronal cells. Sncg has been reported to be one of obesity associated 
genes linked with aP2 (Bag et al., 2015). Recent findings implicate an important role for 
synuclein-γ (Sncg) in energy homeostasis and adipocyte function (Dunn et al., 2015).  
In summary, Gpr120 may have a role in regulating the expression levels of both lipogenic 
and lipolytic genes in BAT, and the absence of Gpr120 may cause metabolic impairment. 
Regulation of glucose and lipid homeostasis is a key function of adipocytes, one that 
critically depends on insulin-mediated glucose uptake by Glut4. Downregulation of Glut4 in 
adipose tissue is one of the earliest events in the pathogenesis of insulin resistance and type 2 
diabetes (Ussar and Tschop, 2014). Furthermore, obesity and diabetes appear to share an 
interconnectivity characterised by inflammation, insulin resistance and metabolic changes, 
and which may be ameliorated by regulation of long chain fatty acid receptor, Gpr120 in 
brown adipose tissue. Understanding the integration of these biological systems is important 
as it relates to energy balance and maintenance of a healthy body weight. Lack of Gpr120 
may result in disorders of lipid metabolism. In fact, there seems to be interdependency 
between glucose and lipids metabolism, and thermogenesis, where Gpr120 may play a pivotal 
role in their regulation.  
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Chapter 7 
Results 
 
Assessment of novel Gpr120- specific ligand-induced 
cellular events in the differentiation and function of BAT 
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7.1 Introduction 
Metabolic diseases such as obesity and type 2 diabetes mellitus are increasing by the day. 
Gpr120 which plays an important role in the control of energy homeostasis and inducing anti-
inflammatory effects is of vital importance in this respect. Synthetic agonists, that will 
selectively bind Gpr120, could be highly invaluable in the search for pharmacological 
treatments of obesity, diabetes and its associated complications. Therefore Gpr120 agonism 
correlates with prevention of the occurrence and development of metabolic disorders such as 
obesity and diabetes (Zhang and Leung, 2014). In this regard, we have used distinct 
compounds that activate Gpr120 to assess their responsiveness in brown adipocytes.  
Three different Gpr120 compounds which are agonists to Gpr120 were assessed, namely 
GW9508, TUG891 and TUG1096. GW9508 is a synthetic non-selective agonist that binds 
both Gpr120 and Gpr40 (Briscoe et al., 2006a), although its agonist activities have been 
studied mainly with respect to Gpr40 (Ou et al., 2013). However, Gpr40 was not detectable in 
IMBAT cells (Figure 5.2) hence its effect in our cell system can be attributable to Gpr120 
binding. GW9508 has been reported to have EC50values of 47 nM and 2.2 µM, respectively, in 
HEK293 cells expressing GPR40 and GPR120 (Briscoe et al., 2006a). A second ligand, TUG891, 
was developed as a potent and selective agonist of human Gpr120 (Hudson et al., 2013). 
Stimulation with TUG891 has been reported to enhance glucose uptake in 3T3-L1 cells, 
inhibit release of proinflammatory mediators from RAW264.7 macrophages and induce 
Ca
2+
 mobilization, β-arrestin-1 and β-arrestin-2 recruitment, and extracellular signal-
regulated kinase phosphorylation in HEK293 cells transfected to express species orthologs of 
Gpr120  (Hudson et al., 2013; Hudson et al., 2014). TUG891 was found to be approximately 
10 times more potent than GW9508, with pEC50 potency values of 7.36 and 7.77 for human 
and mouse Gpr120 respectively (Shimpukade et al., 2012). Therefore, based on the various 
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reported data, standard concentrations of 100µM and 10µM for GW9508 and TUG1096 
respectively (Hudson et al., 2013; Hudson et al., 2014) have been used through in this project.  
The third agonist, TUG1096 was recently developed and provided by our collaborator, Trond 
Ulven, University of Southern Denmark. It is thought to be a more specific agonist, but there 
are currently no published studies that utilised this compound. However, at a dose 10µM, 
they observed physiological response to Gpr120 stimulation (personal communication). 
Therefore experiments were carried out to test and compare these more specific Gpr120 
ligands (TUG891 and TUG1096) to GW9508 in brown adipocytes. We tested the potential of 
these ligands to induce cellular differentiation of brown adipocytes, and regulate metabolic 
and inflammatory processes in brown adipocytes. 
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7.1.1 Effect of Gpr120 agonists on Gpr120 and aP2 gene expression 
Undifferentiated IMBAT cells were treated with the three different ligands every 12 hours 
over a 6-day period, and the expression profile of Gpr120, aP2 (a differentiation marker) and 
some key genes involved in adipose tissue metabolism was determined. Untreated 
undifferentiated IMBAT cells and differentiated cells treated on a standard differentiation 
protocols served as negative and positive controls respectively.  
The expression of the differentiation marker aP2, following the standard differentiation 
treatment, increased steadily with time (Figure 7.1.1). Treatment with GW9508 resulted in an 
early expression of aP2, which gradually reduced over time. While treatment with TUG891 
did not induce any significant changes in aP2 expression, treatment with TUG1096 caused a 
gradual but small increase in the expression levels of aP2 which peaked following 4 days of 
treatment (Figure 7.1.1). GW9508 also stimulated Gpr120 expression that increased steadily 
from the first day of treatment with an approximately 50-fold increase following 6 days of 
treatment which was similar to the levels induced by standard differentiation protocol. 
TUG1096 and TUG891 however, induced only a small increase in Gpr120 mRNA levels 
following 2 days or 6 days treatment respectively (Figure 7.1.1).  
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Figure 7.1.1: mRNA levels of aP2 and Gpr120 in ligand-treated undifferentiated IMBAT cells, 
using q-RT-PCR. The cells were treated 12 hourly for 6 days with GW9508 (100µM), TUG891 
(10µM), and TUG1096 (10µM); a set IMBAT cells was treated with a standard differentiation 
cocktail for 6 days. Gene expression was normalized to beta-actin and depicted with reference to 
the undifferentiated IMBAT cells. All data represent mean ± SEM of three samples in duplicate. 
*P<0.05**p<0.005, ***p<0.001 
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7.1.2 Effect of Gpr120 agonists on expression of metabolic genes 
Gpr120 is known to play roles in the regulation of metabolism, and its agonist has been 
reported to have insulin-sensitizing and anti-inflammatory effects (Hudson et al., 2013; Oh et 
al., 2010). To determine the effect of stimulation of IMBAT cells with Gpr120 ligands on 
expression of genes involved in lipid and glucose metabolism that were decreased in Gpr120 
KO BAT (Chapter 6), a treatment-time course was carried out as in section 7.1.1. There was 
an increase in mRNA levels of all genes with standard differentiation protocol. Treatment 
with GW9508 caused an approximately 40-fold increase in the mRNA levels of Acc2, Glut1 
and Glut4 after 6 days, but did not cause any appreciable change in the mRNA levels of 
Scd2. Whereas just 2 days of treatment, GW9508 induced expression of insulin receptor 
(Figure 7.1.2). 
Treatment with TUG891 or TUG1096 caused a mild, but non-significant increase in the 
mRNA levels of Acc2 and Scd2 after 4 days. No appreciable changes in the levels of Glut4 
were observed following treatment with either TUG891 or TUG1096, however, TUG1096 
significantly increased insulin receptor mRNA levels after 2 days and Glut1 following 6 days 
of treatment. Overall, this data suggests that treatment of brown adipocytes with Gpr120 
agonists can induce differential effects on activation of metabolic gene expression. 
 
 
 
 
 
 
 
 
 
189 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
 
 
190 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1.2: mRNA levels of Glut1, Glut4 and Insulin receptor in ligand-treated 
undifferentiated IMBAT cells using q-RT-PCR. Undifferentiated IMBAT cells treated for 6 
days with Gpr120 ligand. The cells were treated 12 hourly for 6 days with GW9508 (100µM), 
TUG891 (10µM), and TUG1096 (10µM); a set IMBAT cells was treated with a standard 
differentiation cocktail for 6 days. Gene expression was normalized to beta-actin and depicted 
with reference to the undifferentiated IMBAT cells. All data represent mean ± SEM of three 
samples in duplicate. *P<0.05**p<0.005, ***p<0.001 
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7.2 Effects of Gpr120 ligands on Gpr120 KO IMBAT cells 
7.2.1 Gpr120 ligands induce lipid droplet formation in IMBAT cells via Gpr120 
Based on the differential effects that the Gpr120 ligands had on gene expression, further 
experiments were carried out to determine the receptor specificity of the above ligand-
induced effect on differentiation and metabolic gene expression. IMBAT cell lines were 
generated from Heterozygous (Het) and knockout (KO) brown adipocytes (kindly provided 
by Karsten Kristiansen, University of Copenhagen).  
Lipid droplet formation is classically used as a phenotypic manifestation of adipocyte 
maturation. GW9508 was earlier demonstrated to stimulate lipid droplet formation in IMBAT 
cells, suggesting the ability of this ligand to induce the mature brown phenotype in our cell 
system (Figure 5.4). The capacity of GW9508, TUG891 and TUG1096 to stimulate lipid 
droplet formation in IMBAT cells from Gpr120 heterozygous (Het) or Gpr120 knockout 
(KO) lines was compared. This would also determine the specificity of Gpr120 ligands in the 
mouse IMBAT cell system. Undifferentiated Het and KO IMBAT cells were treated with 
GW9508, TUG891 or TUG1096 12 hourly for 8 days and cells stained with Oil red O and 
imaged. As a positive control cells were also treated with the standard differentiation 
protocol.  
Following 8 days of treatment with standard differentiation protocol both the Het and KO 
cells exhibited lipid droplet formation (Figure 7.2.1 A-B). When cells were treated with 
GW9508, there was a reduction in the lipid droplet formation in the Gpr120 KO cells 
compared to the Het (Figure 7.2.1). Whereas TUG891 induced minimal lipid droplet 
formation in Gpr120 Het IMBAT cells, there was almost no visible Oil red O staining in the 
KO cells. Although TUG1096 induced lipid droplet formation, there was no appreciable 
difference in the lipid droplet induced by TUG1096 between Gpr120 Het and KO IMBAT 
cells. Taken together, this suggests that downregulation of Gpr120 in IMBAT cells reduces 
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the ability of the cells to certain different Gpr120 agonists and that such ligands may possess 
different capacity to induce brown adipocyte lipid droplet formation. 
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Figure 7.2.1: Oil Red O (O Red O) staining of Gpr120-/+ and Gpr120-/- IMBAT cells treated 
with Gpr120 agonists. Undifferentiated Gpr120 Het and KO IMBAT cells were treated with 
100µM GW9508, 10µM TUG891, 10µM TUG1096 or standard differentiation cocktail for 6 
days and stained with ORO. Standard differentiation was performed as in materials and 
methods. Images were taken with light microscope (20X magnification).  
100µM GW9508 100µM GW9508 
10µM TUG891 10µM TUG891 
Standard Standard 
Gpr120 -/- Gpr120 -/+ 
10µM TUG1096 10µM TUG1096 
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7.2.2 Gpr120 KO attenuates the Gpr120 ligand-induced induction of metabolic genes. 
It has been demonstrated that downregulation of Gpr120 in BAT reduced the expression of 
certain key metabolic genes (Chapter 6). To assess the ability of Gpr120 ligands to stimulate 
expression of these metabolic genes and to further determine the function of Gpr120 in BAT 
metabolism, the expression levels of Acc2 and Srebp1c, representative metabolic genes, were 
determined. Undifferentiated Het and KO IMBAT cells were treated with GW9508, TUG891 
or TUG1096. Cells were also differentiated using the standard differentiation cocktail. The 
expression levels of Acc2 and Srebp1c in Het cells were robustly increased following 
treatment with GW9508, or standard differentiation cocktail (Figure 7.2.3). In contrast this 
GW9508 or differentiation cocktail-induced expression was dramatically reduced in Gpr120 
KO cells compared to Gpr120 Het IMBAT cells. Both TUG891 and TUG1096 induced a 
small but significant increase in Srebp1c mRNA levels (approximately five-fold) in the 
Gpr120 Het cells but not in in the Gpr120 KO cells. These findings suggest that the ligand-
induced increases in genes induced by these distinct ligands are via Gpr120.  
 
 
 
 
 
 
 
 
 
 
195 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2.2: mRNA levels of Acc2 and Srebp1c in Gpr120 heterozygous (Het) and knockout 
(KO) IMBAT cells using q-RT-PCR. Both Het and KO cells were treated with 100µM GW9508, 
10µM TUG891 or 10µM TUG 1096 12 hourly for 6 days. Another set was either treated with 
standard differentiation cocktail or left undifferentiated. Gene expression was normalized to β-
actin and depicted with respect to the untreated. All data are expressed as the mean ± SEM of 
three samples in duplicate (n=3). *p<0.05, **p<0.005, ***p<0.001 
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7.2.3 Gpr120 ligand activation reduces inflammatory gene expression in IMBAT cells 
Gpr120 has been reported to be an ω-3 fatty acid receptor or sensor with anti-inflammatory 
effects (Oh et al., 2010; Wellhauser and Belsham, 2014). Chapter 6 indicated that knockout 
of Gpr120 in BAT caused an induction in mRNA levels of certain inflammatory genes, 
indicating an anti-inflammatory role in BAT. Therefore the effect of Gpr120 ligand treatment 
of Het and KO cells on inflammatory gene expression was measured. Undifferentiated Het 
and KO IMBAT cells were treated with GW9508, TUG891 or TUG1096 as above. Another 
set of Gpr120 Het and KO IMBAT cells were either left untreated, or differentiated using the 
standard differentiation cocktail for 6 days and the gene expression of IL-6 was determined.  
Interestingly there was more than 20-fold increase in the levels of IL-6 expression in the 
untreated KO cells compared to the Gpr120 Het cells, whereas following treatment with 
standard differentiation protocol IL-6 expression was induced in Gpr120 Het cells, but not in 
Gpr120 KO cells (Figure 7.2.3). Treatment with TUG891 or TUG1096 induced an 
approximately 18-fold increase in the expression of IL-6 in Het cells compared to untreated 
Het cells. However, the increase induced by TUG891, was lost in the KO cells, and only 
partly reduced in KO cells treated with TUG1096. Although IL-6 mRNA levels were higher 
in the Gpr120 KO compared to Het, treatment with GW9508 caused a reduction in mRNA 
levels of IL-6 in both Het and KO cells compared to the untreated (Figure 7.2.3). These 
findings suggest that the distinct ligands may have contrasting pro- and anti-inflammatory 
responses that act via Gpr120 and possibly other receptor targets. 
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Figure 7.2.3:  mRNA levels of IL-6 in Gpr120 heterozygous (Het) and knockout (KO) IMBAT 
cells using q-RT-PCR. Both Het and KO cells were treated with 100µM GW9508, 10µM 
TUG891 or 10µM TUG 1096 12 hourly for 6 days. Another set was either treated with standard 
differentiation cocktail or left undifferentiated. Gene expression was normalized to β-actin and 
depicted with respect to the untreated. All data are expressed as the mean ± SEM of three 
samples in duplicate (n=3). *p<0.05, **p<0.005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
198 
 
7.3 Regulation of Gpr120 expression in brown adipocytes by Gpr120 
7.3.1 GW9508-induced activation of Gpr120 and aP2 in brown adipocytes is dependent 
on PPARγ and PPARα 
It has been demonstrated that Gpr120 agonist induced the expression of Gpr120 and aP2 in 
undifferentiated brown pre-adipocytes (Chapter 5). PPARs are known master regulators of 
adipocyte differentiation (Nedergaard et al., 2005). To determine if PPARs are involved in 
these regulatory activities, the potential of PPAR ligands to alter the Gpr120 agonist-induced 
expression of aP2 and Gpr120 was investigated. For these experiments undifferentiated and 
differentiated IMBAT cells were treated for 5 days with GW9508 in the presence and 
absence of a PPARγ antagonist (GW9662) or PPARα antagonist (GW6471). The effect of 
stimulation of brown adipocytes with Rosiglitazone (PPARγ agonist), GW7647 (PPARα 
agonist) and GW1516 (PPARδ agonist) were also assessed. 
A robust induction in the expression levels of Gpr120 and aP2 was observed following 
treatment with rosiglitazone, and this induction was significantly reduced in the presence of 
the PPARγ antagonist GW9662. However, treatment with a PPARα or PPARδ agonist did 
not induce expression of either Gpr120 or aP2 (Figure 7.3.1 A and B). These findings suggest 
PPARγ activation can increase the levels of Gpr120 in brown adipocytes. 
When IMBAT cells were fully differentiated (Figure 7.3.1 d and D) and stimulated in a 
similar manner, there was a reduction in Gpr120 mRNA levels upon GW9508 activation 
which was only partly reversed in the presence of PPARγ antagonist but not PPARα 
antagonist However, there was an approximately two-fold increase in aP2 expression 
following treatment with GW9508, which was only partially reduced by PPARα antagonist, 
but not by PPARγ antagonist (Figure 7.3.1). Overall, GW9508-induced Gpr120 expression is 
attenuated by PPARγ and PPARα antagonists, and while GW9508 induced Gpr120 mRNA in 
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undifferentiated IMBAT cells, it mildly inhibited Gpr120 expression in differentiated 
IMBAT cells. 
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A 
Rosiglitasone (Rosi): PPARγ agonist  
GW9662:  PPARγ antagonist 
GW7647:  PPARα agonist    
GW6471:  PPARα antagonist    
GW1516:  PPARδ agonist    
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Figure7.3.1: Role of PPARs in the regulation of Gpr120 expression.  IMBAT Cells were 
differentiated using standard differentiation protocol described in materials and methods, and 
differentiated cells were treated for 24 hours with 100µM GW9508 in the presence or absence of 
PPARγ ligands (100nM Rosi and 10µM GW9662), PPARα (100nMGW7647 and 100nM 
GW6471), and PPARδ ligand (1µM GW1561). Gene expression was normalized to β-actin with 
DMSO as the reference value. All data are expressed as the mean ± SEM of two independent 
samples in triplicate. 
D 
Rosiglitasone (Rosi): PPARγ agonist  
GW9662:  PPARγ antagonist 
GW7647:  PPARα agonist    
GW6471:  PPARα antagonist    
GW1516:  PPARδ agonist    
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7.3.2 Gpr120 activation by TUG891 and TUG1096 occurs via a PPARγ-dependent 
mechanism 
GW9508-induced activation of Gpr120 and aP2 in brown adipocytes appears to be via a 
PPAR-dependent mechanism. To determine if TUG891 or TUG1096-induced expression of 
these genes was via a similar mechanism undifferentiated brown adipocytes were stimulated 
for 5 days with rosiglitazone, TUG891 or TUG1096 in the presence or absence of PPARγ 
inhibitor (GW9662) and the relative gene expression levels of Gpr120 and aP2 determined. 
It was observed that GW9662 attenuated the rosiglitazone-induced expression of Gpr120, aP2 
and Ucp1 suggesting that these genes are regulated by PPARγ (Figure 7.3.2). Following 
agonist stimulation, TUG1096 induced approximately a 15-fold induction in the levels of 
Gpr120 mRNA, whereas TUG891 treatment caused about 3-fold increase. However, the 
TUG891 and TUG1096-induced expression of Gpr120 was completely inhibited by the 
presence of PPARγ antagonist. For aP2, PPARγ antagonist completely inhibited the 
TUG1096-induced expression of aP2. However there was no appreciable change in aP2 
expression with TUG891 alone. These observations further suggest that Gpr120 function in 
brown adipocytes is regulated via a PPARγ-dependent mechanism. 
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Figure 7.3.2:  mRNA levels of Gpr120, aP2, Ucp1  Undifferentiated IMBAT Cells were treated 
for 5 days with 100nM Rosi, 100µM GW9508, 10µM TUG891 or 10µM TUG1096  in the 
presence or absence of PPARγ inhibitor (10µM GW9662). Gene expression was normalized to 
β-actin with DMSO as the reference value. All data are expressed as the mean ± SEM of two 
independent samples in triplicate. 
 
 
 
 
 
 
 
 
Rosi:     PPARγ agonist 
GW9662: PPARγ antagonist 
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7.4 Discussion 
The global prevalence of obesity and its associated complications has increased in recent 
times. Research attempting to contribute to the management of this condition is tailored 
towards development of pharmaceutical treatments that can improve energy expenditure. In 
this regards manipulation of BAT to increase its metabolic and energy homeostasis is very 
important. It has been found that Gpr120 is present in the brown adipose tissues at high levels 
and may induce BAT thermogenic and metabolic homeostasis. The objectives of this chapter 
were to begin to investigate the potential actions of novel Gpr120-specific ligands in brown 
adipocytes, and determine which ligand may be specific for Gpr120 activation. 
Although all three ligands tested induced an increase in Gpr120 expression, GW9508 gave 
the highest level of expression of Gpr120 followed by TUG1096, and they may exhibit 
different specificities to Gpr120 with respect to species. TUG891, for example, is reported to 
be potent for both human and mouse Gpr120, yet it is more selective in human between 
Gpr120 and Gpr40 than mouse , hence the potential utility of TUG891 in animal studies may 
be restricted (Zhang and Leung, 2014). TUG891 was also able to induce only a minimal 
increase in the expression of Gpr120, Acc2, Scd2 Glut1, and insulin receptor, although a 
recent study reported an increase in glucose uptake following stimulation of 3T3-L1 cells 
with TUG891 (Milligan et al., 2014) which may reflect the distinct cell types used or that 
TUG891 directly increases glucose uptake but not dependent on changes at the transcriptional 
level. GW9508 is known to bind both Gpr120 and Gpr40, but it is more specific to Gpr40. 
Although GW9508 is not expressed in IMBAT cells and BAT, the lack of specificity of 
GW9508 (Briscoe et al., 2006a) reduces it potential as a likely candidate for use as Gpr120 
agonist in BAT. Stimulation with TUG1096 showed a more sustained response on Insulin 
receptor expression than TUG891 and GW9508. Although the ability of TUG1096 to induce 
expression of Gpr120, Glut1 Scd2 and Insulin receptor marks it as a potential new ligand for 
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regulation of cellular metabolism in BAT, the only partial loss of ligand-induced expression 
in the Gpr120 KO lines may suggest that this compound may not be specific to Gpr120 alone. 
The role of PPARs in the regulation of adipose tissue function is well established. In 
undifferentiated adipocytes PPARγ antagonist completely blocked the Gpr120 expression 
induced by all three ligands. PPARγ agonists also have been reported to show more 
selectivity towards Gpr120 than Gpr40 in adipose tissue and its antagonist blocked Gpr120 
gene expression (Zhang and Leung, 2014). In the differentiated brown adipocytes, GW9508 
reduced the expression of Gpr120 which was increased by PPARγ antagonist. Although this 
effect was not tested for TUG891 and TUG1096, it suggests that GW9508 directly regulates 
Gpr120 expression through PPARγ. Overall, Gpr120 is a PPARγ target gene, and the 
Gpr120-ligand-induced effects are thus regulated in a PPARγ-dependent manner. 
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Chapter 8 
Results 
 
Profiling Gpr120 signalling pathways and their 
downstream roles in IMBAT cells 
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8.1 Introduction 
The potential to promote the number of brown fat cells and to enhance their differentiation to 
improve their thermogenic capacity would be considered attractive, as this could potentially 
represent a new avenue for preventing or at least slowing the development of obesity. An 
understanding of the signalling pathways governing these processes in brown adipocytes is 
therefore of considerable significance. GPCRs have proved to be very successful drug targets 
for the pharmaceutical industry. It has been estimated, that about 50% of all modern drugs act 
on GPCRs (Tautermann, 2014; Thompson et al., 2014).  
GPCRs can signal through both G-protein and non G-protein pathways (Belcheva and 
Coscia, 2002). Gpr120 couples to Gαq/11 family of G-proteins leading to activation of PLC 
which then cleaves PIP2 into DAG and IP3. IP3 causes an increase in the cytosolic calcium 
concentration. Calcium and DAG together activate PKC and MAP kinase pathways (Sun et 
al., 2010). Gpr120 can also recruit the adaptor protein β-arrestins. β-arrestins 1 and 2 bind the 
activated and phosphorylated GPCR. β-arrestins uncouple receptors from their G-proteins 
(desensitization) and target the receptor to the internalization machinery (clathrin and clathrin 
adaptor, AP2) via clathrin-coated pits and subsequent transport to internal compartments 
called endosomes. β-arrestins also activate G-protein-independent signalling via its ability to 
scaffold MAP kinase pathways (Luttrell and Lefkowitz, 2002), a property that is being 
exploited pharmacologically via the identification of ‘biased’ ligands (Rajagopal et al., 
2011).   
Different ligands have been used to investigate Gpr120 signalling primarily in heterologous 
cell lines. Activation of Gpr120 by GW9508, results in rapid elevation of intracellular Ca
2+
 
indicating that Gαq/11 pathway is involved (Briscoe et al., 2006a). Selective knock-down of 
β-arrestin 2, but not β-arrestin 1 in RAW 264.7 cells blocked effects of GW9508 to inhibit 
LPS-mediated inflammatory signals (Oh et al., 2010). Although GW9508 binds both Gpr120 
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and Gpr40, its binding affinity is higher to Gpr40 (Oh et al., 2010). Another agonist, TUG891 
which was reported to be more selective, activates calcium and β-arrestin recruitment in 
HEK293 cells (Hudson et al., 2013).  It also stimulated increase in glucose uptake in 3T3-L1 
adipocytes, and inhibited release of proinflammatory mediators from RAW264.7 
macrophages. Based on the reported signalling pathways of Gpr120 ligands in distinct cell 
types, and the observed differences in downstream responses in brown adipocytes between 
these ligands (Chapter 7), the next question was to decipher which signalling pathways these 
distinct ligands activate in BAT and their potential roles in mediating specific downstream 
actions of Gpr120.  
 
8.2 Agonist-induced calcium mobilization 
8.2.1 Agonist activation of Gpr120 increases intracellular Ca
2+
 mobilization in a ligand 
specific manner 
As Gpr120 is a Gαq/11 coupled receptor in other cellular systems, calcium mobilization was 
used as readout to assess ligand activation of Gpr120 in IMBAT cells. To measure 
intracellular calcium levels upon ligand activation, Fluo-4 a calcium indicator dye and 
confocal microscopy imaging was used. Fluo-4 has a greater absorption and fluorescent 
properties than most Ca
2+
 detectors and exhibits a calcium-dependent increase in 
fluorescence emission upon binding Ca
2+
(Gee et al., 2000). Calcium mobilization assays 
were carried out on Gpr120 WT IMBAT cells. Undifferentiated IMBAT cells were loaded 
with Fluo-4 and challenged with GW9508, TUG891 or TUG106. The calcium response to 
GW9508 is demonstrated in Figure 8.1A. There was no calcium response on addition of 
DMSO (Figure 8.1A-i). However, within seconds of agonist treatment, calcium mobilization 
was observed (Figure 8.1A-ii), which gradually reduced with time (Figure 8.1A-iii). This 
rapid and transient calcium wave is illustrated in Figure 8.1B.  
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Figure 8.1: GW9508 increases intracellular calcium levels in WT undifferentiated IMBAT cells. 
IMBAT cells were loaded with calcium sensitive Fluo-4 before stimulation with DMSO as 
vehicle control and 100μM GW9508. Calcium mobilisation was determined by live confocal 
microscopy. (A) Representative confocal microscopy images showing effects of ligand treatment 
on IMBAT cells. (i) DMSO Control, (ii) ligand treated and (iii) Declining calcium response (B) 
Florescent intensity plot showing calcium response following addition of GW9508 to IMBAT 
cells. Plot represents 20 cells from four different experiments. (n=3) 
 
 
 
 
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
/A
U
 
Time (sec) 
B 
A i ii iii 
 
 
210 
 
8.2.2 Differential activation of calcium signalling by TUG891 and TUG1096 in IMBAT 
cells 
When undifferentiated IMBAT cells were stimulated with TUG891, there was a more robust 
and significantly higher increase in intracellular (Figure 8.2A), Furthermore, TUG891-
induced calcium signals appeared to be more sustained (approximately 200 seconds) than 
calcium waves induced by GW9508 (approximately 80 seconds). However, when cells were 
stimulated with TUG1096, there was no calcium response. In order to confirm that TUG1096 
did not activate calcium signalling, TUG1096-stimulated cells that produced no observable 
calcium response were then challenged with GW9508. There was a robust increase in the 
intracellular calcium mobilization within seconds of addition of GW9508 (Figure 8.2B). 
Overall, the three Gpr120 ligands produced distinct calcium signal responses in IMBAT cells. 
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Figure 8.2: Fluorescent intensity plot showing calcium response following addition of TUG891 
(A) or TUG1096 followed by GW9508 (B). IMBAT cells were loaded with calcium sensitive 
Fluo-4 before stimulation with 10μM TUG891 or 10μM TUG1096. Calcium mobilisation was 
determined by live confocal microscopy imaging. (C) Mean maximal calcium responses induced 
by GW9508 and TUG891. Error bars represent Mean ± SEM of at least 10 cells per 3 
experiments. **p<0.005 (n=3) 
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8.3 GW9508, but not TUG891, mediated Gpr120 Ca
2+signalling is via a Gαq/11 pathway 
Since GW9508 and TUG891, but not TUG1096, increased intracellular calcium levels in 
IMBAT cells, the next step was to determine if these two ligands were signalling via a 
Gαq/11 pathway. A number of pharmacological agents are known to inhibit Gαq/11 pathway, 
such as YM-254890, UBO-QIC and GP-2A (Kamato et al., 2014). In this set of experiments 
UBO-QIC, a novel compound reported to effectively inhibit Gαq/11 signalling in many 
laboratory cell lines, by directly binding to this G-protein and inhibiting the release of GDP, 
was used.  
Undifferentiated IMBAT cells were pre-treated for 2 hours with UBO-QIC followed by 
ligand treatment and measurement of calcium mobilization as above. Following pre-treatment 
with UBO-QIC, there was a significant reduction in GW9508-induced intracellular calcium 
levels (Figure 8.3A). Surprisingly, when the cells were stimulated with TUG891, there was 
no difference in the calcium mobilization in the UBO-QIC treated cells as compared to 
control (Figure 8.4A). This suggests that activation of Gpr120 by GW9508, but not TUG891, 
to induce calcium mobilization is Gαq/11 mediated.  
Since the Gαq/11 inhibitor did not have any effect on TUG891-induced calcium signalling, 
Gpr120 was downregulated via siRNA, to confirm if the TUG891-induced calcium response 
is via Gpr120 activation. There was a significant reduction in TUG891-induced calcium 
response in the IMBAT cells transfected with Gpr120 siRNA compared to the control (Figure 
8.3B). This finding suggests that TUG891 is activating calcium signalling via Gpr120, but in 
a Gαq/11-independent manner. 
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Figure 8.3: (A) Average maximal ligand-induced calcium responses following pre-treatment 
with the Gαq inhibitor (UBO QIC). Undifferentiated IMBAT cells were pre-treated with 2.5µM 
UBO QIC for 2 hours, Thereafter,  IMBAT cells were loaded with calcium sensitive Fluo-4 
before stimulation with ligands. Calcium mobilisation was determined by live confocal 
microscopy (B) Average maximal TUG891-induced calcium responses following Gpr120 
knockdown. siRNA transfected IMBAT cells were loaded with Fluo-4 and stimulated with 
TUG891 (10µM). Calcium mobilisation was determined by live confocal microscopy. Error bars 
represent Mean ± SEM of at least 10 cells from three different experiments. **p<0.005, 
***p<0.001 
A 
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8.4 Gpr120 ligands stimulate β-arrestin recruitment in IMBAT cells 
β-arrestin-1 and β-arrestin-2 are well-known negative regulators of heterotrimeric G-protein 
signalling, but can also function as scaffold proteins to activate GPCR-mediated signal 
transduction (Ma and Pei, 2007). Gpr120 is known to recruit β-arrestins in heterologous cells 
and macrophages (Oh et al., 2010), but its ability to recruit these key GPCR regulatory 
proteins in IMBAT cells is unknown. To determine whether Gpr120 activation induces β-
arrestin recruitment, IMBAT cells were transfected with YFP-tagged β-arrestin-1 or β-
arrestin-2. Fluorescently tagged β-arrestin is classically employed to measure β-arrestin 
dependence of a GPCR. Cells were stimulated with Gpr120 ligands (GW9508, TUG891 or 
TUG1096) for 1, 5 or 20 minutes to determine any transient or stable recruitment of the 
Gpr120-β-arrestin complex. The cells were then fixed and imaged via confocal microscopy.  
Prior to ligand treatment IMBAT cells expressing β-arrestin-1-YFP exhibited a diffuse 
cytoplasmic and nuclear distribution consistent with its localization in other cell types. 
Treatment with GW9508, TUG891 or TUG1096 stimulated a robust β-arrestin-1 recruitment 
from the cytoplasm to the plasma membrane and cytosolic vesicles, likely representing 
endosomes. This was evident following 1 minute of agonist treatment and persisted even after 
20 minute stimulation for all ligands (Figure 8.4.1).  
Cells expressing β-arrestin-2-YFP also exhibited a diffuse cytoplasmic localization prior to 
stimulation. The absence of protein in the nucleus is due to the known nuclear export signal 
in β-arrestin-2 (Wang et al., 2003). Treatment of IMBAT cells with GW9508, TUG891 or 
TUG1096 yielded a small but visible recruitment, as evidenced by the vesicular localization 
of β -arrestin-2, that was also sustained following 20 minute of ligand stimulation. Overall 
these results may suggest that Gpr120 preferentially recruits β-arrestin-1 over β-arrestin-2 
(Figure 8.4.2). Furthermore these results demonstrate that, although TUG1096 did not induce 
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any calcium response, IMBAT cells are responding to TUG1096 via recruitment of β-
arrestins. 
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Figure 8.4.1: Gpr120 ligand-mediated recruitment of β-arrestin-1 in IMBAT cells. IMBAT cells 
were grown to confluence and transfected with YFP-tagged β-arrestin-1 plasmid for 72 hours. 
They were then treated with 100µM GW9508, 10µM TUG891 or 10µM TUG1096 for 1, 5 and 
20 minutes. Another set was treated with DMSO and served as untreated control. The cells were 
then fixed in 4% paraformaldehyde (PFA). Images were taken with confocal microscopy. Each 
confocal image shown is a representative of 20 cells imaged per experiment (n=3). The multiple 
white dots represent recruited β-arrestin.  
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Figure 8.4.2:  Gpr120 ligand-mediated recruitment of β-arrestin-2 in IMBAT cells. IMBAT cells 
were grown to confluence and transfected with YFP-tagged β-arrestin-2 plasmid for 72 hours. 
They were then treated with 100µM GW9508, 10µM TUG891 or 10µM TUG1096 for 1, 5 and 
20 minutes. Another set was treated with DMSO and served as untreated control. The cells were 
then fixed in 4% paraformaldehyde (PFA). Images were taken with confocal microscopy. Each 
confocal image shown is a representative of 20 cells imaged per experiment (n=3). The multiple 
white dots represent recruited β-arrestin.  
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8.5 TUG1096 does not activate Gαs or Gαi signalling 
It was observed that GW9508 and TUG891, but not TUG1096 activated calcium signalling 
(Figure 8.1 and 8.2), yet all ligands effectively recruited β-arrestins (Figure 8.4.1). To 
determine if TUG1096 may be activating distinct G-protein pathways, the potential of 
Gpr120 ligands to activate (Gαs) or inhibit (Gαi) the cAMP pathway was assessed. IMBAT 
cells were serum-starved overnight and pre-treated with a phosphodiesterase inhibitor 
(IBMX) for 5 min. The cells were then stimulated for 5 minutes with Gpr120 ligands 
(GW9508, TUG891 and TUG1096) in the presence or absence of forskolin (a cAMP 
activator).  
Following ligand treatment there was no change in the accumulation of cAMP caused by any 
of the ligands compared to the untreated control (Figure 8.6). Treatment of cells with 
forskolin increased cAMP levels, which combined with TUG891, caused a small but 
significant reduction in the forskolin-induced increase in cAMP levels (Figure 8.5). Neither 
GW9508 nor TUG1096 induced any significant changes in the forskolin-induced cAMP 
accumulation. Therefore, TUG891 may exhibit some Gαi signalling activity. Importantly, 
TUG1096 stimulation did not have any appreciable effect on increasing cAMP levels or 
decreasing forskolin-induced cAMP accumulation. These findings suggest that TUG1096 
does not activate Gαs or Gαi signalling in brown adipocytes. 
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Figure 8.5 Ability of Gpr120 ligands to increase cAMP and /or inhibit forskolin-induced cAMP 
accumulation in undifferentiated IMBAT cells. Undifferentiated IMBAT cells were serum-
starved overnight, pre-treated, with 500µM IBMX for 5min and then incubated with 100µM 
GW9508, 10µM TUG891 or 10µM TUG1096 for 5 minutes. Reactions were terminated by 
addition of 0.1 % HCl /Triton X- 100. cAMP levels were measured via ELISA (see methods). 
Protein concentrations were measured with BCA assay to normalize the cAMP concentrations. 
All relative cAMP levels are presented as mean ±SEM.  
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8.6 Effects of Gpr120 ligands on ERK activation 
8.6.1 GW9508 stimulation causes ERK Phosphorylation in IMBAT cells 
Because GPCRs are known to stimulate ERK phosphorylation through a number of different 
pathways, and the Gpr120 ligands employed in this study exhibit potentially unique G-
protein-dependent and independent (β-arrestin) signal responses, the ability of each ligand to 
activate ERK signalling response was assessed. Cultured undifferentiated and differentiated 
IMBAT cells were serum-starved overnight and then treated with GW9508 over a 30-minute 
period. Western blot analysis was carried out to assess the phospho-ERK and total ERK 
levels in IMBAT cells treated with GW9508. The unstimulated cells served as the control. 
In undifferentiated cells, GW9508 treatment induced an early (5 minute) and significant 
phosphorylation of ERK. This phosphorylation was however diminished after 10 minutes 
(Figure 8.6.1A). When the IMBAT cells were fully differentiated, GW9508 stimulation also 
resulted in an early phosphorylation of ERK similar to the undifferentiated although much 
less robust than undifferentiated cells (Figure 8.6.1B). 
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Figure 8.6.1: GW9508 activates ERK1/2 signalling. Serum starved undifferentiated (A) and 
differentiated (B) IMBAT cells were treated for the time points indicated with 100μM GW9508 
and cells lysed. MAPK activity was detected by Western blot using phospho-specific anti-
ERK1/2 antibody (p-ERK 1/2). Expression levels of ERK were controlled using antibody 
directed against the total kinase population (ERK 1/2). Immunoblot images were taken with the 
Chemillumiscent imager and the densitometry was analysed with the ImageQuant TL software. 
(B) Fold increase in p-ERK/ERK of the levels observed following stimulation in the 
undifferentiated and (D) Fold increase in p-ERK/ERK of the levels observed following 
stimulation in the differentiated IMBAT). Relative intensity for each sample was calculated by 
normalizing its p-ERK to the corresponding control total-ERK. *P< 0.05, **P< 0.005. Error 
bars represent Mean ± SEM. 
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8.6.2 Treatment of IMBAT cells with TUG891 and TUG1096 activates ERK with 
distinct temporal profiles 
Given the potential differences in upstream signals and downstream gene expression induced 
by the more selective Gpr120 ligands (TUG891 and TUG1096), these ligands were used to 
determine their potential to induce ERK phosphorylation. Undifferentiated IMBAT cells 
were serum-starved overnight and then stimulated with TUG891 or TUG1096 over a 30-
minute period and samples were taken at various time points. Western blot analysis was 
carried out to assess the phospho-ERK and total ERK in the treated and untreated (control) 
IMBAT cells.  
Both compounds stimulated an early Gpr120-induced ERK activation of about 2 fold higher 
than the basal following 5 minutes of ligand treatment. However, TUG891 mediated ERK 
activation was reduced following 20 minutes treatment (Figure 8.6.2A and 8.6.2B), while 
stimulation with TUG1096 gave a significantly more sustained activation even after 30 
minutes of ligand stimulation (Figure 8.6.4C and 8.6.4D). These results suggest that TUG891 
and TUG1096, as compared to GW9508, induce distinct temporal profiles in ERK activation 
in IMBAT cells. 
 
 
 
 
 
 
 
 
 
223 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.6.2: TUG891 and TUG1096-mediated ERK1/2 activation. Serum starved 
undifferentiated IMBAT cells were treated for 30 minutes on a time course with 10μM TUG891 
(A) or 10μM TUG1096 (C). Lysates were taken at 5, 10, 20, and 30 minutes. MAPK activity was 
detected by Western blot using phospho-specific anti-ERK1/2 antibody (p-ERK 1/2). Expression 
levels of ERK were controlled using antibody directed against the total kinase population (ERK 
1/2). Immunoblot images were taken with the Chemillumiscent imager and the densitometry 
was analysed with the ImageQuant TL software. (B) Fold increase in p-ERK/ERK of the levels 
observed following stimulation with TUG891 and (D) Fold increase in p-ERK/ERK of the levels 
observed following stimulation with TUG1096 in the treated relative to the untreated (veh). 
Relative intensity for each sample was calculated by normalizing its p-ERK to the 
corresponding control total-ERK. *P< 0.05, **P< 0.005. Error bars represent Mean ± SEM. 
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8.7 Gpr120 agonists may activate multiple downstream signalling pathways in IMBAT 
cells 
GPCR-induced mitogenic signalling involves activation of a number of "mitogen activated 
protein kinases" (MAPK) (Gutkind, 1998) via, transactivatio of receptor tyrosine kinases 
(Liebmann and Bohmer, 2000) or β-arrestin-dependent MAPK signalling. As distinct Gpr120 
ligands stimulate differential signalling responses in IMBAT cells, a more comprehensive 
profiling of Gpr120 signalling was carried out, via a phospho-kinase array that can 
simultaneously detect the relative phosphorylation of 43 kinases. Cultured undifferentiated 
IMBAT cells were serum-starved overnight and then stimulated with GW9508, TUG891 or 
TUG1096. Cell lysates were collected after 5 minutes of treatment, noting that all three 
compounds had previously stimulated ERK activation at this time point (Figures 8.6.1 and 
8.6.2). Levels of phosphorylated protein were then assessed using membranes spotted with 
the distinct phospho-specific antibodies (Figure 8.7A). 
Kinases that exhibited responses following agonist activation are shown in Figure 8.8. All 
three agonists stimulated the activation of ERK1/2, although the TUG1096-induced effect 
was the lowest and possibly reflects that peak activation of ERK by this ligand is following 
20 minutes stimulation (Figure 8.7.2). Only TUG891 stimulated a low level of activation of 
p38α. All three ligands stimulated activation of cyclic-AMP response element-binding 
protein (CREB), although the response induced by TUG1096 was weak. CREB is a cellular 
transcription factor that binds certain gene promoter element, cAMP response element’ 
thereby regulating the transcription of certain downstream genes. Stimulation with GW9508 
or TUG891, but not TUG1096 increased levels of pAMPK. Epidermal growth factor 
receptor, EGFR, a member of the receptor tyrosine kinases, exhibited a small activation 
following TUG891 and TUG1096 stimulation. GW9508 and TUG891 stimulated a minor 
activation of Akt1/2/3. The Akt pathway is important in regulating cell cycle, and leads to 
cell survival by blocking apoptosis.  
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Figure 8.7: Phospho-kinase array ‘hits’ following ligand-stimulated Gpr120 activation. (A) 
Representative blot showing ERK 1/2, AMPKα1 and CREB activation by TUG891 compared to 
untreated. (B) Relative intensity plot. Undifferentiated IMBAT cells were Serum- starved 
overnight and stimulated with 100µM GW9508, 10µM TUG891 or 10µM TUG1096 for 5 
minutes and cell lysates were extracted and analysed using R & D systems Phospho Kinase 
array kit. Levels of phosphorylated proteins were then assessed using phospho-specific 
antibodies and images were taken with the aid of the chemiluminescent imager. Densitometry 
was calculated with Image J software. 
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8.8 Agonist stimulation of Gpr120 activates AMPK in the IMBAT cells  
The identification of AMPK as a signalling pathway activated by Gpr120 ligands in the 
phosphokinase-array was confirmed. AMPK was of interest as it is a sensor of cellular energy 
status, and a regulator of energy balance, and thus highly pertinent to brown adipocytes. It 
modulates multiple metabolic pathways including the cellular uptake of glucose, β-oxidation 
of fatty acids and the biogenesis of glucose transporter 4 in the mitochondria. It is also 
regulated by the adipokines, adiponectin and leptin, hormones that are secreted 
from adipocytes (Carling et al., 2008). Once activated, it switches on catabolic pathways that 
generate adenosine triphosphate (ATP), while switching off ATP-consuming anabolic 
processes.  It is considered a key therapeutic target for the treatment of obesity, insulin 
resistance and cancer (Hardie, 2008; Sanz, 2008). Recent studies indicate that AMPK may 
not only influence metabolism in adipocytes, but also act to suppress this pro-inflammatory 
environment, such that targeting AMPK in adipose tissue may be desirable to 
normalize adipose dysfunction and inflammation.  
Therefore, to investigate the ability of Gpr120 ligands to activate AMPK, cultured 
undifferentiated IMBAT cells were serum-starved overnight, and stimulated with GW9508 
for 5, 10, 20 or 30 minutes, thereafter cells were lysed for Western blot analysis. Although 
there were technical issues with the AMPK antibodies used relating to sensitivity, 
preliminary results indicate an increase in GW9508-induced AMPK phosphorylation in the 
undifferentiated IMBAT cells, peaking at 20-30 minutes (Figure 8.8A). For cells treated with 
TUG1096, AMPK activation occurred after 10 minutes of treatment and was decreased after 
20 minutes of treatment (Figure 8.8B). However, stimulation with TUG891 did not cause any 
detectable activation (data not shown). 
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Figure 8.8: Agonist-mediated AMPK activation. Serum starved undifferentiated IMBAT cells 
were treated for 30 minutes on a time course with 100μM GW9508 (A) or 10μM TUG1096 (B). 
Lysates were taken at 0, 5, 10, 20, and 30 minutes. AMPK activity was detected by Western blot 
using phospho-specific anti-AMPKα1 antibody (P-AMPK). Expression levels of AMPK were 
controlled using antibody directed against the total AMPK (AMPK). Immunoblot images were 
taken with the Chemillumiscent imager.  
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8.9 Role of Gαq/11 signalling in Gpr120 function 
8.9.1 GW9508-induced ERK signalling is via Gαq/11 activation in IMBAT cells. 
Gpr120 is a known Gαq/11 coupled receptor, yet all three ligands stimulated calcium and 
ERK activation in IMBAT cells with distinct profiles. Therefore the requirements for 
activation of Gαq/11 on ligand-induced ERK phosphorylation were determined. 
Undifferentiated IMBAT cells were pre-treated with the Gαq/11 inhibitor UBO-QIC before 
being stimulated with GW9508. The result indicate that inhibition of Gαq/11 attenuated the 
GW9508-induced ERK phosphorylation (Figure 8.9.1A), confirming that Gpr120 activation 
of ERK by GW9508 is via Gαq/11 –Ca2+ pathway. 
In a similar experiment, IMBAT cells were stimulated with TUG891 or TUG1096 in the 
presence and absence of Gαq/11 inhibitor (UBO-QIC). The Gαq/11 inhibitor did not have 
any effect on the TUG891 or TUG1096-induced ERK phosphorylation (Figure 8.9.1B and 
C), suggesting that the ERK signalling induced by these ligands is via a distinct mechanism 
from Gαq/11 signalling. 
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Figure 8.9.1: Gαq/11 inhibitor attenuates the GW9508-induced, but not TUG891 or TUG1096-
induced Gpr120 ERK phosphorylation in IMBAT cells. Undifferentiated IMBAT cells were 
Serum- starved overnight and pre-treated with Gαq inhibitor (1µM UBO-QIC) for 2 hours 
prior to stimulation. The cells were then stimulated with 100µM GW9508 (A), 10µM TUG891 
(B) or 10µM TUG1096 (C)  for 5 minutes and cell lysates were extracted and analysed by 
Western blotting with antibodies against p-ERK, total- ERK.  
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8.9.2 Role of Gαq/11 inhibition on Gpr120-agonist induced gene signalling in IMBAT 
Considering the direct effect of UBO-QIC inhibition of GW9508 action on Gpr120-induced 
calcium and ERK signalling, the effects of Gαq/11 inhibition on ligand-induced gene 
expression of some key adipogenic genes was assessed. Undifferentiated WT IMBAT cells 
were pre-treated for 2 hours with UBO-QIC and stimulated for 5 days with GW9508, and the 
mRNA levels of Gpr120, aP2, Ucp1 and PPARγ were determined. UBO-QIC reduced the 
GW9508 -induced expression of all four of the genes, although only the reduction by UBO-
QIC in aP2 and Gpr120 mRNA levels reached significance (Figure 8.9.2). This result 
suggests that GW9508-induced activation of Gpr120 induces Gαq signalling pathway that is 
required for modulation of adipogenic genes in brown adipocytes. 
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Figure 8.9.2: mRNA level of Gpr120, aP2, Ucp1, and PPARγ measured via q-RT-PCR in 
IMBAT cells. Undifferentiated IMBAT cells were treated for with 100µM GW9508 12 hourly 
for 5 days in the presence and absence of 1µM UBO QIC. Gene expression was normalized to β-
actin and depicted with respect to the untreated. Result was from three independent 
experiments in duplicate. Error bar represent ± SEM (n=3) *p<0.05, **p<0.005. 
 
 
 
 
 
 
232 
 
8.9.3 Inhibition of Gαq/11 attenuates TUG1096-induced activation of Gpr120 and aP2 
expression 
Although Gαq/11 activation is required for GW9508-induced gene expression in IMBAT 
cells, the effect of Gαq/11 inhibition was also assessed for TUG891- and TUG1096-induced 
gene expression in undifferentiated IMBAT cells. As neither compound induced an increase 
in Ucp1 or PPARγ following 5 days treatment (not shown), only Gpr120 and aP2 were 
assessed.  
Unexpectedly, UBO-QIC significantly attenuated TUG1096-induced expression of Gpr120 
and aP2 in undifferentiated WT IMBAT cells. However, pre-treatment with UBO-QIC did 
not seem to inhibit TUG891-induced Gpr120 expression (Figure 8.9.3). These results suggest 
that there may be a requirement for this G-protein signalling pathway in downstream gene 
expression of Gpr120. 
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Figure 8.9.3: mRNA expression levels of Gpr120 and aP2 in IMBAT cells. Undifferentiated 
IMBAT cells were treated for with 100µM GW9508, 10µM TUG891 and 10µM TUG1096 12 
hourly for 5 days in the presence and absence of 1µM UBO QIC. Gene expression was 
normalized to β-actin and depicted with respect to the untreated. Result was from three 
independent experiments in duplicate (n=3). Error bar represent ± SEM. *p<0.05, **p<0.005. 
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8.10 Discussion 
It is now recognized that GPCRs interact with a myriad of proteins, and activate complex and 
diverse signalling pathways via both heterotrimeric G-protein-dependent and -independent 
mechanisms (Stallaert et al., 2011). Given that this project has identified that distinct Gpr120 
ligands produce very distinct downstream cellular responses, the aim of this chapter was to 
identify the upstream pathways activated by these ligands.  
Many GPCRs can trigger an increase in intracellular calcium levels via Gαq/11 activation of 
PLC-β to produce the intracellular messengers, inositol trisphosphate (IP3) and diacylglycerol 
(DAG). IP3 triggers the release of calcium from intracellular stores, and DAG recruits protein 
kinase C (PKC) to the membrane and activates it. Agonist-stimulated Gpr120 is known to 
couple to Gαq/11 leading to elevation in intracellular Ca2+concentration. Both GW9508 and 
TUG891 induced calcium responses, consistent with reports in other cell systems. 
Surprisingly, TUG1096, which is related structurally to TUG891, produced no evident rise in 
intracellular calcium. However, in HEK293 cells expressing human Gpr120 TUG1096 
induces a calcium response (personal communication with Trond Ulven and independently 
acquired data not shown). These differences may thus reflect species-dependent responses to 
TUG1096 by Gpr120. Furthermore, the Gαq/11-independent calcium signalling induced by 
TUG891 indicates that additional G proteins may be activated by Gpr120. One possibility is 
that TUG891 activates a Gαi signalling pathway, the associated βγ subunits of which are able 
to stimulate PLC-β to increase intracellular calcium, and/or activate cell surface calcium 
channels and influx of extracellular calcium. The latter pathway may underlie the more robust 
and prolonged calcium responses observed with this compound. 
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It has become increasingly clear that GPCR signalling is not limited to G-protein coupling 
alone, but other mechanisms mediate its functional responses. GPCRs can engage multiple 
pathways to activate ERK1/2 via both G proteins and/or β-arrestin (Ahn et al., 2004). The 
potential for GPCRs to form complexes with signalling proteins other than G proteins also 
raises the possibility that different ligands can discriminate between these pathways. Gpr120 
has been reported to signal also via the β-arrestin pathway in macrophages (Oh et al., 2010; 
Talukdar et al., 2011). Thus, each downstream signalling pathway measured in a particular 
cell might have its own unique pharmacology depending on the pathway stimulated by each 
unique ligand–receptor conformation or complex involved (Baker and Hill, 2007). 
All three ligands gave a robust β-arrestin-1 recruitment. Interestingly, β-arrestin-1 
recruitment was seen within the first minute of activation. Other researchers have reported 
similar early recruitment of β-arrestin-1 to GPCR in other cell types (N'Diaye et al., 2008; 
Puthenveedu and von Zastrow, 2006). However, recruitment of β-arrestin-2 was not as strong 
as that of β-arrestin-1, indicating preference of activated Gpr120 for β-arrestin-1 over β-
arrestin-2.  This is at variance with a prior classification of GPCRs to arrestin binding where 
Class A receptors preferentially bind β-arrestin-2, whereas Class B receptors bind to both β-
arrestin-1 and β-arrestin-2 with equal affinity and a sustained effect (Moden et al., 2013) that 
consequently impacts the temporal and spatial ERK activation induced by GPCR/β-arrestins. 
The temporal profiles of ligand-induced ERK responses observed in this study also varied 
with the different ligands.  ERK response to TUG1096 activation occurred later and was 
more sustained compared to GW9508. It has been reported that β-arrestin-mediated ERK 
activation is slower in onset and more sustained in duration, and it is sensitive to depletion of 
β-arrestins but not inhibition or loss of G-protein signalling (Ebisuya et al., 2005). This is 
indicated from the rapid and transient GW9509-induced ERK response and inhibition by the 
Gαq/11 inhibitor suggesting primary mechanism of ERK activation is G protein-mediated, 
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despite the efficient recruitment of β-arrestin1 by this ligand. In contrast the slow onset and 
more sustained ERK activation induced by TUG1096 in IMBAT cells, and that TUG1096 did 
not stimulate calcium response or exhibit Gαs or Gai signalling, suggests a primary arrestin-
mediated ERK signalling pathway. Attempts to knockdown β-arrestin-1 and 2 in IMBAT 
cells, in order to measure arrestin-dependent signalling were however, unsuccessful. Thus the 
requirement of this adaptor protein on TUG1096 signalling in IMBAT cells remains to be 
determined. It is known that distinct ligands acting at a GPCR may show varying degrees of 
bias with respect to the potency and efficacy with which they may activate distinct 
heterotrimeric G-protein and β-arrestin signalling, including a complete or “perfect” bias 
toward the activation of the β-arrestin pathway (Southern et al., 2013). Likewise, this study 
suggests that TUG1096 may be acting as a biased agonist of Gpr120 to the β-arrestin 
pathway in IMBAT cells.  
In terms of signalling, there is paucity of information on Gpr120 in brown adipocytes. To 
further elucidate the possible signalling pathways mediating Gpr120 function in brown 
adipocytes, a phosphokinase array was carried out and identified that Gpr120 activates 
AMPK.  All three ligands exhibited differential abilities to activate AMPK. AMPK plays a 
major role in energy balance by integrating signals in the periphery and central nervous 
system to regulate glucose and lipid metabolism, food intake and body weight. AMPK is 
thought to be expressed in all cell types but its expression is highest in tissues that regulate 
energy homeostasis (Hutchinson et al., 2008), such as brown adipose tissue, but its role in 
regulating the acute metabolic state and chronic thermogenic potential of BAT is unknown 
(Towler and Hardie, 2007). Both LKB1 and Ca
2+
/calmodulin-dependent protein kinases have 
been identified to regulate AMPK, suggesting that they may be activated by stimuli that 
signal through second messengers which may occur even in the absence of increase in AMP 
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(regulation of AMPK by upstream kinases). From the standpoint of treating obesity and 
insulin resistance, Gpr120-ligand activation of AMPK appears to be an attractive target. 
When considering both the upstream signalling pathways activated by the distinct ligands and 
their downstream effects on gene expression, GW9508 seems to primarily activate Gαq/11, 
as the Ca
2+ response, ERK activation and gene expression are all sensitive to Gαq/11 
inhibition. Although TUG891 activates similar pathways, the ability to induce expression of 
the same genes as GW9508 are considerably weaker. As suggested above one possibility for 
the differences in gene expression between GW9508 and TUG891 is that TUG891 signals via 
Gαi, which may explain its lack of Gαq/11 inhibitor sensitivity for calcium and ERK 
signalling. Surprisingly, the increase in gene expression of Gpr120 and aP2 induced by 
TUG1096 was sensitive to Gαq/11, even though this ligand did not induce a calcium signal 
response. It is therefore possible that TUG1096 induces a weak activation of Gαq/11, that is 
is not sufficient to result in a detectable calcium signal, but that this small activity is 
amplified downstream resulting in increases in these target genes. This may also underlie the 
less robust responses obtained with TUG1096, in terms of gene expression compared to 
GW9508.  Therefore it seems that the key pathway for switching on these genes is Gαq/11, 
and these distinct ligands have also been tools to potentially ‘unveil’ distinct and novel 
pathways of Gpr120 activation in brown adipocytes. Indeed, crystallographic and 
pharmacological studies indicate that an individual GPCR can exist in different active 
conformations that differ in their capacity to activate specific signalling pathways (Gonzalez-
Maeso and Sealfon, 2012). This complexity of GPCR signalling led to the concept of bias 
agonism, such that some agonists produce activation of some but not all available pathways 
(Kenakin, 2009; Shukla et al., 2008). From this study it appears that all three Gpr120 ligands 
could be biased compounds, depending on the downstream readout. Such ligands are not only 
tools in understanding the multiple conformations that can be induced in Gpr120 and 
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consequent distinct signalling profiles that can be activated, but also may form the basis of 
identifying appropriate screening platforms for this receptor for future novel drugs targeted to 
this receptor in BAT. 
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Chapter 9 
 
General Discussion 
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Discussion 
The prevalence of obesity and other metabolic diseases are increasing worldwide (Ng et al., 
2014), leading to serious health consequences for individuals and increased burden for the 
health care system as a whole.  Since the recent identification of active BAT in adult human, 
and the discovery that adipose tissue can interconvert from one form to another depending on 
temperature changes, the anti-obesity and anti-diabetic role of BAT is of significant interest 
to researchers. While BAT has long been appreciated as an important player in cold defence 
in human infants, BAT thermogenesis was thought to be completely blunted during 
adulthood. Importantly, active BAT in humans appears to be negatively correlated with body 
mass index, body fat mass (Yoneshiro et al., 2013). Therefore, the potential to induce even a 
small amount of BAT to enhance energy homeostasis will be of significance in addressing 
obesity, and its associated complication. 
Earlier, a microarray-based gene expression analysis of mice that had been exposed to cold 
for 10 days was carried out and a number of genes were identified to be regulated in a 
temperature-dependent manner. Nrg4 and Gpr120 were identified as two of the genes 
regulated following cold acclimation are highly expressed in BAT. Although adipocytes are 
the main cellular component of adipose tissue, there are other cell types present in the adipose 
tissue that constitute the stromal vascular fraction (SVF), which include precursor cells 
(including pre-adipocytes), fibroblasts, vascular cells and immune cells, and these cells 
constitute the stromal vascular fraction of adipose tissue. Vascular cells include both 
endothelial cells and vascular smooth muscle cells, which are associated with the major blood 
vessels (Ouchi et al., 2011).  It was therefore important to determine whether tissue 
expression of Nrg4 is due to expression in adipocytes rather than other cells. Nrg4 and 
Gpr120 were expressed at low levels in brown adipocytes but these expressions were 
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significantly upregulated in mature adipocytes. Based on these expression patterns, Nrg4 and 
Gpr120 were therefore selected for further study.   
We found NRG4 protein to be secreted by brown adipocytes but not preadipocytes. Using 
PC12 pheochromocytoma cells stably expressing the receptor for Nrg4 (HER4), we have 
been able to show for the first time that NRG4 is a BAT secreted adipokine (Rosell et al., 
2014b). Our finding that that brown adipocyte-secreted NRG4 promoted neurite formation 
supports a potential role in enhancing sympathetic nerve stimulation of BAT through β3-AR 
stimulation, which is essential for thermogenesis (Bartness et al., 2010a). The neurite- 
stimulating effect was specific to Nrg4 as neurite outgrowth was prevented in conditioned 
media from brown adipocytes in which Nrg4 was knocked down by shRNA interference. 
This neurotropic role for Nrg4 is further supported by studies that reported Nrg1, a related 
member of the neuregulins family, affected the development of neuronal cells (Liu et al., 
2005; Wen et al., 2010).  
Apart from Nrg4 that has been found to be secreted by BAT, there are other paracrine factors 
synthesized by BAT. These include nerve growth factor (NGF), vascular endothelia growth 
factor (VEGF), angiotensin and nitric oxide. NGF is also produced by cultured brown 
adipocytes with a potential role in adipocyte-neuronal communication and obesity (Nisoli et 
al., 1996).  VEGF causes an increase in BAT thermogenesis, and promotes the browning of 
WAT (Xue et al., 2009). Angiotensin has a regulatory role in obesity-induced hypertension 
(Cassis et al., 2008). However, the action of Ngr4 is not restricted to adipocyte-neuronal 
signalling. A recent study has reported that Nrg4 is involved in endocrine and other paracrine 
functions affecting lipid metabolism in the liver, by autonomously attenuating de novo 
lipogenesis in hepatocytes, and its deficiency exacerbated diet-induced obesity (Wang et al., 
2014). Future studies will be directed towards the use of Nrg4 as a potential therapeutic new 
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player for treating obesity, and its associated metabolic disorders through it interaction with 
other tissues. 
Gpr120 had been identified as a lipid sensor expressed in macrophages and mature 
adipocytes, and having anti-inflammatory anti diabetic effects (Oh et al., 2010). Our results 
suggest that Gpr120 regulates adipogenic processes such as adipocyte development and 
differentiation. Investigating the downstream signalling effects of Gpr120 activation showed 
that Gpr120 activation generated diverse signalling effects induced by the same agonist. ERK 
has been shown to have a diverse range of substrates as it can translocate to the nucleus and 
phosphorylate transcription factors or it can regulate the activity of other cytoplasmic protein 
kinases (Roux and Blenis, 2004).  
It has become increasingly clear that Gpr120 signalling is not limited to G-protein coupling, 
and agonist-induced activation of Gpr120 is a complex process, which may involve 
integration of different signalling pathways (Zhang and Leung, 2014). In search for specific 
pharmacological activators of Gpr120, three different ligands, GW9508, TUG891 and 
TUG1096, were tested.  Although all three ligands activated Gpr120, they all showed various 
levels of bias towards the receptor. Other studies have reported this type of molecular bias 
with TUG891-induced Gpr120 activation (Hudson et al., 2014). In this study, the use of 
TUG1096 to activate the receptor has further defined the diverse signalling function of 
Gpr120.  
Alterations in cellular calcium homeostasis are widely employed as a potent regulatory 
mechanism that modulates many functionally distinct physiologic processes (Wolf et al., 
1997). While TUG1096 did not induce any calcium signalling response, it activated 
downstream ERK signalling, and a robust β-arrestin recruitment. This effect by TUG1096  
might have occurred through pathway interaction (Puckerin et al., 2006). This is the first 
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study in which agonist activities have been assessed on Calcium, cAMP and β-arrestin 
signalling events within the IMBAT cell system. The same agonist can activate different 
signalling cascades upon binding to Gpr120. In addition to coupling to Gαq/11, Gpr120 
couples to β-arrestin and both pathways mediate Gpr120-dependent ERK activation. Profiling 
Gpr120 signalling pathways and their downstream roles in IMBAT cells showed that 
TUG891 and TUG1096 activate ERK with distinct temporal profiles. 
One GPCR can signal through multiple different downstream pathways, by either signalling 
through G-proteins, signalling through β-arrestin or direct signalling through receptor 
associated kinases (Ritter and Hall, 2009). The signalling and trafficking properties of 
GPCRs are often highly malleable depending on the cellular context (Ritter and Hall, 2009). 
Distinct GPCR conformations induced or stabilized by ligands can differentially recruit and 
interact with different cellular effectors to elicit specific signalling cascades (Eishingdrelo 
and Kongsamut, 2013). Thus, ligand binding to GPCRs might initiate a second wave of 
signalling and represent a novel mechanism of GPCR signal transduction. There is also a 
cross-talk between GPCRs. One such mechanism is the heterologous desensitisation, which 
involves the activation of one GPCR to generate a signal that causes inhibition of signalling 
by a second, heterologous GPCR mediated via phosphorylation by G protein coupled 
receptor kinases or PKA and PKC (Bunemann and Hosey, 1999).  
Gpr120 agonists may activate multiple downstream signalling pathways in IMBAT cells. 
Based on our data, GW9508, TUG891 and TUG1096, all demonstrated various levels of bias 
agonism to Gpr120. Although GW9508 appeared to have activated more pathways, it is 
however not a specific ligand for Gpr120. TUG891 demonstrated the least effect on gene 
expression following Gpr120 activated, although had robust calcium effects, and it is reported 
to activate both mouse and human Gpr120 (Hudson et al., 2013). Activation of Gpr120 by 
TUG1096 resulted in significant gene expression changes and showed more β-arrestin 
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response as well as response to PPARγ regulation. Considering all these effects, TUG1096 
appears to be a candidate that should be exploited further. Exploiting biased ligands for 
therapeutic benefit represents a promising opportunity to develop safer and more efficacious 
drugs, as there is often a cross talk between signalling pathways (Siso-Nadal et al., 2009). 
Since many of the functionally beneficial physiological effects of Gpr120 are noted to be β-
arrestin-mediated (Burns et al., 2014), these findings could provide insight into the structural 
requirements for agonist-induced Gpr120 function. 
In assessing the impact of loss of Gpr120 in BAT on gene expression changes, a microarray 
analysis was carried out to determine the genes regulated by Gpr120 knockout in BAT. We 
demonstrated that Gpr120 KO BAT showed increase in the expression of inflammatory gene 
markers, reduced lipolytic and lipogenic gene markers and reduced expression of genes 
involved in glucose metabolism. Since FFAs can promote adipogenesis in adipose tissue by 
activating Gpr120 (Zhang and Leung, 2014), dysfunction of Gpr120 may lead to a failure of 
adipocyte differentiation in adipose, resulting in lipid accumulation in the liver and tissues 
This finding is supported by a study that reported that dysfunction of Gpr120 has been shown 
to result in obesity in both mice and humans (Ichimura et al., 2012b). The pharmacological 
properties of Gpr120 ligands were further characterized by assessing their agonist-induced 
effects on Gpr120 heterozygous and knockout cells. Treatment of brown adipocytes with 
Gpr120 agonists induced differential effects on activation of metabolic gene expression, and 
on the expression of differentiation markers, with expression of metabolic marker reduced in 
the Gpr120 KO cells. Therefore both at the tissue and at the cellular levels, dysfunction of 
Gpr120 lead to increased inflammation and metabolic disorders.  
Although all Gpr120 agonist induced differential amount of lipid droplets in IMBAT cells 
only GW9508-induced lipid droplet formation showed a higher amount in Het cells as 
compared to the KO cells. These findings suggest that brown adipocyte differentiation can be 
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regulated by stimulation with GW9508 and TUG1096, and while GW9508 can stimulate 
early induction of brown adipocyte differentiation, TUG1096 is involved in the late stage of 
differentiation. As Gpr120 was induced during differentiation, we also reasoned that PPARγ 
could be central to its transcriptional region. PPARγ ligands induced it expression which was 
blocked by antagonists. This action was specific for PPARγ as other PPAR ligands had little 
or no effect.  
Gpr120 may have a role in the regulation of metabolism through it effect on the expression 
both lipogenic and lipolytic genes in BAT. Adipose tissue inflammation impairs insulin 
sensitivity and metabolic homeostasis in part through augmented proinflammatory cytokine 
signalling (Osborn and Olefsky, 2012). Although our data showed that Gpr120 is highly 
expressed in mature brown adipocytes, Gpr120 is also expressed in other cell type within 
BAT. Gpr120 activation has been shown to produce anti-inflammatory effects in 
macrophages by repressing the activation of toll-like receptor 4-induced NF-κB signalling, 
which can inhibit downstream pro-inflammatory cascades like IL-6 (Zhang and Leung, 
2014). Apart from its effects in adipose tissue, Gpr120 activation also affects other tissue. 
Gpr120 activation may promote pancreatic β-cells survival and proliferation, and stimulation 
of insulin (Whalley et al., 2011). It is expressed in the stomach where it is involved in the 
inhibition of gastric hormone ghrelin, in the taste buds where it is involved in lipid sensing. In 
the skeletal muscle, Gpr120 is expressed at moderate levels where it functions to enhance 
insulin sensitivity by exerting anti-inflammatory effects (Zhang and Leung, 2014). Having 
determined the effects of Gpr120 ligands in cultured adipocyte, the next stage is to explore 
the ability of these ligands to stimulate similar effects in vivo. It has been reported that 
GW9508 and TUG891 stimulated Gpr120-induced anti-inflammatory and anti-diabetic 
effects in mice (Hudson et al., 2014; Oh da et al., 2014). Future work will therefore include 
testing this effect using TUG1096. This can be used to investigate BAT-specific role for 
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Gpr120 by treating Gpr120 KO mice and WT littermates with this specific ligand, and 
determine the gene expression changes that follow. Also in vivo metabolic studies will be 
evaluated with this ligand. 
GPCRs are among the most heavily investigated drug targets in the pharmaceutical industry, 
and in my views, it will remain at the hub of drug discovery activities for the foreseeable 
future. There are still a lot of questions about how GPCRs work and how they can be 
selectively activated. Because of the complexity and diversification in the function of these 
receptors, there may not be an easy path to the development of novel GPCR-targeted drugs. 
However, since the discovery of the phenomenon of biased agonism, there is a need for a 
paradigm shift towards agents that will preferentially activate a particular pathway. Certainly 
there are many researches looking at the role of GPCRs in obesity (Bjenning et al., 2004). 
But clearly, based on our findings, BAT is a definitive tissue-type important to target for 
some therapeutic benefits and the Gpr120 expressed in it is a unique heterodimer within BAT 
(Holliday et al., 2011). Future researches will therefore be directed towards probing more 
deeply into the functional activity of compounds that will selectively activate Gpr120 
function in BAT. 
GPCRs also transactivate cell surface transmembrane kinase receptors of protein tyrosine 
kinase and protein serine/threonine kinase families, such as the epidermal growth factor 
receptor (EGFR) and transforming growth factor-β (TGF-β) (Cattaneo et al., 2014), 
expanding the role of GPCRs in physiology and pathology. Since Nrg4 and Gpr120, are both 
highly expressed in BAT and regulated in a temperature-dependent manner, and regulated by 
PPARγ network, they appear to share some common cellular effects. The possibility of 
Gpr120-HER4 transactivation could therefore be explored for future work. 
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Appendix II 
Murine primers used for gene expression experiments, written in a 5’ to 3’ direction 
 
 
 
 
 
 
 
 
Aacs CTGTCAGTGCTGGAGGAGAA TGGCCCATGAAACAGGAGAT 
Acaa2 AGAAGGCCCTGGATCTTGAC CTCCAATGCAAGCTGATCCC 
Acsl1 CAGAACCCGAAGATCTTGCG CGGTCTCAAACATATGGGCG 
Adcy4 CCTCATTGCCCGCCTTTATC GTCTCAGTCTCCTCTCGCTC 
Adhfe1 CCAGCTCCCTCCTGTACAAA CCCACAGCAACATAGGCATC 
Adrbk2 GGCAGCATGTGTACTTACGG TTCCTCCTGGCCTCGATTTT 
Aldh2 GAGCAGAGCCATGTCATGTG TGTCACACATCCAGGCATCT 
aP2 ACACCGAGATTTCCTTCAAACTG CCATCTAGGGTTATGATGCTCTTCA 
Apoc1 GAGGGCGGTGGTGAATACTA ATGCTCTCCAATGTTCCGGA 
C/EBPα TGGAGTTGACCAGTGACAATGAC CAGTTCACGGCTCAGCTGTTC 
Egfl7 CTTGGAGGAACATCTGGGGT ATGCCCAAGTCCTAGGAACC 
FAS TGCGGAAACTTCAGGAAATGT AGAGACGTGTCACTCCTGGACTT 
Glut-4 CTATTCAACCAGCATCTTCGAG CTACTAAGAGCACCGAGACC 
Gpr108 ACCACGTCATTCACCCATCT  CAGTCCCAACACCTGATCCT 
GPR120: ACATTGGATTGGCCCAACCGCA TCCGCGATGCTTTCGTGATCTGT 
Gpr34 TTGCCTGGATCCTGTCATGT CACGGACAGATCATGCAAGG 
Gys2 ATCCTTTCTCGTGCCAGGAA GCGGTGGTATATCTGCCTCT 
Mlxipl CCCTCAGACACCCACATCTT TCAGAAAGGGGTTGGGATCC 
Nrg4: TGTGGACCATACGACGAGAG GTGCAAGGTCAACACAGGAA 
Paqr9 GGTTTGCGTGGAGTTTCTGT TGTTTCACCTCCCATCTCCC 
Pnpla3 ACCTGAGAGCCTGCAATCTT AACAGAACCCTTCCCAGAGG 
PPARγ CGAGTCTGTGGGGATAAAGC GGATCCGGCAGTTAAGATCA 
Sncg CAAGGAAGGTGTTGTGGGTG CTTGTTGGCCACTGTGTTGA 
Ucp1: ACTGCCACACCTCCAGTCATT CTT TGC CTC ACT CAG GAT TGG 
Vldlr GCCCTGAACAGTGCCATATG CATCACTGCCATCGTCACAG 
β-actin: TTGCTGACAGGATGCAGAAG CCACCGATCCACACAGAGTA 
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Primers used for molecular cloning experiments, written in a 5’ to 3’ direction 
shNrg4-a 
F GATCCCCCCTTAATTCTTCCATCAAGTTCAAGAGACTTGATGGAAGAATTAAG
GTTTTTA 
R AGCTTAAAAACCTTAATTCTTCCATCAAGTCTCTTGAACTTGATGGAAGAATT
AAGGGGG 
shNrg4-b 
F GATCCCCATTAAGATGCCAACAGATCTTCAAGAGAGATCTGTTGGCATCTTAA
TTTTTTA 
R AGCTTAAAAAATTAAGATGCCAACAGATCTCTCTTGAAGATCTGTTGGCATCT
TAATGGG 
  
shNrg4-c 
F GATCCCCGATGCCAACAGATCACGAGTTCAAGAGACTCGTGATCTGTTGGCA
TCTTTTTA 
R AGCTTAAAAAGATGCCAACAGATCACGAGTCTCTTGAACTCGTGATCTGTTGG
CATCGGG 
shNrg4-d 
F GATCCCCTGGGGGGATTTGTTATGTGTTCAAGAGACACATAACAAATCCCCCC
ATTTTTA 
R AGCTTAAAAATGGGGGGATTTGTTATGTGTCTCTTGAACACATAACAAATCCC
CCCAGGG 
 
Directional Topo cloning into pcDNA-v5/His:  
Nrg4 
F C ACC ATG CCA ACA GAT CAC GAG CAG 
R GTG TTC TCT GTG GCT GTG ACG G 
 
5’RACE:   
Nrg4 
Inner reverse AATGGGCTGGGGATAGTAGG 
Outer reverse CCATTGAGGCAAAATGACCT 
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Physiol Endocrinol Metab 306: E945–E964, 2014. First published
February 18, 2014; doi:10.1152/ajpendo.00473.2013.—Brown adi-
pocytes dissipate energy, whereas white adipocytes are an energy
storage site. We explored the plasticity of different white adipose
tissue depots in acquiring a brown phenotype by cold exposure. By
comparing cold-induced genes in white fat to those enriched in brown
compared with white fat, at thermoneutrality we defined a “brite”
transcription signature. We identified the genes, pathways, and pro-
moter regulatory motifs associated with “browning,” as these repre-
sent novel targets for understanding this process. For example, neu-
regulin 4 was more highly expressed in brown adipose tissue and
upregulated in white fat upon cold exposure, and cell studies showed
that it is a neurite outgrowth-promoting adipokine, indicative of a role
in increasing adipose tissue innervation in response to cold. A cell
culture system that allows us to reproduce the differential properties
of the discrete adipose depots was developed to study depot-specific
differences at an in vitro level. The key transcriptional events under-
pinning white adipose tissue to brown transition are important, as they
represent an attractive proposition to overcome the detrimental effects
associated with metabolic disorders, including obesity and type 2
diabetes.
brown adipose tissue; subcutaneous white adipose tissue; visceral
white adipose tissue; cold; brite; adipokine
ADIPOSE TISSUE IS A HIGHLY DYNAMIC ENDOCRINE ORGAN with
central roles in the regulation of energy metabolism. Discrete
adipose tissue depots have distinct contributions to energy
balance, and metabolic disorders are associated with its distur-
bance (21, 43, 56, 59). The major fat depots in mammals,
including humans, are the subcutaneous and the intra-abdom-
inal depots. These are composed of varying amounts of the two
different types of adipose tissue: white adipose tissue (WAT)
that stores energy in the form of triacylglycerol (TAG) and
brown adipose tissue (BAT) that dissipates energy as heat,
“burning” fatty acids to maintain body temperature. WAT and
BAT have significant transcriptional, secretory, morphological,
and metabolic differences. The main murine BAT depot is
located subcutaneously in the interscapular region, but it can
also be found in the cervical, axillar, and paravertebral regions.
BAT is a highly vascularized and innervated tissue, and brown
adipocytes possess multilocular lipid droplets and a high num-
ber of mitochondria and demonstrate a high rate of fatty acid
and glucose uptake and oxidation (9). WAT is found primarily
under the skin (subcutaneous) or inside the abdomen (gonadal,
mesenteric, omental, and perirenal), and it is much less inner-
vated and vascularized than BAT. White adipocytes have a
unilocular lipid droplet, few mitochondria, and a low oxidative
rate. Important differences exist between subcutaneous and
visceral depots, which support their different involvement in
insulin sensitivity and type 2 diabetes, with visceral WAT
being more closely associated with an adverse metabolic pro-
file (28).
In recent years, considerable interest has risen in the poten-
tial beneficial effects of acquiring BAT features (browning) in
nonclassic BAT locations such as WAT. It is known that
subcutaneous WAT is more sensitive to acquisition of BAT
characteristics than visceral depots in mice and humans (47,
53). However, it is still a matter of debate as to whether mature
white adipocytes undergo transdifferentiation into brown adi-
pocytes (12, 16) or whether precursors committed to the brown
lineage already present in the tissue differentiate into mature
brown adipocytes (42, 63). Brown in white (brite) or “beige”
adipocytes are distinct from the adipocytes in interscapular
BAT in that they arise as multilocular adipocytes in WAT
during adrenergic stimulus (30, 42, 46, 61, 63). They have low
levels of uncoupling protein 1 (UCP1) compared with classic
brown adipocytes but possess the capacity to induce UCP1
expression to a very high extent and the ability to increase their
oxygen consumption upon adrenergic activation. It has been
reported recently that the adipocytes found in human BAT
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could be of this brite type, and a defined bona fide interscapular
BAT depot is found in infants (13, 31, 36, 49, 63). Several
classes of factors have been identified to promote a BAT
phenotype either in white adipocytes and/or WAT. These
include transcription factors [e.g., peroxisome proliferator-
activated receptor- (PPAR), CCAAT/enhancer-binding pro-
tein beta (C/EBP), and Foxc2], coregulators [e.g., PPAR
coactivator-1 (PGC-1), Prdm16, and Plac8], growth factors
[e.g., bone morphogenetic protein (Bmp)7, Fgf21, Bdnf, and
Bmp8b], enzymes (e.g., Ptgs2), lipid droplet-associated pro-
teins (e.g., perilipin), and cell survival factors (e.g., necdin) as
well as the miR193b-365 microRNA cluster (reviewed in Ref.
51). Although these factors have important roles in promoting
a brown fat phenotype, to date, only fibroblast growth factor 21
(FGF21) has been reported in a therapeutic study (17). Under-
standing WAT-BAT plasticity in different depots, it is impor-
tant for the design of future treatments to target type 2 diabetes
and obesity by BAT-inducing drugs or other therapies, such as
tissue transplantation or gene therapy.
For this study, we have compared gene expression in four
different mouse adipose depots with very specific physiologies
upon prolonged cold exposure. We sought to identify differ-
entially regulated genes and thereby novel signaling pathways
during cold-induced adipose tissue “remodeling.” Further-
more, we identified motifs that are enriched in the promoters of
brite genes. We have been able to confirm that subcutaneous
adipose tissue is the most prone to changing to display a brite
phenotype identified as a number of temperature-regulated and
differentially expressed genes that represent new targets for
further studies. In addition, we have established cell models
that will allow the comparison of different adipose tissue
depots at an in vitro level. From these investigations, we have
demonstrated that neuregulin 4 (Nrg4)is a novel cold-induced
adipokine that promotes neurite outgrowth.
MATERIALS AND METHODS
Mice
Cold exposure experiments. Groups of four 10-wk-old female
129Sv mice (Charles River, Milan, Italy) were housed separately and
kept at 22°C. Subsequently, one group of mice was placed at 28°C and
another one at 6°C for 10 days. Another group was kept at 22°C.
Animals were singly caged with a 12:12-h light-dark cycle and free
access to standard chow diet and water. At the end of the treatment,
the body weights of single animals did not change significantly either
during cold exposure or in warm acclimatization. Mice were culled as
reported previously (7), and adipose tissues (interscapular BAT and
subcutaneous, mesenteric, and gonadal WAT) were collected. Care
and handling were in accordance with institutional guidelines. Proce-
dures were approved by the Ethics Committee for Animal Experi-
ments at the University of Ancona (11 Gen. 2007, protocol no. 585).
3-Adrenoceptor agonist administration experiments. Two groups
of four 10-wk-old C57BL/6 female mice kept at 22°C were given an
intraperitoneal injection either with saline (200 l) or CL316,243 (1
mg/kg body wt in 200 l of saline) 5 h after injection mice were
culled by cervical dislocation and adipose tissues collected.
Tissue panel. FVB/N female mice kept under normal housing
conditions were culled by cervical dislocation and the different tissues
collected. Experiments were carried out in accordance with UK Home
Office regulations.
Immunohistochemistry and Immunocytochemistry
Immediately after removal, adipose tissues were fixed overnight by
immersion at 4°C in 4% paraformaldehyde. Paraffin-embedded dew-
axed sections were stained with hematoxylin and eosin or incubated
with anti-UCP1 (cat. no. 10983; Abcam) or anti-Nrg4 (anti-127; see
Ref. 24) according to the avidin-biotin complex method (27). Staining
was never observed when the primary antibody was omitted.
RNA Extraction and qRT-PCR
Total RNA was extracted with Trizol. RNA for microarray analysis
was purified using Qiagen RNeasy mini columns. The expression of
target genes was determined using SYBR green reagent and gene-
specific primers (sequences available on request). Relative expression
levels were normalized to -actin.
Microarray Analysis
Gene expression microarray was performed by Almac diagnostics
UK using GeneChip Mouse Genome 430A 2.0 Array (Affymetrix) on
RNA extracted from interscapular BAT and subcutaneous and mes-
enteric WAT from mice exposed to 28 or 6°C. Three biological
replicates were used. The analysis was conducted using R program-
ming language and Bioconductor (55). After background adjustment,
summarization, and normalization of the raw intensities, the data were
analyzed using affy (19) and limma (14). Pairwise comparisons
between conditions were performed. A linear model was fitted to the
expression values of each probe, modified to account for the replicated
samples and assuming no interaction between the genes. The moder-
ated t-statistic was computed for each probe and for each contrast
providing P values that were corrected for multiple testing using the
Benjamini and Hochberg’s method to control the false discovery rate
(10). Probes with adjusted P values of 0.01 were considered statis-
tically significant. The microarray data have been deposited in NCBI’s
Gene Expression Omnibus (15) and are accessible through GEO
Series accession no. GSE51080 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?accGSE51080). Heatmaps were produced based on
the Euclidian distance. Pathway analysis was generated by Ingenuity
IPA software.
Protein Expression
Tissues and cultured cells were lysed in Laemmli loading buffer,
and proteins were electrophoresed on a 10% SDS-PAGE gel and
transferred to PVDF membrane. Membranes were probed with spe-
cific antibodies UCP1 (cat. no. U6382; Sigma), cell death-inducing
DNA fragmentation factor -subunit-like effector A (CIDEA; cat. no.
AB16922; Chemicon), p-Akt (Ser473), and t-Akt, all from cell-signal-
ing technologies and -actin (Sigma).
Preparation of adipocytes vs. stromal vascular fraction-enriched
fractions
Adipose tissues from four mice were cut into 2-mm pieces and
digested in serum-free DMEM-F-12 culture medium containing 1
mg/ml collagenase A (Roche) and 10 mg/ml DNAse (Roche). After
digestion, the cells were separated by centrifugation at 170 g for 10
min, and mature adipocytes (floating fraction) and stromal vascular
fraction (SVF; in the cell pellet) were collected separately for RNA
extraction.
Cell Culture
Generation of immortalized cell lines. Primary cultures of brown
adipose and subcutaneous, mesenteric, and gonadal white adipose
tissues were generated by first digesting the tissue and pelleting the
SVF, as described above. Preadipocytes were purified by collecting
the cells that passed through 100 m of mesh. Next, cells were passed
through strainers of 70- or 25-m mesh size for brown and white
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preadipocytes, respectively, and were plated and cultured in DMEM-
F-12, 10% FBS, and 1% antibiotic-antimycotic. After culture for 2
days, preadipocytes were immortalized by retroviral-mediated expres-
sion of temperature-sensitive SV40 large T-antigen H-2kb-tsA58 (a
gift from P. Jat). Cells were cultured at 33°C and selected with G418
(100 mg/ml) for 2 wk and then maintained in 50 g/ml G418.
Experiments were performed between passages 12 and 22. Cells were
differentiated as described previously (22, 39).
PC12-HER4. The PC12-HER4 cell line (24) was cultured in
RPMI-1640 supplemented with 10% horse serum and 5% fetal bovine
serum. Cells were plated on poly-L-lysine-coated glass coverslips and
exposed to unconditioned DMEM-F-12, 10% FBS medium, or con-
ditioned medium from differentiated adipocytes.
Metabolic Studies
9,10-[3H]palmitate oxidation. Assessment was performed as re-
ported previously (18). Briefly, differentiated adipocytes were starved
in glucose-deprived DMEM for 1 h. Cells were then incubated at 37°C
in DMEM containing 0.3 mM palmitate (9,10-[3H]palmitate, 12
Ci/ml), 2% BSA, 0.25 mM L-carnitine, and 3 mM glucose for 3 h.
Palmitate oxidation was assessed by measuring 3H2O produced in the
incubation medium. Data were normalized to DNA content/well
measured with a Fluorescent DNA Quantitation Kit (Bio-Rad).
Glucose uptake. Glucose uptake was measured using 2-[N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose (2-NBDG; Mo-
lecular Probes). Differentiated adipocytes in 96-well plates were
serum starved for 3 h. Then cells were incubated in HBSS buffer with
or without insulin (100 nM) for 30 min. Glucose uptake was initiated
by the addition of HBSS containing 500 M 2-NBDG and 2.5 mM
deoxyglucose. After 15 min, plates were washed with cold HBSS
buffer containing 25 mM glucose. Cells were lysed, and fluorescence
was read at 466 nm. Fluorescence was normalized to protein content.
Nrg4 ELISA
NRG4 levels in culture medium were determined by ELISA
(SEC147Mu; Caltag Medsystems), following the manufacturer’s pro-
tocol.
IL-6 ELISA
Antibodies and standards were sourced from R & D Systems, and
the ELISA was performed according to the manufacturer’s instruc-
tions. Data were normalized to DNA content/well measured with a
Fluorescent DNA Quantitation Kit (Bio-Rad).
Nrg4 Knockdown
Conditionally immortalized BAT cells were transfected with shRNA
(short-hairpin RNA) targeting Nrg4 (pSuperior-shNrg4). Oligonucleo-
tides (shNrg4 forward, 5=-GATCCCCUGGGGGGAUUUGUUAU-
GUGTTCAAGAGACACUAACAAAUCCCCCCATTTTTA-3=; and
shNrg4 reverse, 5=-AGCTTAAAAAUGGGGGGAUUUGUUAU-
GUGTCTCTTGAACACAUAACAAAUCCCCCCAGGG-3=) were an-
nealed and ligated into pSuperior vector. Cells stably expressing the
shRNA were achieved by selection with puromycin.
Statistical Analysis
ANOVA tests were performed, and only P values 0.05 consid-
ered statistically significant. In all figures, the data are the average of
a minimum of three independent replicates  SE.
Motif Detection in Upstream Flanking Regions of Differentially
Expressed Genes
Lists of differentially expressed genes from the expression exper-
iments were ordered using fold change, and Ensembl Gene IDs were
obtained for lists of interest. The Ensembl Gene IDs were subse-
quently submitted to BioMart (Ensembl Genes 72, Mus musculus
GRCm38.p1 dataset) to retrieve the corresponding 1,000-bp upstream
flanks of the transcripts of the genes of interest from the genome
annotation. To remove sequence repeats arising from overlapping
transcript variants, the FASTA sequences were assembled into con-
tiguous sequences with CAP3. Mixed contiguous sequences com-
posed of flanks from more than one gene were verified to identify
overlaps generated in CAP3 due to sequence similarity alone rather
than contiguity. Such false mixed contiguous sequences were re-
moved from the set of contiguous sequences. The original flanking
regions making up the false mixed contiguous sequences were then
collected, and a contiguous sequence was rebuilt if there was more
than one transcript-flanking region for a particular gene, whereas
singlets were simply added to the final set. The final set of sequences
was then collated, which included the initial true contiguous se-
quences, the singlets, and the singlets or contiguous sequences which
arose from the false mixed contiguous sequences. The resulting
FASTA sequence file was submitted as a single cluster to MEME-LaB
to detect 10 motifs between six and 12 base pairs, with the promoter
maximum length adjusted to accommodate the longer contiguous
sequences.
RESULTS
Fat Depots Vary in Their Response to Cold
To study the ability of different adipose tissue depots to
respond to changes in temperature, 129Sv female mice were
exposed to temperatures of 28 or 6°C. This mouse strain is
reported to be diabetes and obesity resistant due to a greater
amount of active BAT (3). It has a greater amount of adi-
pocytes expressing UCP1 in different adipose depots and has
been used for several studies addressing cold-induced transdif-
ferentiation of adipose tissues (7, 40). Global changes in
expression were monitored by microarray analysis of BAT and
inguinal subcutaneous and mesenteric WAT. BAT showed the
most dramatic changes upon prolonged cold exposure, with
11,180 gene probes sets differentially expressed (P  0.01)
(Fig. 1A). In subcutaneous WAT, 2,178 probes were altered,
but only eight were altered in mesenteric WAT.
By considering the up- and downregulated probes sepa-
rately, we identified the most significantly differentially ex-
pressed pathways in each tissue. The top 20 pathways for BAT
and subcutaneous WAT are shown in Fig. 1B. The number of
genes altered in the mesenteric depot was too low to be used
for pathway analysis. In BAT, the top upregulated pathways
involve protein degradation (protein ubiquitination), metabo-
lism (fructose, mannose, fatty acid, glucose, and propanoate
metabolism), reduced power generation (pentose phosphate
pathway), signal transduction [thyroid hormone receptor/reti-
noid X receptor regulation, Toll-like receptor (TLR) activation,
AMPK, IL-17, PI3K/Akt], and oxidative stress regulation.
Among the downregulated probes, the most significantly al-
tered pathways are cell cycle- and growth regulation-related
pathways (purine metabolism, DNA methylation, cell cycle
G1/S checkpoint, DNA damage repair) as well as signaling
pathways (mTOR, estrogen, RAR, androgen, and VEGF sig-
naling). On analysis of the subcutaneous data set, it becomes
evident that this particular depot shows a shift toward a brown
or brite phenotype when animals are exposed to 6°C. Most of
the top upregulated pathways are those that are highly ex-
pressed in BAT (oxidative phosphorylation, citrate cycle, fatty
acid metabolism, ubiquinone synthesis, pyruvate metabolism).
Downregulated probes belong mostly to pathways related to
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Fig. 1. Global expression analysis of brown adipose tissue (BAT) and subcutaneous and mesenteric white adipose tissue (WAT) in mice exposed to cold. A: global
mRNA expression was measured in BAT and subcutaneous and mesenteric WAT depots of mice exposed at either 28 or 6°C using Affymetix 2.0 ST microarrays. A
row-centred heat map of hierarchical clustering carried out on the differentially expressed gene probes at a 5% false discovery rate is shown. Probe sets are colored
according to the average expression level across all samples, with green denoting a lower expression level and red denoting a higher expression level. B: top pathways
that were altered by cold exposure in BAT and subcutaneous WAT. The bars represent significance, and the ratio of genes altered out of the total genes per pathway
is indicated. Pathway analysis was performed using up- and downregulated probes separately. mTOR, mammalian target of rapamycin; EIF, eukaryotic initiation factor;
NRF2, nuclear factor-E2-related factor; PI3K, phosphatidylinositol 3-kinase; CNTF, ciliary neurotrophic factor; RAR, retinoic acid receptor.
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Fig. 2. Global expression comparison of BAT and subcutaneous (sWAT) and mesenteric WAT (mWAT) at 28°C. A: global mRNA expression was measured
in BAT, sWAT, and mWAT depots of mice housed at 28°C, using Affymetix 2.0 ST microarrays. Shown is a row-centred heat map of hierarchical clustering
carried out on the differentially expressed gene probes at a 10% false discovery rate. Probe sets are colored according to the average expression level across all
samples, with green denoting a lower expression level and red denoting a higher expression level. B: top pathways that are enriched in each of the different depots
compared with each other. The bars represent significance, whereas ratio shows the genes altered out of the total genes per pathway. Pathway analysis was
performed using up- and downregulated probes separately.
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the immune system (lipid antigen presentation, natural killer
cell signaling, antigen presentation), signaling, and endoplas-
mic reticulum stress.
Intrinsic Differences of WAT and BAT Depots at
Thermoneutrality
Using the microarray data, we analyzed the intrinsic differ-
ences between each adipose depot at 28°C. In Fig. 2A, the heat
maps for each of the comparisons are shown. Comparison of
BAT to subcutaneous and mesenteric WAT indicated that
25,625 and 30,242 probes, respectively, were differentially
expressed, whereas only 9,647 probes were differentially ex-
pressed for subcutaneous vs. mesenteric. As expected, these
data show that WAT depots are more similar to each other than
to BAT.
The most highly expressed pathways in BAT were those
involved in energy expenditure, metabolism, and signaling
(Fig. 2B), with those enriched in WAT related to the immune
system, including T cell activation, antigen presentation, com-
plement system activation, and lymphocyte apoptosis. When
comparing subcutaneous to mesenteric WAT, the enriched
pathways in subcutaneous WAT are related to neuronal sig-
Table 1. Top gene probes up- and downregulated after cold exposure in BAT and subcutaneous and mesenteric WAT
BAT 6°C vs. 28°C Upregulated BAT 6°C vs. 28°C Downregulated
Gene Symbol FC
Adjusted
P Value Gene Name Gene Symbol FC
Adjusted
P Value Gene Name
Elovl3 76.76 0.001 Elongation of very-long-chain
fatty acid-like 3
EG666481 68.85 0.001 Predicted gene 8126
Bmp8b 32.25 0.001 Bone morphogenetic protein 8b 1110059M19Rik 37.60 0.001 RIKEN cDNA 1110059M19
9030619P08Rik 30.40 0.001 RIKEN cDNA 9030619P08 Snhg11 11.86 0.001 Small nucleolar RNA host gene 11
(nonprotein coding)
4933433H22Rik 15.12 0.001 RIKEN cDNA 4933433H22 Myh4 11.67 0.019 Myosin, heavy polypeptide 4
Serpina12 14.88 0.001 Serine peptidase inhibitor,
clade A member 12
Rab17 11.06 0.001 RAB17 member RAS oncogene
family
Gyk 11.83 0.001 Glycerol kinase Myh2 10.73 0.014 Myosin heavy polypeptide 2
Ncan 11.71 0.001 Neurocan Asb5 10.06 0.005 Ankyrin repeat and SOCS
box-containing 5
Rims2 10.38 0.001 Regulating synaptic membrane
exocytosis 2
Ddit4l 9.97 0.016 DNA-damage-inducible transcript
4-like
Slc25a34 9.62 0.001 Solute carrier family 25,
member 34
Casq1 9.89 0.017 Calsequestrin 1
Sgk2 9.51 0.001 Serum/glucocorticoid regulated
kinase 2
B3 galt2 8.52 0.001 UDP-Gal -GlcNAc -1.3-
galactosyltransferase, polypeptide 2
Subcutaneous WAT 6°C vs. 28°C Upregulated Subcutaneous WAT 6°C vs. 28°C Downregulated
Gene symbol FC
Adjusted
P value Gene name
Gene
symbol FC
Adjusted
P value Gene name
Elovl3 31.98 0.001 Elongation of very-long-chain
fatty acid like 3
Csn2 50.46 0.004 Casein-
Slc27a2 16.64 0.001 Solute carrier family 27 (fatty
acid trasporter) member 2
Nnat 16.72 0.001 neuronatin
9030619P08Rik 13.29 0.001 RIKEN cDNA 9030619P08 Kera 5.15 0.001 Keratocan
Ucp1 12.54 0.001 Uncoupling protein 1 Defb1 5.06 0.002 Defensin-1
Fabp3 10.21 0.001 Fatty acid-binding protein 3 Gm266 4.98 0.001 predicted gene 266
Cpt1b 9.88 0.001 Carnitine palmitoyltransferase
1b, muscle
Col9a1 4.17 0.001 Collagen type IX, 1
Cox7a1 9.21 0.001 Cytochrome c oxidase,
subunit VIIa 1
Htr4 4.17 0.004 5 hydroxytryptamine (serotonin)
receptor 4
Kng1 7.84 0.001 Kininogen 1 Slc15a2 3.24 0.001 Solute carrier family 15
(H	/peptide transporter),
member 2
Otop1 7.49 0.001 Otopetrin 1 Bdnf 3.15 3.93E-03 brain derived neurotrophic factor
Ppara 7.48 0.001 Peroxisome proliferator-
activated receptor-
Adamts2 3.10 1.70E-04 A disintegrin-like metallopeptidase
throm-bospondin type1, motif2
Mesenteric WAT 6°C vs. 28°C Upregulated Mesenteric WAT 6°C vs. 28°C Downregulated
Gene
symbol FC
Adjusted
P value Gene name Gene symbol FC
Adjusted
P value Gene name
Ucp1 7.88 0.001 Uncoupling protein 1 LOC100046232 2.66 0.001 Nuclear factor interleukin 3, regulated
Orm3 2.84 0.001 Orosomucoid 3 Tmem182 1.84 0.001 Transmembrane protein 182
Nrg4 2.18 0.001 Neuregulin member 4
Cabc1 2.17 0.001 Chaperone, ABC1 activity of
bc1 complex like
Acsf2 1.77 0.001 Acyl-CoA synthetase family
member 2
BAT, brown adipose tissue, WAT, white adipose tissue; FC, fold change.
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naling, whereas the most prominent pathways in mesenteric
WAT seem to be related to interleukin production and signal-
ing as well as carbohydrate and amino acid metabolism.
Identification of Differentially Expressed Genes Sensitive
to Temperature
From the microarray analysis, we aimed to identify genes
that were significantly altered in expression by temperature
with potential relevance for the temperature-induced acquisi-
tion of brite features. The top 10 up- and downregulated genes,
due to cold exposure, are presented for BAT and subcutaneous
and mesenteric WAT in Table 1, and the top genes for
comparisons of the depots at 28°C are presented in Table 2. We
chose a set of genes for further study that were more highly
expressed in BAT compared with WAT depots and were also
increased in subcutaneous WAT following cold exposure. This
Table 2. Top gene probes up- and downregulated when comparing BAT, subcutaneous WAT, and mesenteric WAT at
thermoneutrality
BAT 28°C vs. Subcutaneous 28°C Upregulated BAT 28°C vs. Subcutaneous 28°C Downregulated
Gene symbol FC
Adjusted
P value Gene name
Gene
symbol FC
Adjusted
P value Gene name
Zic1 111.91 0.001 Zinc finger protein of the
cerebellum 1
Csn3 106.07 0.001 Casein kappa
Cpn2 77.41 0.001 Carboxypeptidase N, polypeptide 2 Btn1a1 90.95 0.001 Butyrophilin, subfamily 1,
member A1
Slc27a2 76.77 0.001 Solute carrier family 27 (fatty acid
transporter), member 2
Foxa1 88.56 0.001 Forkhead box A1
2310014F07Rik 61.34 0.001 RIKEN cDNA 2310014F07 gene Areg 82.96 0.001 amphiregulin
Kng1 53.07 0.001 Kininogen 1 Ehf 81.38 0.001 Ets homologous factor
EG666481 44.08 0.001 Predicted gene 8126 Serpinb5 78.90 0.001 Serpin peptidase inhibitor,
clade B, member 5
Olig1 42.44 0.001 Oligodendrocyte transcription
factor 1
Cxcl15 78.77 0.001 Chemokine (C-X-C motif)
ligand 15
Ppara 40.04 0.001 Peroxisome proliferator-activated
receptor-
Krt8 75.07 0.001 keratin 8
9130214F15Rik 38.03 0.001 RIKEN cDNA 9130214F15 gene Slc5a5 64.96 0.001 Solute carrier family 5 (sodium
iodide), member 5
Chkb-cpt1b 35.86 0.001 Carnitine palmitoyltransferase 1b,
muscle
Hoxa10 59.03 0.001 homeobox A10
BAT 28°C vs. Mesenteric 28°C Upregulated BAT 28°C vs. Mesenteric 28°C Downregulated
Gene symbol FC
Adjusted
P value Gene name
Gene
symbol FC
Adjusted
P value Gene name
Ucp1 210.01 0.001 Uncoupling protein 1 Upk3b 108.35 0.001 Uroplakin 3b
Slc27a2 171.79 0.001 Solute carrier family 27 (fatty acid
transporter), member 2
Phox2b 101.69 0.001 Paired-like homeobox 2b
Zic1 138.04 0.001 Zinc finger protein of the
cerebellum 1
Colec10 95.85 0.001 Collectin subfamily member 10
2310014F07Rik 124.87 0.001 RIKEN cDNA 2310014F07 gene Bnc1 91.40 0.001 Basonuclin 1
Cpn2 107.34 0.001 Carboxypeptidase N, polypeptide 2 Scg2 87.39 0.001 Secretogranin II
Myo5c 65.24 0.001 myosin VC Snap25 85.13 0.001 synaptosomal-associated protein
25
Myh4 64.22 0.001 Myosin, heavy polypeptide 4,
skeletal muscle
Isl1 81.38 0.001 ISL1 transcription factor,
LIM/homeodomain
EG666481 58.31 0.001 Predicted gene 8126 Rims1 78.79 0.001 regulating synaptic membrane
exocytosis 1
Six1 50.30 0.001 Sine oculis-related homeobox 1
homolog (Drosophila)
Calcb 77.62 0.001 calcitonin-related polypeptide, 
Chkb-cpt1b 47.65 0.001 Carnitine palmitoyltransferase 1b,
muscle
Bcl11a 74.34 0.001 -cell CLL/lymphoma 11A
(zinc finger protein)
Subcutaneous 28°C vs. Mesenteric 28°C Upregulated Subcutaneus 28°C vs. Mesenteric 28°C Downregulated
Gene
symbol FC
Adjusted
P value Gene name
Gene
symbol FC
Adjusted
P value Gene name
Csn3 174.98 0.001 Casein kappa Rims1 339.50 0.001 Regulating synaptic membrane exocytosis 1
Areg 169.91 0.001 Amphiregulin Upk3b 263.18 0.001 Uroplakin 3b
Foxa1 164.17 0.001 Forkhead box A1 Snap25 235.42 0.001 Synaptosomal-associated protein 25
Tcfap2c 150.16 0.001 Transcription factor AP-2, gamma Scg2 152.72 0.001 Secretogranin II
Cxcl15 116.61 0.001 Chemokine (C-X-C motif) ligand 15 Nmu 142.19 0.001 Neuromedin U
Muc15 113.45 0.001 mucin 15 Phox2b 131.78 0.001 Paired-like homeobox 2b
Btn1a1 113.12 0.001 Butyrophilin, subfamily 1, member A1 Colec10 130.78 0.001 Collectin sub-family member 10
Elf5 109.85 0.001 E74-like factor 5 Vip 113.28 0.001 Vasoactive intestinal polypeptide
Esrp1 98.22 0.001 Epithelial splicing regulatory protein 1 Gal 99.00 0.001 galanin
Tmprss2 79.11 0.001 Transmembrane protease, serine 2 Resp18 95.51 0.001 Regulated endocrine-specific protein 18
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group included genes involved in several different processes.
Nrg4 is a regulator of neuronal development (23), and Bmp8b
regulates thermogenesis in BAT (62). The G protein-coupled
receptor (GPCR) Gpr120 is linked with obesity (29), and Rgs7
(4) has the potential to affect the signaling through many
GPCRs important for BAT function. Slc27a2 (26) and Letm1
(60) have key roles in lipid metabolism and mitochondrial
function, respectively. We also identified the uncharacterized
transcript 9030619P08RIK for further study, as it is highly
regulated and could be a potential cell surface marker of brown
adipocytes. This gene shares a high homology with the Ly-6
protein family and is found in the vicinity of a genomic region
that contains the genes for this family (6). Hence, we term it
cold-induced lymphocyte antigen 6-like (Cil6l). Neuronatin
(Nnat), a gene that has been involved in calcium signaling and
ER stress and adipose biology (20, 32), was selected because it
was downregulated in cold conditions in BAT and subcutane-
ous WAT.
Prior to the microarray, we determined the expression of
UCP1, a classic cold-induced target gene in BAT by qRT-PCR
in the different adipose tissues. We included another visceral
fat depot, the gonadal WAT, and tissues from animals housed
at 22°C (Fig. 3A). UCP1 was induced in all depots after
exposure to 6°C compared with either 28 or 22°C, with the
subcutaneous depot showing the largest increase. We also
measured the expression of Cidea, which was increased in
subcutaneous WAT but only modestly in BAT. Hematoyxlin
and eosin staining showed a large increase in multilocular cells
of the subcutaneous depot upon cold exposure (Fig. 3B).
Protein expression of UCP1 was monitored in the different
Fig. 3. Expression of selected genes induced by cold exposure or by a 3-adrenergic-specific agonist in different adipose depots. A: mRNA expression of
uncoupling protein 1 (UCP1) and cell death-inducing DNA fragmentation factor -subunit-like effector A (Cidea) in BAT, sWAT, gonadal WAT (gWAT), and
mWAT of mice exposed to 28, 22, or 6°C. B: hematoxylin and eosin staining (H & E) and UCP1 immunohistochemistry. UCP1-immunoreactive brown
adipocytes interspersed among unilocular white adipocytes of subcutaneous adipose tissue of mice exposed at 28 or 6°C. C: mRNA expression of genes identified
by microarray in BAT, sWAT, gWAT, and mWAT of mice exposed to 28, 22, or 6°C. D: mRNA expression of selected genes in different adipose depots of
mice injected intraperitoneally with the selective 3-receptor agonist CL-316,243 (1 mg/kg body wt) after 5 h; n  4. All mRNA data are expressed as fold
induction compared with BAT of mice either at 28°C or injected with saline. Bars represent the means  SE of at least 3 mice/group, and significant differences
are shown. *P  0.05; **P  0.005; ***P  0.001.
Fig. 4. Adipocyte-selective expression of temperature-regulated genes. mRNA expression of in cells from the stromal vascular fraction (SVF) or mature
adipocytes prepared from interscapular BAT, sWAT, gWAT (Gon), and mWAT. Perilipin protein levels from gWAT are shown as an indicator of the quality
of the fractionation (top right). Nrg, neuregulin; Nnat, neuronatin; Cil6l, cold-induced lymphocyte antigen 6-like; Letm1, leucine zipper EF hand-containing
transmembrane protein 1.
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depots by immunohistochemistry. Figure 3B shows staining of
subcutaneous WAT. UCP1 staining increased with exposure to
low temperatures in all adipose depots studied (data not
shown).
We next validated expression of our genes of interest (Fig.
3C). At both 28 and 22°C, Slc27a2 and Letm1 expression was
higher in BAT compared with the other depots, and Bmp8b
expression was higher in BAT and subcutaneous WAT,
whereas Nrg4, GPR120, and Rgs7 were highly expressed in
BAT and gonadal WAT depots. In the gonadal depot, the
relatively high levels of these genes are likely due to consti-
tutively present brown adipocyte pockets observed in the
129Sv strain even at 28°C (57). Cil6l was expressed largely in
subcutaneous WAT, whereas Nnat was preferentially ex-
pressed in gonadal WAT, followed by subcutaneous and mes-
enteric WAT and BAT. Upon cold exposure, we found genes
with expression induced in all depots (Rgs7, Letm1), genes
with expression induced in BAT and subcutaneous and gonadal
WAT (Nrg4, Gpr120), genes induced only in BAT and subcu-
taneous WAT (Bmp8b, Cil6l, Slc27a2), and a gene that was
reduced in all depots (Nnat).
To investigate whether the cold-regulated genes were af-
fected directly by the 3-adrenergic signaling pathway, mice
were treated with the 3-specific adrenergic agonist CL-
316,243. Examination of the expression of the cold-responsive
genes (Fig. 3D, right) revealed that only Bmp8b (very mod-
estly) and GPR120 mRNAs were significantly induced by
acute adrenergic treatment and only in BAT. These results
indicate that many of the genes that are upregulated in WAT
result from long-term remodeling effects rather than rapid
direct transcriptional events and are likely to be important for
brite cell function rather than driving the “browning” process.
Alternatively, the genes may initially be refractory to the
3-stimulus.
Because adipose tissues are composed of several cell types,
we determined whether the identified genes were expressed in
mature adipocytes or nonadipocyte cells that constitute the
SVF. Fractionation of the different depots showed that all the
genes were preferentially expressed in either brown or white
mature adipocytes (Fig. 4).
Gene Expression in Immortalized Cell Lines Generated
From Different Adipose Tissue Depots
Considering that all of the genes we identified were prefer-
entially expressed in mature adipocytes, we next investigated
whether their expression was maintained in cells in vitro. We
took the approach of immortalizing adipocyte precursors from
each adipose depot. This allows the comparison of adipocytes
from depots where both large and small numbers of precursors
can be obtained, using fewer mice. First, we examined whether
the in vitro-differentiated adipocytes retained the features that
define each depot. For all the cell lines, 80–100% of cells were
differentiated as judged by Oil Red O stain (Fig. 5A). The
ability to differentiate into adipocytes was maintained after
more than 30 passages. At the expression level, the preadi-
pocyte marker Pref-1 and mature adipocyte markers aP2 and
PPAR were downregulated or highly induced, respectively,
upon differentiation in the four cell lines (Fig. 5B). The brown
adipocyte marker UCP1 (Fig. 5A) was highly induced in BAT
cells after differentiation and to a much lower extent in white
adipocyte cells. Expression of UCP1 was almost undetectable
in gonadal and mesenteric WAT cells. We then analyzed
expression of the identified set of temperature or differentially
expressed genes throughout differentiation (Fig. 5C). Nnat and
Slc27a2 mRNA levels were undetectable at different time
points in all cell lines. Expression of the other identified genes
was induced upon differentiation to a higher or lower extent in
all cell lines. Nrg4, Rgs7, and Letm1 were more highly ex-
pressed in differentiated BAT cells compared with the white
adipocyte lines. Cil6l was highly expressed in differentiated
subcutaneous cells and to a lower extent in gonadal. We next
investigated gene regulation due to 3-adrenergic signaling.
We exposed differentiated adipocytes to an acute (5 h) treat-
ment with CL-316,243. This compound was able to induce
UCP1 and PGC-1 mRNA (Fig. 5D), showing that the 3-
adrenergic signaling pathway is fully functional. Regarding the
genes identified from the array, we obtained results similar to
the in vivo CL-316,243 treatment; GPR120 was the most
sensitive to acute adrenergic activation in BAT and subcuta-
neous cells. In general, Bmp8b was present at low levels in
adipocyte cell lines, unlike adipose tissues. However, it was
present at higher levels in differentiated brown compared with
white adipocytes and was induced by CL-316,243 only in the
brown adipocytes (Fig. 5D). Nrg4 and Letm1 showed modest
induction of mRNA expression in BAT cells and a tendency to
increase in subcutaneous cells but not in any of the others.
These results highlight that pathways in addition to the 3-
adrenergic signaling pathway are necessary for the induction of
certain genes (Cidea, Nrg4, Rgs7) upon cold exposure,
whereas others (UCP1, PGC-1, GPR120) are regulated di-
rectly by this pathway.
We also performed a series of functional metabolic assays to
investigate whether the differences observed at the transcriptional
level had physiological relevance in our cell lines. Basal -oxi-
dation was highest in BAT and subcutaneous WAT (Fig. 6A).
Because cold activates BAT -oxidation (65), we treated the cells
with 10 M CL-316,243 for 5 h. We detected an increase in the
-oxidation by BAT and subcutaneous WAT cells, whereas it
remained unchanged in gonadal and mesenteric WAT cells.
Basal glucose uptake, assessed with a fluorescent glucose
analog (2-NBDG) in mature adipocytes, was the highest in
gonadal WAT cells, followed by mesenteric and subcutaneous
WAT and BAT (Fig. 6B). Considering the recent findings by
PET scans, surprisingly, BAT had the lowest basal glucose
uptake. This cannot be explained by the expression levels of
the glucose transporters GLUT1 and GLUT4 that were present
Fig. 5. Immortalized cell lines from different adipose tissue depots. A: Oil Red O staining of differentiated cells on days 8–10 of differentiation. B: mRNA
expression of UCP1, PPAR, and preadipocyte factor (Pref-1; n  3) and a representative example of Western blot for UCP1, CIDEA, and aP2. C: mRNA
expression in cells from different immortalized cell lines on days 0, 2, and 8 of differentiation. Data are expressed as fold induction compared with BAT cells
on day 0; n  3. D: mRNA expression in differentiated cells from the different immortalized cell lines that had been treated for 5 h with 3-receptor agonist
CL-316,243 (10 M) or vehicle control (Ctrl). Data are expressed as fold induction compared with nonstimulated BAT cells; n  3. For all of the mRNA data,
bars represent means  SE, and significant differences are shown. *P  0.05; **P  0.005; ***P  0.001. PGC-1, PPAR coactivator-1.
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at higher levels in BAT compared with WAT cell lines (Fig.
6B) and is likely due to differences between white and brown
adipocytes in the pathways controlling glucose uptake. Upon
insulin stimulation, glucose uptake increased in gonadal and
subcutaneous WAT cells by 30 and 20%, respectively, whereas
CL-316,243 treatment increased BAT adipocyte glucose up-
take (Fig. 6B), showing that -adrenergic stimulus is more
important than insulin for BAT glucose uptake. Furthermore,
Akt phosphorylation was increased by insulin stimulation in all
cell lines very potently in WAT and subcutaneous WAT,
indicating that insulin signaling was intact in the differentiated
adipocytes (Fig. 6B).
Adipocytes are an important source of inflammatory cytokines
(34), and our microarray analysis revealed that WAT depots
preferentially expressed gene pathways associated with inflam-
matory processes. Because previous investigations showed that
differentiated adipocytes from human primary cultures were
highly sensitive to LPS-stimulated secretion of IL-6 (11), we
investigated the inflammatory response of differentiated adi-
pocytes derived from distinct adipose tissues. Basal IL-6 se-
cretion was detected in all cell lines except for BAT, and
stimulation with LPS increased IL-6 production in a dose-
dependent manner in subcutaneous and gonadal WAT cells
(Fig. 6C). The lack of response of the mesenteric adipocytes
was somewhat surprising given the link between visceral
depots and inflammatory activity. Similar levels of TLR4
mRNA, the receptor for LPS, were detected in all cell lines
following differentiation and induced 
2,000-fold in all of the
cell lines in differentiated compared with preadipocytes (data
not shown).
This is the first time immortalized cell lines from four
different adipose depots (interscapular BAT and subcutaneous,
gonadal, and mesenteric WAT) have been generated and com-
pared. Results demonstrate that it is possible to maintain
depot-specific differences in expression and physiology in in
vitro systems.
Genes and Motifs Defining Browning of White Fat
To characterize the transcription profile of WAT subject to
browning in response to cold, we first prepared a list of genes
that were enriched in both BAT vs. subcutaneous WAT and
BAT vs. mesenteric WAT (comparisons at 28°C), which pro-
vides BAT genes. Next, we determined which genes from this
list were also increased in subcutaneous WAT by cold expo-
sure. The genes of this brite transcriptome are presented in
Table 3. This stringent analysis confirmed the association of
UCP1, PGC-1, Cidea, Plin5, PPAR, and Otop1 with the
Fig. 6. Functional characterization of immortalized cell lines from different
adipose tissue depots. A: [3H]palmitate oxidation in differentiated adipocytes
generated from interscapular BAT and sWAT, gWAT, and mWAT treated
with or without CL-316,243 (CL; 10 M) for 5 h. Results are expressed as a
mean of 3 experiments and radioactivity count numbers normalized to DNA
content. B: basal, insulin (100 nM), and CL (10 M, 5 h) stimulated glucose
uptake measured with the fluorescent glucose analog 2-[N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino]-2-deoxy-D-glucose. Results are expressed as a mean of
3 experiments and fluorescence normalized to protein content. p-Akt was
measured by Western blot with antibody against phosphorylated Ser473. A
representative blot is shown. GLUT1 and GLUT4 mRNA relative expression
levels are shown in differentiated cells. C: IL-6 production by differentiated
adipocytes after 24-h treatment with increasing amounts of LPS. Bars represent
means  SE, and significant differences are shown. *P  0.05; **P  0.01.
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browning of adipose tissue and also revealed additional genes
that were part of the brown/brite transcription “fingerprint,”
including GPR120, Nrg4, Rgs7, and Letm1. To investigate the
regulatory motifs associated with brite genes, we took the
1,000-bp upstream flanking region from the top 308 sequences.
After the removal of duplicates and rebuilding of mixed con-
tigs, a total of 471 sequences were submitted to MEME-LaB.
The 10 most significant motifs between six and 12 bp were
identified and their similarity to known eukaryotic transcription
factor-binding sites determined (Fig. 7). For motif 2, which
was present in 100% of promoter sequences, the transcription
factors Klf4, CAC-binding protein, Pu.1, and Sp1 were the
nearest fit from their position-specific scoring matrix (PSSM).
Other transcription factors that were identified as fitting the
motifs included C/EBP, p53, Pax6, Pax2, BCL-6, ATF-5,
Kid3 (Zfp354c), and the nuclear receptors SF1, LRH-1, and
HNF-4. Examination of the microarray data reveals that
C/EBP, BCL-6, SF1, Pax6, and ATF-5 are more highly
expressed in brown vs. white adipose tissues at thermoneutral-
ity. This highlights the potential of these factors through
binding to their respective motifs to affect brown adipocyte
gene expression.
Finally, the microarray data was analyzed to determine
which transcripts were temperature regulated but not specifi-
cally associated with higher levels in BAT. We generated a list
of genes that were more highly expressed at 6 vs. 28°C in
subcutaneous WAT but not more highly expressed in BAT vs.
mesenteric WAT or BAT vs. subcutaneous WAT (Table 4).
Remarkably, of this list of 53 cold-induced genes in subcuta-
neous WAT, 40 were also cold-induced in BAT. Genes that
were increased in both WAT and BAT in response to cold
include Cil6l, Acaa1b, Dbp, Drd1a, Gys2, Lipf, Pla2g2e, and
Sphk2. They are likely to be important for changes required
only in response to cold and may be required for elevation of
metabolic activity that will occur in both WAT and BAT in
cold conditions. Although these genes are not more highly
expressed in BAT vs. WAT at thermoneutrality, they may still
be important for the brite program.
Nrg4 is a Brown Adipocyte Adipokine That Promotes
Neurite Outgrowth
Nrg4 was one of the genes for the group that define the brite
transcription signature and was selected for further study. It
showed an expression pattern similar to the BAT marker gene
Cidea in that expression was greater in BAT vs. WAT and that
cold stimulated a large increase in WAT, whereas only a small
increase was detected in BAT. Along with Nrg1, -2, and -3, it
is a member of the epidermal growth factor family of proteins
that are involved in normal development and in the pathology
of many diseases. Analysis of a panel of mouse tissues re-
vealed that Nrg4 was highly expressed in adipose tissues, being
the highest in BAT, followed by gonadal and subcutaneous
WAT (Fig. 8A). Analysis of in vivo protein expression by
immunohistochemistry revealed the presence of NRG4 in BAT
and gonadal WAT (Fig. 8B). For in vitro studies, we deter-
mined expression of Nrg4 mRNA in our immortalized BAT
cell line. Expression progressively increased upon differentia-
tion treatment, being the highest after 8 days (Fig. 8C), con-
firming adipocyte-specific expression (Fig. 5C). Efficient dif-
ferentiation was confirmed by the induction of the adipose
marker aP2 (Fig. 8C). To test whether NRG4 was secreted into
the culture media and whether this had any effect in promoting
neurite outgrowth, conditioned medium of mature brown adi-
pocytes was used to treat PC12 cells stably expressing ErbB4
(25). NRG4 was detected by ELISA in conditioned medium
Table 3. List of genes that define the “browning” of
cold-activated white adipose tissue
Mitochondria Metabolism Signaling
Bckdha Acaa2 2310014F07Rik
Cabc1 Acads Adcy3
Chchdh10 Acadvl Adora1
Coq3 Acc Adrb3
Coq5 Acot11 Akap7
Coq9 Acot4 Angp13
Cox7a1 Acsf2 Angpt14
Cox8b Cacb Arl4a
Crat Coasy Gnao1
Cyc1 Cyp2b10 Gpr120
Decr1 Fbp2 Gpr135
Etfdh Fn3k Gpr146
Hsha Gyk Gpr4
Idh3a Ldhb Igsec2
Letm1 Pank1 Map2k5
Letmd1 Pck1 Mtor
Me3 Pdhb Pde8a
Plat Pdhx Prkaca
Rilp Pdk2 Prkar2b
Sirt3 Pdk4 Rgs7
Ucp1 Pfkb3 Adora1
Uqcr10 Sod2 Immune/Inflammatory
Uqcrfs1 Transcription C8 g
Transporters Esrra Ifnar2
AI317395 Esrrg Igsf21
Aqp7 Klf11 Il15ra
Cpt1 Nr1d1 Kng1
Cpt2 Nr1d2 Serpina12
Fabp3 Ppargc1a Lipid droplet
Fabp4 Ppargc1b Cidea
Slc27a2 Ppara Cideb
Slc1a5 Sox6 Plin5
Slc25a20 Tef Pnpla2
Slc25a33 Tfb2m Lipe
Slc25a34 Tfdp2 Cell cycle
Slc25a42 Zfp703 Ccno
Slc4a4 Cytoskeleton Cdkl3
Tmem37 Ka7na12 Inca1
Hormone/vitamin Fam82b Apoptosis
Cyp2b10 Tuba8 Nol3
Dio2 Nucleic acid Otopn
Retsat Asp Ion binding
Rdn16 Carhsp1 Adprhl1
Peroxisomes Gchfr S100b
Hacl1 Gna13 Smyd4
Pex3 Oplah Calr3
Pex19 Pn1dc1 Unknown
Poln 4122401k19Rik
Structural Satv2 8430408G22Rik
Krt79 Secretion/vesicles 9130214F15Rik
Chpt1 9530008L14Rik
Circadian rhythm Cpn2 Fam13a
Per3 Fam15a Fam195a
Protein degradation Otop1 Fam69b
Fbxo21 Pm20d1
Cell adhesion Growth factor
Tspan18 Nrg4
Genes listed were upregulated in subcutaneous WAT and more highly
expressed in both BAT versus subcutaneous WAT and BAT versus mesenteric
WAT.
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from differentiated brown adipocytes and was undetectable in
unconditioned medium and medium from preadipocytes (Fig.
8D). Conditioned medium induced neurite outgrowth (mea-
sured by staining with anti-Tuj1 antibody) after 24 h in a
dose-dependent manner (Fig. 8E). This effect was specific for
Nrg4, as neurite outgrowth was prevented in conditioned
medium from adipocytes in which it was knocked down by

75% by shRNA interference (Fig. 8F). Thus, we can con-
Fig. 7. Motif analysis of brite gene promoters. Motif logos are presented from the MEME-LaB-analyzed gene cluster for transcripts induced by cold in
subcutaneous WAT and more highly expressed in BAT vs. WAT depots. The MEME-LaB software determined 10 motifs, and these were analyzed for similarity
to know motifs from JASPAR, PLACE, and TRANSFAC using position-specific scoring matrix (PSSM). Eukaryotic transcription factor binding sites are
indicated for each relevant PSSM.
Table 4. Genes that are induced by cold in subcutaneous WAT and are not more highly expressed in BAT versus
subcutaneous WAT or BAT versus mesenteric WAT
Gene Name Gene Induced by Cold in BAT Gene Function
4921536K21Rik RIKEN cDNA 4921536K21 gene Yes
9030619P08Rik RIKEN cDNA 9030619P08 gene Yes
9430098F02Rik RIKEN cDNA 9430098F02 gene Yes
Abca6 ATP-binding cassette, sub-family A (ABC1), member 6
Abhd1 Abhydrolase domain containing 1 Yes
Acaa1b Acetyl-Coenzyme A acyltransferase 1B Yes
Acoxl Acyl-coenzyme A oxidase-like
Adrm1 Adhesion regulating molecule 1 Yes
Apoc2 Apolipoprotein C-II Yes Extracellular
Apoc4 Apolipoprotein C-IV Extracellular
Apold1 Apolipoprotein L domain-containing 1 Yes
Aqp11 Aquaporin 11 Yes Plasma membrane
Atrn Attractin Yes Plasma membrane,
C2cd2l C2 calcium-dependent domain containing 2-like Yes
Catsper3 Cation channel, sperm associated 3 Plasma membrane
Ccny Cyclin Y Yes
Chrna2 Cholinergic receptor, nicotinic, alpha polypeptide 2 Yes Plasma membrane
Cir1 Corepressor interacting with RBPJ, 1
Cldn22 Claudin 22 Plasma membrane
Cmbl Carboxymethylenebutenolidase-like (Pseudomonas)
Crtac1 Cartilage acidic protein 1 Extracellular
Cyp4a10 Cytochrome P450, family 4, subfamily a, polypeptide 10 Yes
Dbp D site albumin promoter binding protein Yes Transcription factor
Dcst1 DC-STAMP domain containing 1
Drd1a Dopamine receptor D1A Yes Signaling Molecule
Fabp12 Fatty acid-binding protein 12 Yes
Fndc8 Fibronectin type III domain containing 8 Yes
Gys2 Glycogen synthase 2 Yes
Katna1 Katanin p60 (ATPase-containing) subunit A1 Yes Cell Cycle
Klhl2 Kelch-like 2, Mayven (Drosophila)
Kras v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog Yes Signaling Apoptosis
Lipf Lipase, gastric Extracellular
Lsm1 LSM1 homolog, U6 small nuclear RNA associated Yes
Mfsd3 Major facilitator superfamily domain containing 3 Yes
Mpv17l Mpv17 transgene, kidney disease mutant-like Yes
Nploc4 Nuclear protein localization 4 homolog (S. cerevisiae) Yes
Nxnl1 Nucleoredoxin-like 1 Yes
Padi3 Peptidyl arginine deiminase, type III
Pex16 Peroxisomal biogenesis factor 16 Yes
Pla2 g2e Phospholipase A2, group IIE Yes Extracellular
Psmd4 Proteasome (prosome, macropain) 26S subunit, nonATPase Yes
Rcl1 RNA terminal phosphate cyclase-like 1
Reep6 Receptor accessory protein 6 Yes
Rnf146 ring finger protein 146 Yes
Rora RAR-related orphan receptor alpha Yes Transcription factor
Slc9a6 Solute carrier family 9 member 6 Yes
Sphk2 Sphingosine kinase 2 Yes Signaling molecule
Tbata Thymus, brain and testes associated
Tinag Tubulointerstitial nephritis antigen Yes
Tmem120a Transmembrane protein 120A Yes
Trfr2 Transferrin receptor 2 Yes Plasma membrane
Vmn2r1 Vomeronasal 2, receptor 2 Yes
Zwint ZW10 interactor Yes Cell cycle
Boldface indicates genes that are within the top 200 most significantly upregulated genes in 6°C versus 28°C subcutaneous WAT.
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clude that NRG4 produced by brown adipocytes in culture can
affect the neurite development in neural cells. This indicates
that NRG4 represents a novel brown adipose tissue adipokine
with important autocrine/paracrine functions in the develop-
ment of the innervation net in adipose tissues, with implica-
tions in the acquisition of BAT features in WAT depots.
DISCUSSION
In the present study, we aimed to identify factors, pathways,
and regulatory elements that are important for acquiring brown
fat features in WAT depots. We conducted global expression
analysis on discrete adipose tissue depots, with well-recog-
Fig. 8. Nrg4 is a BAT adipokine promoting neurite outgrowth. A: Nrg4 mRNA expression in mouse tissues (n  4). Data are expressed as a fold difference
compared with kidney. B: inmunohistochemistry of Nrg4 in murine BAT and gonadal WAT. C: Nrg4 and aP2 mRNA expression in immortalized BAT cells
throughout differentiation. Data are shown as fold induction compared with time 0. D: NRG4 levels in unconditioned medium (control), conditioned medium
from undifferentiated brown adipocytes (Undiff Cond), and 4-wk-differentiated brown adipocytes (Diff Cond) in 6-well plates, determined by ELISA. DNA
content was 28.65  1.38 and 26.04  1.96 g/well for differentiated and undifferentiated cells, respectively. E: neurite staining with anti-Tuj1 antibody of
PC12-HER4 cells incubated with different concentrations of conditioned medium from differentiated brown adipocytes. Neurite outgrowth measured in m and
expressed as fold induction over control cells. F: neurite staining by anti-Tuj1 antibody of PC12-HER4 treated with conditioned medium of differentiated brown
adipocytes stably expressing shNrg4 or a nontargeting shRNA. For all of the data, bars represent means  SE, and significant differences are shown. *P  0.05.
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nized differential physiology and involvement in metabolic
disease, in mice that had been exposed to cold for 10 days. This
stimulus drives the appearance of brown adipocytes or the
browning of determined WAT depots. Our results support
previous findings that the subcutaneous adipose depot is most
reactive to acquiring BAT characteristics, whereas visceral
depots are much less responsive (28). Female gonadal WAT
shows a certain degree of induced expression of UCP1, PGC-
1, Cidea, and other BAT-specific genes upon adrenergic
activation triggered by cold exposure. Mesenteric WAT seems
to be almost completely insensitive at the level of gene expres-
sion, although interestingly, adipocytes here become multiloc-
ular, albeit UCP1-ve, in response to cold (40). In contrast, BAT
shows the highest number of genes that are affected upon cold
exposure. We have also identified a set of genes and pathways
that are either induced or repressed by the tissue remodeling
that occurs after the long-term adrenergic activation induced by
cold exposure. VEGF signaling was identified as downregu-
lated by cold exposure, with Vegfc specifically reduced and
also more highly expressed in WAT compared with BAT. This
contrasts with Vegfa, which was found to be present at higher
levels in BAT. This agrees with previous reports that associate
Vegfa (64) with angiogenesis in BAT and Vegfc being nega-
tively regulated by adrenergic signaling (5) and indicates
distinct roles for Vegfc and Vegfa signaling in white and
brown adipocytes, respectively.
We have highlighted a set of genes, the expression of which
can be induced by these signaling events. These include
Bmp8b, a member of the TGF family that has recently been
found to be involved in brown adipose tissue activation (62);
Nrg4, a member of the neuregulin family involved in neurite
growth (23); GPR120, a GPCR that has been shown to mediate
the anti-inflammatory and insulin-sensitizing effects of -3
fatty acids, with its absence making mice prone to obesity (29);
Rgs7, a regulator of G protein signaling that can inhibit signal
transduction by increasing the GTPase activity of G protein-
subunits (4); Slc27a2, an isozyme of the long-chain fatty
acid-coenzyme A ligase family that has the capacity to convert
free long-chain fatty acids into fatty acyl-CoA esters and also
function as a fatty acid transporter (26); Letm1 a mitochondrial
protein involved in calcium transport (60); and Nnat, a member
of the proteolipid family of amphipathic polypeptides that
exhibits paternally inherited imprinted expression and is con-
sidered to play an important role in brain development (33) and
glucose-mediated insulin secretion (32). For some, this is the
first time that expression has been described in adipocytes.
More importantly, with our strategy, we have been able to
identify genes that have implications in metabolic pathophys-
iology in mouse and/or humans, including GPR120 (29), Rgs7
(2), and Nnat (58), that have been reported to be associated
with human obesity in linkage and single-nucleotide polymor-
phism analysis. Further studies will address the relevance of
these molecules for adipocyte/adipose tissue functionality.
We have compared the transcriptional differences in our
microarray with other available data sets. In the present study,
because intact females were used, some genes may be subject
to cyclical hormonal changes. Although there were a number
of technical differences between studies, including using the
C57BL/6 strain, the use of males, and maintenance at 23°C
[GEO accession no. GSE44059 (44)], the fact that the same
microarray platform was used and expression values were
available for exactly the same probes allowed us to perform a
direct comparison of the differentially expressed transcripts.
This was conducted in OrderedList, a package in R, for
meta-analysis of ordered gene lists like those acquired from
differential gene expression analysis (37). The P value for a
significant overlap between the two expression studies being
substantially different from random studies is 1016. Nrg4,
Slc27a2, Rgs7, and Nnat were differentially expressed in the
GSE44059 data sets for BAT vs. inguinal WAT and BAT vs.
epididymal WAT. The same genes were also differentially
regulated in an independent microarray of BAT vs. epididymal
WAT [GEO accession no. GSE8044 (48)]. Our experiments
were performed at thermoneutrality, which may reduce the
baseline expression of BAT genes in WAT, thereby allowing
the identification of additional cold-regulated genes such as
GPR120 and Bmp8b, which were not differentially expressed
in the other data sets.
In contrast to BAT-enriched genes, the data sets are remark-
ably divergent for genes that are more highly expressed in
WAT compared with BAT. Upk3b showed the greatest differ-
ence in expression between BAT and Mes WAT in our study
at 28°C and was found in GSE44059 (BAT vs. epididymal
WAT) and GSE8044 (BAT vs. subcutaneous WAT). Similarly,
Nnat was also found in these analyses. Other genes consis-
tently elevated in WAT compared with BAT across the differ-
ent data sets include Sncg, Ighv14-2, Ildr2, Samsn1, and
Synpo2.
With regard to other analyses of cold-dependent changes in
gene expression in inguinal WAT, the genes we have identified
are highly consistent with a comparison of a 5-wk exposure to
4 vs. 30°C male C57BL/6 mice [GEO accession GSE13432 no.
(64)]. Importantly, Nrg4, GPR120, Slc27a2, Rgs7, Letm1,
Bmp8b, and Cil6l (9030619P08Rik) were also cold induced in
this microarray. In contrast, there was little consistency in the
genes more highly expressed at 30 vs. 4°C in the independent
experiments. It is noteworthy that Nnat was one of the few
genes that was found in both microarrays (Acin1, Ccr2, Far1,
Pida3, Zfp36l, Tnfrsf21, and Ostc were also more highly
expressed at thermoneutrality in the 2 analyses).
The consistency across our microarray, GSE44059, GSE8044,
GSE13432, and other published studies confirms the expres-
sion profile of already identified BAT and brite genes impli-
cated in transcriptional regulation (Zic1, Lhx8, PGC-1, and
Prdm16), mitochondrial function (Cox7a1, UCP1), lipid me-
tabolism (Gyk, Fabp3, Plin5, Elovl3, Pank1, and Cidea), cy-
tokine signaling (Otop1), enzymatic activity (Dio2, Cpn2), and
coagulation regulation (Kng1).
It is transcriptional regulators that will be pivotal to expres-
sion of the brown fat phenotype. Our analysis of relevant
controls showed PGC-1 and PRDM16 were more highly
expressed in BAT compared with WAT depots, and the sub-
cutaneous WAT depot showed increased levels of both factors
in response to cold exposure. Therefore, these transcriptional
regulators or their interplay with coregulators such as RIP140,
which at 4°C was lower in BAT vs. WAT, may be central to
the changes in gene expression due to cold or the depot-specific
profiles. Further work is necessary to determine the role of
other factors such as Zic1 and Lhx8 in brown and brite gene
expression.
We sought to identify regulatory motifs that were specifi-
cally enriched in the promoters of the cluster of brite genes
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found from the microarray. Analysis using the MEME-LaB
software determined the association of Sp1-binding sites with
one of the motifs. This transcription factor may be relevant to
induction of BAT genes due its interaction with PPAR (1,
52). Other notable transcription factors that had putative bind-
ing sites enriched in the promoters of the brite cluster include
p53 and C/EBP, which are known regulators of BAT differ-
entiation (35, 38). HNF-4 has recently been reported to be
downregulated in WAT by cold, and therefore, it may serve to
repress BAT gene expression in this tissue (50). Other factors
with putative binding sites, such as BCL-6, SF1, Pax6, and
ATF-5, showed elevated expression in BAT compared with
WAT, and therefore, they represent novel potential regulators
of the brown or brite gene expression pattern.
It is well established that adipose tissues are composed of
lipid-filled mature adipocytes and other nonadipocyte cells,
which form the SVF. The SVF consists of various types of
cells, including immune cells, fibroblasts, pericytes, endothe-
lial cells, adipocyte progenitors, and stromal cells as well as
undefined pools of stem cells. Fractionation of the different
depots showed that all of the genes that were selected from the
microarray for validation or further study were enriched in
adipocytes compared with the SVF. To evaluate isolated adi-
pocytes from discrete depots, we generated cell lines from
precursors of four different adipose depots (BAT and subcu-
taneous, gonadal, and mesenteric WAT). Our immortalization
protocol, which involves the inactivation by temperature of the
SV40 T antigen prior to differentiation, prevents sequestration
of retinoblastoma protein, avoiding the risk of driving white
preadipocytes into “brown-like” adipocytes (45). The adi-
pocyte cell lines demonstrate clear characteristics that corre-
spond to their depot of origin, with the highest expression of
UCP1, Cidea, Rgs7, and Nrg4 detected in the differentiated
brown adipocytes. Cil6l was present at the highest levels in
differentiated subcutaneous white adipocytes, in agreement
with tissue expression pattern. The induction of UCP1 and
PGC-1, in response to a 3-stimulus, was greatest in the
adipocytes generated from BAT, followed by subcutaneous
WAT and gonadal WAT, with mesenteric WAT being unre-
sponsive. The cell lines we generated retain functional -ad-
renergic and insulin pathways, oxidative metabolism, and an
inflammatory response that very similar to what is found in the
different adipose tissue depots. Overall, we can conclude that
these cell lines are a reliable model for in vitro studies of
different adipose tissue depots and are a powerful tool for
future drug discovery studies.
We undertook further study of Nrg4, as it was both highly
enriched in BAT vs. WAT and upregulated in WAT following
cold exposure and seemed likely to be an important novel
signaling factor in adipose tissue that could have a key role in
adipocyte-neuronal cross-talk. We found NRG4 to be secreted
by brown adipocytes but not preadipocytes. Using PC12 pheo-
chromocytoma cells stably expressing the receptor for NRG4
and ERBB4, we have been able to show that NRG4 is a
BAT/brite adipokine. One of the key differences between
brown and white adipose tissue is the degree of sympathetic
innervation (54). Previous studies have indicated that nerve
growth factor is produced in BAT (41). Our data indicate that
NRG4 could be a key factor for the development of BAT and
acquisition of BAT features of WAT depots by promoting the
growth of neurites and thus enhancing innervation of the tissue
needed to activate the thermogenic functions. To fully evaluate
the role of Nrg4 in the regulation of adipose tissue innervation,
further studies will require the generation of mouse models
with depot-specific ablation of the gene.
The discovery that adult humans possess functional BAT has
opened the possibility for future treatments against obesity that
would boost BAT activity or promote the appearance of brown
adipocytes in nonclassical BAT locations where white fat
predominates by BAT-inducing drugs or other therapies, such
as tissue transplantation or gene therapy. The identification of
the key transcriptional events associated with browning of
WAT is important for the understanding of how gene expres-
sion governs this tissue remodeling.
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